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Abstract  
 
A detailed, fundamental understanding of the surface properties of molecular crystals and their 
interaction with adsorbing molecules (e.g. excipients) is important for tailoring the stability of 
formulations and the bioavailability of Active Pharmaceutical Ingredient (APIs). Few 
fundamental experimental studies with surface sensitive probes have been carried out for organic 
molecular crystals. X-ray photoelectron spectroscopy (XPS) is an established surface analysis 
method in the fields of adsorption, catalysis and surface chemistry of inorganic crystals. It has 
high surface sensitivity, probing approximately the top 1-3 nm of a crystal, and allows surface 
elemental analysis combined with the determination of the chemical state of the elements. To 
explore the possibilities and limitations of XPS for the surface characterisation of molecular 
crystal systems, investigation has been made on a range of paracetamol systems, three different 
poloxamers and blends of paracetamol with poloxamer 188. 
 
 It was found by investigations of a range of polycrystalline paracetamol forms that the C1s, 
N1s and O1s core level emissions from the amide group of paracetamol allow to quantify, for the 
first time, the influence of surface contamination and adsorbed species on the paracetamol XPS 
data. Results of quantitative XPS analyses must be critically evaluated taking the material and 
energy-specific escape depth of the photoelectron signals into account. Analysis of the 
polycrystalline powder samples, including two different polymorphs and various partially 
amorphous forms of paracetamol, indicated that the core-level shifts associated with varying 
intermolecular interactions do not perturb the local electronic structure variations in paracetamol 
enough to become detectable through chemical shifts in the core level photoemission spectra. 
 
 Subsequently, large, high quality single crystals of the monoclinic form I (with facet 
diameters between ~5 and ~10 mm) were obtained from different solvents (methanol, ethanol, 
acetone) to examine the influence of the crystallisation medium on the surface properties. Small 
spot XPS analysis was performed in several areas across facets to examine the possible influence 
of roughness and other lateral inhomogeneities. Careful curve-fitting of all results reveals only 
minor variations in the XPS data as a function of facet orientation, crystallisation medium or 
degree of crystallinity. Moreover, results indicate that any variations seen in XPS data very likely 
stem from low-level surface contamination, which is very difficult to avoid, even in a clean-room 
laboratory environment. In fact, the results indicate that the level of surface contamination 
depends significantly on the crystallisation apparatus cleanliness. Even minute concentrations of 
surface active components in the solutions, i.e. below the detection level of techniques for routine 
analytical methods, are likely to cause significant surface concentrations on crystal facets emersed 
from the solutions. The study thus highlights the paramount importance of microscopic surface 
cleanliness when assessing macroscopic facet-specific phenomena such as contact angles. 
 
 Finally, XPS was employed to analyse milled and physical mixtures of paracetamol with 
poloxamer 188 at different percent. At minimum mass percentages poloxamer 188 adsorbs on the 
paracetamol surfaces; in the presence of poloxamer 188 excess the conformation of adsorbed 
poloxamer on the paracetamol surface changes. 
 
 Studies of radiation damage on the poloxamer samples were performed both for several 
pure polxamers as well as for milled mixtures with paracetamol. They allowed the proposal of 
radiation-induced degradation mechanisms. 
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1. CHAPTER 1: INTRODUCTION 
1.1. Introduction 
Market research by many global pharmaceutical companies and other reports indicate a 
significant growth in the pharmaceutical market, which was anticipated to grow by four 
to six percent in 20101. Thus, there is a vital need for the enhancement of available 
commercial pharmaceutical products. 
The purpose of the surface analysis of the active pharmaceutical ingredients (APIs) 
of a compound is mainly to enhance or improve the drug. Ninety percent of small 
molecule drugs are delivered to the human body in crystalline form2. Crystallinity confers 
better physical and chemical stability, forming a robust processing platform and storage 
conditions, resulting in a stable product which can be delivered safely to the patient.  
However, 90% of crystalline drugs have low solubility in water. Therefore the well 
controlled crystallisation of APIs is a vital operation in pharmaceutical manufacturing. 
The uncertainty of the pharmaceutical forms which may appear during the scaling-up of 
crystallisation from the laboratory to the manufacturing plant makes all pharmaceutical 
processes complicated. Of all drugs formulated, only 10% survive testing for safety and 
clinical efficacy to be available for commercial purposes.2 Therefore, formulation must 
be optimized to ensure sufficient bioavailability and the efficacy of each drug in humans. 
It is vital to understand the root behaviour of drugs, such as their morphology, the 
orientation of their molecules at the main crystal facets and their mechanisms of reaction. 
Single crystals of drug compounds may yield much information in the search for 
fundamental knowledge. They can be prepared so that the different facets can be 
examined by some analytical techniques such as X-ray photoelectron spectroscopy (XPS) 
and X-ray diffraction (XRD). An individual crystal has a number of facets or surfaces, 
each of which can exhibit different physical and chemical properties. These properties of 
the facets are important, as they transmit to the bulk material properties such as 
wettability, flowability and tabletability3. Therefore, knowledge of the surface structure at 
the atomic level is the first step towards understanding the physical and chemical 
properties of the crystal facet. In practice, the preparation of single crystals using solvents 
as the medium of nucleus growth may result in the distortion of the molecular structure 
and the inclusion of solvent in the crystal lattice, impairing the properties of the API 
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itself, which has led researchers to enhance the bioavailability, stability and other 
properties of APIs by introducing excipients into drug formulations. Excipients are by 
definition inert compounds, but ageing may result in their interaction with APIs by means 
of several possible mechanisms, including adsorption, complexation, chemical 
interaction, pH effects and eutectic formulation, resulting in drug products with desired or 
undesired properties. Therefore, it is important to explore and understand the mechanisms 
of the surface behaviour of drug molecules and their interactions when mixed with 
excipients.  
1.2. Objectives 
The objectives of the study are as below: 
i) To prepare, characterise and analyse surface composition of different forms of 
paracetamol (untreated powder, treated powder and single crystal) by using X-
ray Photoelectron Spectroscopy (XPS) advanced surface technique; 
complement with other techniques such as Differential Scanning Calorimetry 
(DSC), Attenuated Total Reflection- IR (ATR-IR) and X-ray Diffraction 
(XRD).   
ii) To characterise surface composition three different types of Poloxamers; 
Poloxamer 188 (P188), Poloxamer 338 (P338) and Poloxamer 407 (P407) by 
using XPS.  
iii) To determine the best ratio of paracetamol and poloxamer188 mixture 
composition for coating purposes using XPS surface technique. 
1.3. Pharmaceutical Surfaces 
The terms ‘surface’ and ‘interface’ are to some extent interchangeable, depending 
on the phases involved. The surface represents a discontinuation from the bulk, as in 
crystalline solids, where the surface involves termination of the crystal structure. 
Chemical sciences considered surface to include the first few atomic layers, and it is this 
small magnitude that causing problems with assessing and characterising the surface. 
Where two visible phases are concerned, it is normal to refer to a solid-liquid or solid-
solid interface, while a solid-gas interface is commonly known as a surface. Figure 1-1 
summarizes the classifications of interfaces.  
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Figure 1-1: Classification of interfaces by phases 
It is important to justify the focus of this study on the surface interactions of 
paracetamol, rather than its bulk properties. The surface properties of a pharmaceutical 
are not necessarily important at a biochemical level, as the substance will most likely be 
in solution when it has its clearest physiological and pharmacokinetic effects, especially 
the initial interaction of the product with the body. From the manufacturing perspective, 
however, the surface properties of pharmaceuticals impact upon the physical properties of 
formulations, such as their stability.  
 
 
Figure 1-2 : Depth analysis of typical spectroscopic and physical methods used for 
surface characterisation 
 
Many common techniques have been applied in surface analysis, ranging from 
simple to complicated instrument setup and methodology (Figure 1-2)4. For instance, 
attenuated total reflection infrared (ATR-IR) spectroscopy is a simple analytical 
technique which penetrates up to 2 m below the surface, can be used to study surface 
Interface
Liquid-Liquid (L-L) Solid-Gas (S/G) Solid-Liquid (S/L)
Liquid-vapour (L/V)
ATR-IR spectroscopy
(2 m) Fluorescence spectroscopy,  
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functional groups and is typically employed in the qualitative analysis of hydrogen 
bonding. However, such surface analysis is limited to a small region compared to the 
bulk material. The topmost atomic layer of a typical metal solid surface contains around 
1015 atoms per cm2 – a number both too large and too small. On the other hand, the 
number is smaller, for example, than the typical number of atoms (1023 atom per cm3) 
involved in bulk chemical reactions in solutions, which means that surfaces present a 
challenge for even the most sensitive traditional analytical techniques. This makes 
changes in surface properties far too small to detect using conventional bulk sensitive 
techniques such as nuclear magnetic resonance (NMR). In order to detect impurities at 
the 1% level, techniques used in surface analysis must be sensitive to the presence of 1013 
atoms. Therefore, specialized techniques are needed to study surface regions. Solid 
surfaces are exposed to airborne contamination in the form of particles, gases or 
hydrocarbons. Therefore, surface analysis with an ultra-high vacuum (UHV) system must 
be used to prepare the sample and to overcome any surface contamination by ensuring a 
clean and inert environment. Figure 1-3 illustrates some surface-sensitive techniques, 
showing the incident and outgoing radiation beams4. 
 
Figure 1-3: Schematic of some surface characterization techniques using different 
types of radiation for incident and outgoing beams 
 
The surface analysis of pharmaceuticals serves a number of purposes. First, it 
plays a critical role in verifying composition and detecting contaminants that could 
interfere with the performance of the product. The composition of the outermost atomic 
layer of pharmaceuticals critically affects or determines properties such as chemical 
XPS
HREELS/SEM
SIMS
SIMS
XPS/HREELS/SEM
SEM
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activity, adhesion, wettability, electrostatic behaviour, bio-compatibility and many other 
aspects of processing enhancement.  
 
Figure 1-4: Paracetamol unit cell 
 
In addition, contaminants, process residues, diffusion products and impurities are 
typically present at the surface of solid samples or at the interface of thin film structures; 
qualitative and quantitative studies of these are vital for the improvement of 
pharmaceutical products and processes. A typical metal solid surface, as noted above, has 
1015 atoms per cm2, which means that even slight contamination on the metal surface can 
influence the surface analysis. Because of the relative complexity of organic material 
surfaces, with exact positions of atoms usually unknown, the number of surface 
molecules per unit area can often only be estimated. In the case of paracteamol, the unit 
cell (CSD: HXACAN) contains a single molecule, with 4 molecules crossing the four 
unit cell faces (Figure 1-4). An estimate of the surface density of molecules can be 
carried out as follows. 
The mass density of paracetamol is  = 1.263 g cm–3. The molar mass, M, is 
151.17 g mol–1. The concentration of molecules in the crystal is therefore  / M = 8.35 × 
10–3 mol cm–3, and the number density is 5.031×1021 molecules cm–3. Penetrating into the 
crystal normal to the (001) surface we encounter one (001) plane every interplanar 
spacing of 11.66 Å. For a cube with a volume of 1 cm3 the top molecular layer on the 
(001) surface has a volume of 11.66×10–10 × 10–2 × 10–2 m3 = 11.66 × 10–7 cm3. A cm2 of 
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the (001) surface of a paracetamol crystal therefore exposes approximately 5.031×1021 × 
11.66×10–7 molecules = 5.866×1014 molecules. 
1.4. Paracetamol as an Active Pharmaceutical Ingredient (API) 
Paracetamol, which was first prepared by Morse in 18785 and is also known as 
acetaminophen or N-acetyl-aminophenol, has been used as a drug since 1956 for its 
antipyretic and analgesic properties. The names paracetamol originate from its chemical 
name, para-acetylaminophenol. It can be prescribed as a single medication or combined 
with other pharmaceuticals and has been used for fever, headache and mild to medium 
pain6. Paracetamol was synthesised by Harmon Northrop Morse via the reduction of p-
nitrophenol with tin in glacial acetic acid. The invention was sparked by the research on 
aspirin, obtained from the bark of the cinchona tree in the middle of the 19th century. 
When cinchona bark became scarce in 1880, the production of aspirin as an antipyretic 
was depleted and two alternative antipyretics, acetanilide and phenacetin, were invented 
in 1886 and 1887 respectively. The discovery of paracetamol was made accidently in the 
1880s, when acetanilide was added to a patient’s prescription, but it was largely ignored 
until 1946. Since acetanilide was found to be toxic at moderate usage levels, a less 
harmful alternative analgesic had to be found. Following a grant from the Institute for the 
Study of Analgesic and Sedative Drugs, New York City’s Department of Health 
successfully reproduced paracetamol and sold it to McNeil Laboratories as a pain and 
fever reliever for children with the brand name Tylenol Children’s Elixir7. Paracetamol is 
commonly administered in tablet form but exists in many forms, including liquids, 
capsules and suppositories. It has been accredited as an over-the-counter (OTC) drug 
since 19636 as it is safe and efficacious in therapeutic doses. Paracetamol is not 
categorised as a nonsteroidal anti-inflammatory drug (NSAID), like aspirin and 
ibuprofen, because it does not inhibit cyclooxygenases in the presence of peroxide and 
does not participate in the inflammatory response8. In addition to its antipyretic and 
analgesic uses, paracetamol is also used as an intermediate in the manufacture of azo dyes 
and photographic chemicals9. The maximum dose of paracetamol is 4 g/day10 and 90 mg 
daily for children. The misuse of paracetamol will lead to hepatoxicity, which in severe 
cases will lead to acute liver failure8.   
Paracetamol is a derivative of aniline compounds11. The OH at the para position 
distinguishes the molecules from other acetanilide derivatives. Paracetamol is a weak 
Chapter 1  Introduction 
28 
 
acid, pKa = 9.70.5 Figure 1-5 shows the chemical structures of paracetamol, acetanilide 
and phenacetin.  
 
 
Figure 1-5: Structure of (a) paracetamol (b) acetanilide (c) phenacetin 
 
Paracetamol can be synthesised in many ways: its industrial production can be by the 
classical route or the Hoechst-Celanese process, as illustrated in Figure 1-6 below12. 
a) Classical route of paracetamol synthesis12 
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b) Hoechst-Celanese process 
 
Figure 1-6: Synthesis of Paracetamol  
 
Paracetamol polymorphs have been known for decades. The common commercial 
polymorph is form I, with a monoclinic crystal structure, which was first reported in 1976 
by Haisa, who obtained it from aqueous solution, while the orthorhombic form II was 
obtained two years earlier, also by Haisa, by slow evaporation of an ethanol solution.13, 14-
16 Recently, an unstable crystal structure, form III, has been observed during fusion 
experiments and is reported to be so unstable that no crystals have been isolated to enable 
its structure or physicochemical properties to be determined2, 17. Form I, a monoclinic 
form, is commercially available and stable at ambient temperature and pressure18. 
Nevertheless, this polymorph is characterised by poor technological and 
biopharmaceutical properties, which include flowability, compactibility, wettability and 
dissolution rate. The lack of slip planes in the monoclinic form of paracetamol requires 
the addition of plasticisers or excipients as supporting materials for compaction of the 
drug. The existence of slip planes is a prerequisite for plastic deformation upon 
compaction19. Secondly, form II, which is orthorhombic, undergoes plastic deformation 
and is suitable for direct compression18. In addition to forms I and II, paracetamol can 
exist as a monohydrate crystal structure, but this is unstable with respect to loss of water 
and will dehydrate within five minutes on exposure to air, becoming the monoclinic 
form20. Paracetamol form III has a crystal structure which has not yet been determined, 
due to its high physical instability18. Solvates and hydrates of paracetamol are also 
reported in the literature21. Table 1-1 summarises the physicochemical properties of the 
three polymorphs. 
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Table 1-1: Physicochemical properties of the three paracetamol polymorphs 
Polymorph Melting 
Point (°C) 
Crystal 
Structure 
Method of 
Preparation 
Solubility in water 
(mg mL-1 at 20 °C) 
I 
II 
III 
168-172 
157-159 
120-130 
Monoclinic 
Orthorhombic 
n.a. 
Recrystallisation 
Recrystallisation / 
from the melt 
From the melt 
13.12 
13.28 
n.a. 
 
1.5. Excipients 
Excipients are inactive pharmaceutical ingredients22 added to the formulation of 
drugs to aid their manufacture, administration or absorption23, 24. Other concerns are for 
product differentiation, appearance enhancement, retention of quality and bioavailability 
in the body. All such excipients must be biocompatible, nontoxic and non-carcinogenic; 
they should not induce immunological or allergic responses and should not accumulate in 
the tissues or organs.25 In the USA, the Food and Drug Administration (FDA) is the body 
which maintains a list of safe and established excipients and information on these26. The 
chosen excipients must have combined hydrophilic and hydrophobic properties. They 
should be system-specific, hydrosoluble and biocompatible, so that they can be cleared 
from the body by dissolution in physiological fluids25. The second requirement of any 
excipient is the support of the pharmacological agent. This component can be linked 
directly to the drug through the spacer group to increase the flexibility and mobility of the 
side residue, to minimize the steric hindrance of the neighbouring groups and therefore to 
facilitate the pharmacological action and the enzymatic cleavage of the active side 
residue.25 After the cleavage of the side drug residue, the functional groups of the drugs 
such as amides or esters, promoted by enzymes such as esterase or lipases, are 
transformed into corresponding sodium salts which are readily soluble in the 
physiological fluids and cleared from the body through the normal urinary pathway25.  
However, excipients may have functional groups or contain impurities or 
residues, or they may undergo degradation which in turn leads to the decomposition of 
the drug formulation6, 27. These phenomena can initiate, propagate or prolong the 
participation of an excipient in chemical or physical interactions with the API. Three 
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phases of drug decomposition have been identified as the lag, acceleration and 
deceleration phases, as presented in Figure 1-726.  
 
 
 
 
 
 
 
Figure 1-7 : Typical solid state decomposition curve 
Understanding the molecular mechanisms of APIs and excipients is essential to 
comprehend the physical or chemical interaction between them. Physical mixtures must 
be studied to provide a comparison or benchmark for further investigation of the API and 
the excipients. In recent years, research has found that excipients can be adsorbed directly 
onto drug particles to produce powders with optimised physicochemical properties28. The 
interactions of drugs and excipients can be studied using solid dispersion techniques such 
as co-evaporation or co-precipitation, physical mixture or milling of the mixture29, 30.  
Milling is the classical micronization technique, but gives rise to disorder and defects on 
the crystal surface, which may influence the processing properties and the performance of 
a formulation28. The type of tumbling mill most commonly used in pharmacy is the ball 
mill. Several parameters are involved in the ball mill method, such as rotation speed, mill 
size, wet or dry milling and amount of material to be milled. Prolonged milling time may 
be detrimental to compound crystallinity and stability26. The improvement of drug and 
excipients processing has been reported by precipitation of drugs in the presence of 
excipients28. In this technique, drug particles are grown by association of molecules 
rather than breakage of crystal structure28.  
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Changes in the morphology, habits and growth of specific faces during the 
crystallisation of drugs and excipients may be anticipated from the original drug crystal 
properties28. This phenomenon arises from the adsorption of excipient or drug onto one of 
the compounds. A study by atomic force microscopy (AFM) revealed that surfactants do 
not always form a homogenous layer at the interface31.  
Poloxamer 188, has been chosen excipient for its unique hydrophilic and 
hydrophobic properties. Poloxamers are block copolymers consisting of poly(ethylene 
oxide) (EO) and poly(propylene oxide) (PO). They form a class of amphiphilic surface 
active agents in aqueous solution but are also shown to form structures in the absence of 
solvents.32 However, they have been found to have a greater ability to self-assemble in 
solution than in the absence of solvent32. Poloxamers are always used in the formulation 
of suppository drugs because of their gelling properties in the presence of body fluids.  
1.6. X-ray Photoelectron Spectroscopy  
A surface-sensitive technique is needed for the surface characterisation of single 
crystals. The analysis of solid surfaces by one of the soft X-ray techniques, XPS, is based 
on irradiation by an X-ray beam under UHV and the consequent emission of electrons, 
whose kinetic energy is then analysed. It is a surface-sensitive technique which is applied 
only at a solid-air interface. The resulting spectrum is plotted as a function of the binding 
energy, EB, or kinetic energy, EK of the photoemitted electron. Two basic analyses are 
normally performed: a wide survey analysis and a high resolution analysis on each 
selected element. The peaks in the spectra arise from electrons bound in atomic core 
levels (1s, 2s, 2p, etc). The EB is influenced by the chemical environment of the element 
and thus provides information on the functional chemical groups in which it is 
incorporated. Through inelastic scattering of electrons in the solid the emission peaks are 
specific to outermost molecular or atomic layers, with electron emission arising from 
approximately 2 to 5 nm from the surface. The position and shape of the peaks give 
information on the bonds and thus on the chemical functions in which the elements is 
involved33, 34.  
1.7. Motivation: API/Excipient Interactions 
Most pharmaceutical products are based on active ingredients which have organic 
properties such as insulation and which also tend to have high vapour pressure values. 
These characteristics make XPS a poor choice for studying pharmaceuticals. The only 
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study of paracetamol single crystal faces was by Heng,35 who used a high vacuum XPS 
instrument (Kratos AXIS HSi), equipped with a charge neutraliser, with Mg K as the X-
ray source. The analysis revealed that facet (001) was the most nitrogen-deficient face 
and correspondingly carbon-enriched. The (001) facet was also found to be the most 
polar, with water molecules detected at the surface, as indicated by an O 1s deconvoluted 
peak at 534.6 eV. The surface polarity of paracetamol facets was determined by XPS to 
decrease in the order (001) > (011) > (110) > (010) 35 . 
The XPS technique is widely and efficiently used to determine a range of chemical 
compositions, the concentration of hydrocarbon contaminants, the atomic concentration 
present in samples, adsorbed layers on substrates, oxidation states and the reactivity of 
microorganisms to inorganic and organic compounds33. It has been used in the analysis of 
food, wood species surface and ageing analysis.36 The ratios of elemental concentration 
or intensity (e.g. C/O or O/C) can be used as indicators of oxidation processes undergone 
by compounds or to characterise the surface of samples.36 The shift of binding energy of 
each deconvoluted peak from the standard or reference value indicates the occurrence of 
oxidation, protonation or deprotonation in the core electrons of carbon, C 1s, oxygen, O 
1s, or nitrogen, N 1s34.  
For example, XPS has been used in the determination of the heterogeneity of D-
mannitol single crystal faces, by detecting the hydroxyl concentration on each of the 
chosen faces 37. In another study, a poorly water-soluble drug, siramesine hydrochloride, 
was precipitated by the antisolvent method in various polymeric and surface active 
excipients. By using AlK X-ray sources at the elemental analysis depth of 100 Å, XPS 
was used to quantify the amount of excipient adsorbed to the surface of the drug 
particles28. The adsorbed excipients were detected by the increased O coverage compared 
with other elements such as N, F and Cl. Poloxamer 188 was one of the excipients used 
and was shown to be adsorbed inhomogeneously on the surface in thin layers and 
multilayers.  
An XPS study of the adsorption of pyrrole, aniline, 3-pyrroline and pyrrolidine on 
the surface of silicon revealed that the bonding of pyrrole or aniline was through the 
cleavage of N-H bonds, leaving the benzene ring intact. The XPS study of pyrrole, aniline 
and their saturated analogues at a silicon surface has helped to establish some general 
trends for understanding the chemistry of organic amines at the (001) face of silicon 
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crystals38. The adsorption of a surfactant, sodium lauryl sulfate (SLS), onto drug crystals 
of Siramesine revealed that the SLS layer on the drug surface was 0.6 nm thick, with a 
patchy monolayer structure. It was assumed that monolayer coverage was about 30%.28  
Extensive studies of biomedical materials have thus shown that the wide-scale use 
of XPS on pharmaceutical materials is feasible, and the popularity of recent reviews in 
pharmaceutical surface science show that such applied systems are of increasing interest 
to surface science workers. With advances in instrumentation it now appears that XPS 
could become a routinely used technique for fundamental study and formulation 
development. The present study uses XPS with the aid of surface structure techniques 
such as functional group spectroscopy (ATR-IR) and thermal analysis by differential 
scanning calorimetry (DSC) for the abovementioned purposes. In addition, the 
crystallinity and Miller Index of samples will be analysed by Powder X-ray Diffraction 
(PXRD) or Single crystal X-ray Diffraction.  The fundamental analysis of a single crystal 
is compared with that of paracetamol powder. Milled and treated pure powder in an 
amorphous state are characterised in order to analyse the changes to paracetamol 
polymorphism using the XPS technique. The aromatic ring structure is revealed in XPS 
spectra as a shakeup satellite and the loss of aromaticity is anticipated to cause the loss of 
the shakeup peak. Previous studies have found that the adsorption of aromatic compounds 
by a silicon surface was accompanied by a loss of aromaticity38. 
1.8. Structure of the Thesis 
This thesis is organised as follows. 
Chapter 1, the present chapter, has discussed the motivation and background of the 
research, then presented a literature review of the techniques used in the studies, with a 
section on the main technique used, which is X-ray photoelectron spectroscopy. 
Chapter 2 summarises the properties of paracetamol and the chosen excipients. It covers 
the theory and instrumental background of all the techniques used in the study. In 
addition, the interaction strength of three common drugs named as paracetamol, 
ibuprofen and aspirin with some choosen excipients have been calculated.  
Chapter 3 discusses paracetamol crystallisation. It reports the study of single crystal 
preparations including a brief account of the techniques of crystallisation. The 
background study of crystallisation is also included. 
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Chapter 4 is about degradation of poloxamers. In addition, it draws attention to the 
importance of poloxamer degradation in the deep study of paracetamol-poloxamer 
interactions, concluding that the existence of a carbonyl peak in XPS analysis is an 
indication of degradation. 
Chapter 5 is concerned with the analysis of paracetamol powder by XPS, supported by 
the XRD and ATR-IR techniques. The powdered paracetamol was treated by several 
mechanical techniques such as milling and grinding, by melting under an inert flow of 
nitrogen gas in a DSC chamber and by melting and abrupt cooling in liquid nitrogen. 
Chapter 6 reports the quantitative analysis by XPS of single paracetamol crystals grown 
in three different solvents. The quantification of the crystals facets by XPS is explained. 
Chapter 7 reports the interaction of physical mixtures of paracetamol and poloxamer 
188, following the same structure as set out above for chapter 6. 
Chapter 8 draws conclusions from the studies and offers suggestions for the 
enhancement of the existing research. 
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2. CHAPTER 2: MATERIALS, METHOD AND TECHNIQUES 
2.1. Introduction 
In order to understand the molecular mechanisms by which pharmaceutical compounds 
interact in multiphase and multicomponent mixtures, the single crystal form of the drug 
must be prepared, as the known crystallography gives a deeper understanding of the 
drug’s molecular interactions than the powdered form, which will not replicate the real 
conditions of the molecules’ behaviour. 
Some compounds can be arranged in more than one crystal structure arrangement, 
a phenomenon called crystal polymorphism, which can result from differences in crystal 
packing, conformers and properties. The conformers will crystallise in ways which are 
favourable to the minimising of the surface free energy, while the surface energy is 
influenced by intermolecular forces such as van de Waals, dipole-dipole and hydrogen 
bonding forces, which differ in strength according to crystal orientation. At different 
conformations and different angles of molecular rotation, the flexibility and stability of 
the molecules are affected1.  
The crystallisation process is best understood as proceeding by stages. It starts 
with the aggregation of asymmetric molecules forming a small network known as a unit 
cell at the pre-nucleation stage. These nuclei will then aggregate and grow into larger 
networks to form mature crystals1. The unit cells are arranged like a line of networks in 
three dimensions. The intersection of the lines, known as the lattice point (lattice site), 
has the same environment in the same direction. The summation of the intermolecular 
interactions and those between central molecules and the surrounding molecules yields 
the lattice energy, Elatt2. The distortion of crystal arrangement forms Bravais lattices of 
the crystal14. Bravais lattices can be illustrated as crystal unit cells. The growth of crystals 
is the result attachment of solute molecules at the crystal facets. 
Crystallisation is the process of formation of solid crystals from a homogenous 
solution3. The crystallisation process involves two basic steps, which are nucleation and 
crystal growth. Nucleation is the process where a solute disperses in the solvent and 
creates nuclei, clusters or embryos. Before crystals can develop, a number of solid bodies 
in the form of seeds, embryos or nuclei must exist in the solution as the centres of 
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crystallisation. The nucleation process can be induced spontaneously or artificially4. 
Nucleation can be divided into primary and secondary types, and further classified as 
homogeneous or heterogeneous. Homogeneous nucleation occurs without the influence 
of foreign particles, while heterogeneous nucleation involves foreign particles5. 
Secondary nucleation is that induced by other crystals existing in the solution. Nuclei can 
be stabilised by controlling the operating conditions such as the supersaturation 
temperature. Environmental conditions such as vibration and humidity, solution solubility 
and mass will create good nuclei. Any unstable clusters will be redissolved in the solvent, 
while stability is reached when the cluster exceeds a specific size, forming a critical 
nucleus5. Critical nuclei are thus those formed by clusters of the minimum size required 
to become crystals5. Physically, the phenomenon occurs when the solution becomes 
supersaturated, which depends on solubility. In the so-called labile zone of 
supersaturation, spontaneous nucleation will be feasible, while the metastable zone is 
where spontaneous crystallization is improbable but possible with the help of a seed 
(Figure 2-1).  Finally, in undersaturated solutions, any crystal will be redissolved and 
nucleation will be impossible5.  
 
Figure 2-1: Nucleation Zones of Crystallisation  
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Figure 2-2: Examples of plane direction according to the Miller Indices System 
In order to relate a surface to the crystal structure, the system of Miller indices 
was introduced (Figure 2-2). This is a notation used to describe lattice planes and 
directions in a crystal. It defines the orientation of the surface in relation to the 
crystallographic unit cell. The direction of the crystal plane is represented by three 
integers, obtained from the intersections of the face with the three crystallographic axes: 
x, y and z. In the Bravais-Miller indices system a crystal plane direction will be written as 
(hkl), as shown in Figure 2-25.  
 
 
Figure 2-3: Macromorphology of paracetamol crystals grown at (a) low, (b) medium 
and (c) high supersaturation all images shows habits and the forms of the 
paracetamol crystals 
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Figure 2-3 shows the differing morphology of paracetamol single crystals grown 
in solutions at different levels of saturation. The macromorphology of a crystal will 
depend on the relative growth rates of the different crystallographic faces6. The crystal 
will exhibit differences in growth at its various facets, under the influence of external 
parameters such as supersaturated conditions and impurities, and of internal parameters 
such as crystal structure, bonds and crystal defects6, 7. Crystal facets appear because some 
crystal surfaces grow more slowly than others. Over time, these unit cells are 
interconnected to form a structure or pattern. The general rule for the mechanism of face 
formation is that the slower a face grows, the larger its relative size on the crystal6. The 
formation of a face depends mainly on the nature of the molecular incorporation and 
binding at different crystal faces, the density of active growth sites, layer by layer of the 
crystal growth, and the environmental conditions6 (Figure 2-4) . The anisotropic 
properties of organic compounds result in a crystal with distinct facets of differing 
surface areas and orientations. Each crystal facet forms an angle with another facet. Faces 
with high molecular densities are more energetically stable and grow more slowly than 
ones with low molecular densities. Only strong chemical bonds can build a crystal 
structure. The effective time during which strong bonds build the crystal structure is 
known as the periodic bond chain vector. The large amount of energy which is released 
when strong bonds form is known as the attachment energy8, defined as the energy 
released when a mole of molecules attaches onto a given crystal face6, 9. A high 
attachment energy indicates a rapid growth of the face, because the growth rate of a 
surface is proportional to its attachment energy6. Such a rapidly growing face tends to be 
offset by slower growing faces9. Thus, the largest crystal facet, which has the most 
important morphology, is grown with the lowest attachment energy2. On this basis the 
morphologies of compound faces can be anticipated. 
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Figure 2-4: Illustration diagram of the seed growth by deposition of material on 
seed surface. 
 
The three principal theories concerning crystal facet mechanisms which allow the 
morphology prediction of crystal indexes began with the study of crystal lattice geometry 
by Bravais (1866), whose ideas were modified by Friedel (1907) and finally by Donnay 
and Harker (1937). The resulting BFDH model states that the most energetically stable 
and slowest growing faces are the ones with the highest density of material and the 
largest spacing between the adjacent layers of molecules. The concept was expanded for 
better understanding by Wells (1946). The same concept as that of the BFDH model, but 
with a different approach, was developed from the intermolecular interaction approach of 
Hartman and Perdok, based on attachment energy, Eatt, and energy calculations6, 10.  
Crystal faces may be divided into three classes: flat or F-faces, stepped or S-faces 
and kinked or K-faces. F-faces are the most important, followed by S- and K-faces. K-
faces occur rarely or not at all, due to their fast growth and high attachment energy, while 
F-faces comprise the largest group in crystal morphology11. 
Paracetamol crystal morphology is known to depend strongly on the supersaturation 
of the solution. Crystal facet analysis has revealed a dead zone for faces12 and beyond this 
a relatively rapid increase in crystal growth rate13. Studies have also revealed that the 
fastest paracetamol crystal facet growth was at (100) and that the facet disappeared 
quickly from the crystal habit6, 13. Moreover, analysis of the crystal surface by 
interference contrast micrography concluded that the ((201), (011), (100) and (001) faces 
all grew with a spiral growth mechanism in the presence of screw and mixed dislocation 
crystal sources6, 13, 14,whereas for the (110) faces, relatively few well separated 
dislocation sources were observed13.  
In the theoretical study of crystal faces, the energy of interaction between the growth 
units is calculated using molecular mechanics. A computerised calculation known as the 
Deposition of material on seed 
facet layer by layer 
Seed crystal 
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force field technique takes account of energy values and the charges on molecules. 
Different force field models may use different expressions and numerical constants to 
calculate the energy term. The most common force field model is the Dreiding model, 
which is based on experimentally observed geometries and has been shown to work well 
on most organic crystals taken from the Cambridge Structural Database (CSD). 
Compound charges used in the Dreiding model are derived from the molecular 
electrostatic potential (ESP). Alternatively, the Compass force field model has its own 
charge set, based on ab initio calculations, while the DMA force field model treats crystal 
molecules as rigid bodies, as it contains no intramolecular calculations13. The 
abovementioned models were used as attachment energy models for the calculation of 
flat faces. The flat faces were determined by crystallography and analysed by connected 
net analysis. They were confirmed by the existence of connected nets on the crystal 
graph13.  
2.2. Paracetamol 
Paracetamol is a very common API, known as acetaminophen in the United States, 
Canada, Hong Kong, Iran, Colombia and other Latin American countries. It is also 
known as p-hydroxyacetanilide and was launched as a drug in 195615. Its solid forms 
include tablets, suppositories and capsules, while liquid paracetamol is commercially 
available as suspensions and solutions16. It is widely available as an Over the Counter 
(OTC) drug.  
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Figure 2-5: Paracetamol structure (C: Carbon, H: Hydrogen, O: Oxygen, N:  
Nitrogen). (Source: Mercury Software) 
The molecular structure of paracetamol (Figure 2-5) comprises two main active 
groups, hydroxide (OH) and amide (N-C=O), attached to an aromatic ring. The study of 
single paracetamol crystals has proved that the symmetry and the arrangement of the ions 
are manifested by the anisotropy of the crystal structure. The paracetamol molecules 
possess several potential centres at which the reaction can be initiated. Four places in the 
structure have been identified: the benzene ring, OH, NH and CO (C=O). These are the 
basic fragments for the formation of hydrogen bonds, providing the structure of the 
paracetamol lattice17. The surface structure of paracetamol carries high negative charges 
which remain undetermined and unexplained. The lone pair electrons of nitrogen and 
oxygen atoms are good electron donors, giving paracetamol useful chemical and 
electrical properties. This structure can be characterised using highly surface sensitive 
methods to determine the surface composition, binding energy and elemental analysis.  
A characteristic of paracetamol crystals is that they undergo severe cracking and 
fracture because of the highly brittle nature of the material. This fracture behaviour of 
paracetamol can be explained on the basis of the molecular packing and attachment 
energies in the crystal structure18. The study of crystals relies on five concepts: atomic 
position, symmetry, asymmetric unit, unit cell and space group 9. The crystal structure of 
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paracetamol has been studied by many researchers19, 20. Given the physical differences in 
crystal structure between paracetamol forms I and II, they can be differentiated in terms 
of their crystal packing architectures: form I has a zigzag crystal pattern, while form II 
has a more planar arrangement, as shown in Figures 2-6 and 2-716 . 
 
Figure 2-6: Crystal packing architecture of form I paracetamol. 
(black: C, red: O, yellow: H, blue; N, light blue; hydrogen bond) 
 
 
Figure 2-7: Crystal packing architecture of form II paracetamol 
(black: C, red: O, yellow: H, blue: N, light blue: hydrogen bond) 
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The crystal structure of paracetamol is determined by hydrogen bonding,15 which 
plays a significant role in paracetamol morphology21. Potential electron donors in the 
structure are detected as lone pairs of electrons of oxygen and nitrogen in the aromatic 
ring22. Each crystalline paracetamol molecule is linked to four neighbouring ones via O-
H...O and N-H...O hydrogen bonds. It has been proven by the application of density 
functional theory (DFT) that O=CNH makes a vital contribution to the crystalline 
paracetamol hydrogen bonding interactions21.  
Many techniques of paracetamol crystallization, including slow evaporation, 
solvent diffusion and slow crystallization, have been reported in various studies including 
investigations of macromorphology, micromorphology, computational and theoretical 
morphology, identifying oxyanions and dioxane within the molecules and studying 
interactions with excipients. In another line of enquiry, powdered monoclinic 
paracetamol23 has been extensively studied mechanistically with regard to its poor 
compaction properties during the process of tableting 23, 24.  
Single crystals of form I have been successfully prepared by slow evaporation 
crystallization using several solvents including methanol, ethanol and acetone6, 18, 25-27. 
Form I can also be prepared by slow cooling of a saturated ethanol solution6. It has 
further been reported that form I single crystals can be grown from the vapour by 
sublimation in vacuo on a temperature gradient6. The crystals harvested from the mother 
liquor were dried using a clean soft tissue18.  
Form II single crystals can be prepared from melted paracetamol powder, 
followed by slow cooling crystallization.28, 29 Alternatively, form II can be crystallized by 
slow evaporation from an ethanol solution or produced by the milling of polycrystalline 
paracetamol28. Form II has high yields at low temperature but is readily transformed into 
form I as the temperature increases.25 Form II is spontaneously converted to form I at 70 
°C,30 so precautions must be taken during the preparation of pure form II in order to 
avoid producing a mixture of form I and form II crystals.28 
Forms I and II of paracetamol can be distinguished by the melting temperature in 
DSC analysis: form I will melt between 168 and 171 °C, form II at around 157 to 
159 oC30-32 .It has been reported that the thermodynamic stability of form I is caused by 
entropy rather than lower energy packing.30 
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It has also been shown that the packing arrangement of form I has more degrees 
of freedom in the vibrational motions related to the crystal lattice, intramolecular and 
intermolecular interactions30. The monoclinic crystal system of paracetamol form I has 
the space group P21/n28. Form II, the orthorhombic crystal structure, is assigned to the 
space group Pbca28. Thus, form II and form I paracetamol can be distinguished by using 
powder XRD (PXRD). In order to prevent form II from being converted to form I, it is 
important for crystallization to occur at low temperature and for the crystals to be 
harvested within one hour of the onset of nucleation.28 
Forms I and II can also be distinguished by using vibrational spectroscopy. The 
two forms can be identified in the IR region of 1260-1225 cm-133. The spectrum of the 
monoclinic form I has three relatively strong absorptions of approximately equal intensity 
at 1260, 1244 and 1227 cm-1, while for the orthorhombic form II only two absorptions 
were observed: a strong one at 1240 cm-1 and one of medium strength at 1218 cm-133. A 
mixture of the two forms can thus be detected by the existence of two absorption peaks, 
at 1227 cm-1 and 1240 cm-1, the former being characteristic of form I and the latter of 
form II.33 Structural and vibrational calculations have been carried out on paracetamol in 
a DFT approximation using hybrid (B3LYP) potentials34. IR characterisation in 
combination with these theoretical studies revealed the intermolecular hydrogen bonds 
formed by the O-H…O and N-H…O groups.34 
The molecular structure of paracetamol crystals can be briefly affected by the 
crystallisation environment35. Some of the solvent used during crystallization is reported 
to be trapped as an impurity in the crystal lattice or to be present as a solvent inclusion in 
the crystal. The choice of solvent will determine the solubility of the solute and the 
quality of the saturated solution prepared for crystallization. The solvent also influences 
the kinetics of nucleation, crystal growth, crystal shape, crystal size distribution and 
degree of agglomeration, which decreases with increasing solvent polarity.36 The 
interaction of solute and solvent during crystallization will affect the properties of the 
final crystal. The inclusion of solvent on the crystal surface has been predicted by 
theoretical studies6. Such inclusion of solvents and impurities affects the crystal habit by 
influencing the growth kinetics and growth process.6 
Paracetamol is more soluble in ethanol than in water and has low solubility in 
nonpolar solvents6. In the crystallization of paracetamol from ethanol solution, the 
paracetamol molecules and ethanol are reported to interact by hydrogen bonding, with 
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ethanol acting as hydrogen bond donor. In contrast, in the crystallisation of paracetamol 
from a saturated acetone solution, there is a dipole-dipole interaction between 
paracetamol and acetone37. The presence of impurities has the potential to modify the 
solubility of the primary solute and affect the crystallization process15. Impurities such as 
excipients, solvent or contamination can block the adsorption of solute molecules and 
induce morphological changes. They can also dock onto the surface and become 
incorporated into the crystal lattice, disrupting the emerging nucleus and thus inhibiting 
the nucleation process15.  
Amorphous paracetamol can be prepared by melting paracetamol powder and 
quench cooling in liquid nitrogen32, 38. The amorphous paracetamol will partially 
recrystallize immediately after quench cooling and in a recent experiment it was reported 
that the entire crystallization process was completed in 14 days, even though the material 
was being stored well below the glass transition temperature, Tg31. Amorphous 
paracetamol can also be prepared by a heating and cooling programme in a hermetic DSC 
pan31.  
DFT studies have shown that in an aqueous ethanol medium, the phenolic -OH 
group of paracetamol partially ionizes reversibly into the corresponding phenolate ion 
(conjugate base, CB) and hydroxonium ion, H3O+ 22 .The DFT calculation reveals the 
delocalization of the negative charge of the phenolate ion into the ring during ionization. 
This delocalization does not spread to the N atom, as is evident from the length increase 
in C6-N- (Figure 2-8) upon ionization. The DFT calculation also shows that the N-C15 
bond length decreases, while the C15-O16 bond length increases, in the transformation 
from paracetamol to CB during ionization in ethanol22.  
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Figure 2-8: DFT optimized structure of paracetamol. H: Hydrogen, C: Carbon, N: 
Nitrogen, O: Oxygen.22 
 
It has been suggested that the most polar face of paracetamol is the (001) face26, 27. 
Form I single crystals grown in ethanol (industrial methylated spirit) had a prismatic to 
platy habit that was elongated in the direction of the c-axis but parallel to the (101) face,28 
while form II consisted of prisms that were elongated along the c-axis. The cleavage face 
of paracetamol is (010).39 Single crystals with columnar habit had major faces at (110), 
while tablet-like crystals had major (001) faces.18 Single crystal paracetamol is reported 
to have a pinacoid open form. A mature single crystal (grown for a longer time) grown in 
ethanol shows the development of pinacoids (10-1) and (101) and of prisms (011) and 
(110) as the dominant forms, whereas the immature crystals have pinacoids (001) and 
prisms (111), which are the fastest growing faces28. An increase in saturation of the 
crystallization solution yielded crystals of a flat, tabular morphology, where the (001) 
faces were morphologically most important and dominated the habit6. The fastest 
growing face in a highly saturated solution was at (110) 6. The (110) growth sectors were 
characterized by a much larger density of solvent inclusions than observed in any of the 
other sectors6. It was observed that in a supersaturated solution the hillock morphology 
growth on the crystal surface would lead to the capture of solvent in the crystal 
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micromorphology6. Face (010) has been reported as being the preferred cleavage plane of 
paracetamol, as the attachment energy is the lowest at this face26.  
The morphology of paracetamol forms I and II has been established using the 
Bravais, Friedel, Donnay and Harker (BFDH) algorithm on the Mercury program version 
2.3 and the attachment energy model. The morphology of form I predicted in this way 
was in agreement with the experimental results but in poor agreement with that of form 
II.28 The morphology of paracetamol has also been predicted using the Dreiding II and 
Momany force field programs,6 while the paracetamol crystal habit has been calculated 
using the HABIT95 program,6 which considers both the structure of the material and the 
nature of the intermolecular force fields in the crystal. It may be as a result of the 
technique of melting and abrupt cooling in liquid nitrogen that the form II crystal solution 
did not achieve a dynamic equilibrium during the crystallisation process. In contrast, the 
BFDH modelling assumed that the crystal solution had achieved dynamic equilibrium.6 It 
was shown that form II was not converted to form I by grinding, nor by compression.28, 33 
X-ray topography experimentally indicates their presence at certain faces of the crystal6. 
Paracetamol molecules are polar, with the charge distribution shown in Figure 2-940. 
 
 
Figure 2-9: The distribution of partial charge of Paracetamol by MOPAC. 
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In the present study, the molecular structure of paracetamol was compared with that 
of acetanilide and found to differ only by the OH group in the para position. The 
paracetamol benzene ring is practically flat, with deviations of C atoms from the common 
plane not exceeding 0.007 Å. The flat benzene ring forms dihedral angles with the 
acetamido and hydroxyl groups at 20.5° and 17.2° respecively20. The large 
electronegative value of O and H, the hydroxyl (O-H) group at para position was 
expected to form a covalent bond41. The amide (N-C=O) group in paracetamol is very 
sensitive to the hydrogen bond environment19. The trans position between hydroxyl and 
amide groups is the most thermodynamically stable42. Single crystal paracetamol 
molecules were found to be rigid at a variety of temperatures. Atoms and molecules in 
crystals are not immobile but move with changes of temperature or pressure. Therefore, 
atomic displacement parameters (ADPs) are usually taken as a measure of the thermal 
motion of atoms9. The rigidity of the methyl group in the crystal structure affects the 
crystal facet concentrations and the methyl group gives static disorder to the crystal 
molecules. However, the shorter C-H methyl group bond showed liberation due to the 
high thermal vibration detected by neutron diffraction analysis43, 44. 
2.3. Excipients 
An excipient is an inert compound in a formulation with an API. Most drugs are not easy 
to administer or easily absorbed by the human body45 because of their physicochemical 
properties, so have to be dissolved or mixed with inert components that overcome these 
barriers to use, which is the function of excipients. Nonionic polymers are widely used in 
the formulation of pharmaceuticals because of their compatibility, high stability,low 
toxicity and good suspending and steric stabilising effects, especially on suspension 
solutions46, 47. Non-ionic molecules comprise both polar and non-polar segments, 
possessing a wide range of interfacial activity and versatile functions as wetting agents, 
emulsifiers, solubilisers, ocular permeability enhancers and in some cases as inhibitors46.  
For example, many pharmaceutical compounds have few slip planes48. At the slip 
plane lines, the crystal arrangement has mobility during the process of drug compaction 
or tableting. Drugs with fewer slip planes have less mobility and therefore difficulties 
may affect the compaction process. During compaction, the drug particles will be 
rearranged, allowing elastic deformation and volume reduction, while at the yield point, 
plastic deformation of the drug will occur. Plasticity of drugs will lead to the formation of 
interparticular bonds and enhance the coherent strength of tablets. However, some drugs 
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are very elastic and resist plastic deformation. Such elasticity has to be avoided, because 
it will lead to lamination of the drug and mechanical instability of the tablets. Excipients 
are needed to enhance the plasticity of drugs6, 18, 48-50 and to maintain their reactivity and 
stability. However, the proportion of excipients in any formulation must be minimal for 
safety reasons49. The traditional techniques used in the characterisation of drugs and 
excipients are DSC, ATR-IR, XRD and Raman spectroscopy, which determine the 
functionality, crystalline structure and thermal behaviour of mixtures51, 52. 
2.3.1. Interactions between paracetamol and excipients 
The molecular mechanisms of drug-excipient interactions can be studied by calculating 
the miscibility of drugs and selected excipients, in order to enhance the bioavailability 
and solubility of the blend. Miscibility may be facilitated scientifically, based on the 
selection of polymeric partners for given pharmaceutical substances53. The degree and 
type of interaction will contribute to the overall free energy of mixing. Two methods 
were considered in the calculation of drug-polymer miscibility: measuring solubility and 
the depression of the melting point respectively. 
Solubility is a parameter used to describe the cohesive forces within materials; it has 
been used to describe the physical properties of a material and to predict interactions 
between materials54. The units of solubility are (J/m3)1/2, MPa1/2 55 or (cal/cm3)1/2, where 
1 (cal/cm3)1/2 is equivalent to 2.0421 MPa1/2. Knowing the solubility values for different 
excipients allows the prediction of the magnitude of interactions between the components 
of formulations as well as the stability of a product. Solubility can be evaluated and 
predicted by four methods54: measuring the solubility of test materials in solvents of 
known solubility parameters; measuring refractive index values using inverse gas 
chromatography; using heat of evaporation data (not suitable for polymers); and the 
group contribution method (GCM). 
Measuring differences in solubility parameters between drugs and excipients has 
been advocated as a method to predict miscibility in pharmaceutical systems. Compounds 
with similar solubility are likely to be miscible. The solubility difference between two 
compounds is designated ; pairings with < 7.0 Mpa1/2  are likely to be miscible, 
while those where >10.0 will be immiscible56,54, 57.  
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2.3.2. Solubility parameter calculations 
The energy required to separate the constituent atoms and molecules of a material to an 
infinite distance is known as its cohesive energy and can be considered a direct 
measurement of the attraction that the atoms or molecules have for one another. It is the 
net effect of all the interatomic or molecular interactions, including van der Waals 
interactions, covalent bonds, hydrogen bonds, electrostatic interactions, induced dipole 
and permanent dipole interactions58.   
The cohesive energy is commonly quantified by solubility parameters, whose 
values for different pharmaceutical compounds allow the prediction of the magnitude of 
interactions between the components of a formulation as well as the stability of a product. 
The solubility parameter was first developed by Hildebrand and co-workers58, 59. The 
Hildebrand solubility parameter, δ, is restricted to non-polar systems and is related to the 
cohesive energy density (CED), which in turn relates the free energy of vaporisation, E, 
with molar volume, Vm, by the following equation58-61:  
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Where H is the enthalpy of vaporization, R is the gas constant and T is the absolute 
temperature. The Hildebrand parameter was extended by Hansen to polar and hydrogen 
bonding systems. The Hansen parameter assumes that cohesive energy can be considered 
to be the sum of contributions from dispersive interaction (Ed), polar interactions (Ep) and 
hydrogen bonding interaction (Eh) by the following relation58: 
-Ecoh = -Ed – Ep - Eh    
 Equation 2-2 
From the above equation Hansen derived the total solubility, T, as given by the following 
equation55: 
2
h
22         pdT        Equation 2-3  
Where d is the partial solubility of the intermolecular dispersive force, p is the partial 
solubility of the intermolecular polar force and h is the partial solubility of the 
intermolecular hydrogen bond force59.  
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drug has been calculated by the group contribution method (GCM), which is used 
widely in the pharmaceutical industry62. The GCM approach, which is a development of 
the theories of Hildebrand and Hansen, is based on the assumption that the total 
intermolecular interactions among the molecules of a liquid are given by the linear sum 
of the contributions of the various chemical moieties within the molecules. The 
Hildebrand and Hansen solubility parameters are related by the following equation61, 62: 
 2222 hpd          Equation 2-4
 
Where subscripts d, p and h refer to dispersion forces, polar forces and hydrogen bonding 
respectively.   
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Fdi, Fpi and Ehi refer to the contributions of various chemical moieties and the value 
obtained from the Hoftyzer-Van Krevelen method, while the value of F can be obtained 
by the Fedors method62. Table 2-1 shows the Paracetamol GCM value of all the Fpi, Fhb 
and Vm as referred from the Hoftyzer-Van Krevelen table.  From Table 2-1 the solubility 
parameters of paracetamol were estimated. Table 2-2 shows the solubility parameters 
estimated for all the chosen compounds 54. 
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Table 2-1: Estimated values of Fpi, Fhb and Vmfor paracetamol functional groups 
Group Fpi Fhb Vm 
CH3 0 0 33.5 
NH (210)2 = 44100 3100 4.5 
C= 0 0 -5.5 
O (400)2 = 160000 3000 3.8 
OH (at adjacent C atom) (500)2 = 250000 20000 13.0 
Phenylene (110)2 = 12100 0 52.4 
 466200 26100 101.7 
 
Table 2-2: Calculated solubility for Paracetamol, Ibuprofen, Aspirin and potential 
excipients  
Compounds d p hb T 
Paracetamol 21.93 6.71 16.02 27.97 
Poloxamer 188 17.71 13.42 9.56 24.19 
Poloxamer 338 17.70 13.39 9.49 24.14 
Poloxamer 407 17.58 12.95 9.35 23.75 
PVP 17.96 10.30 5.88 21.52 
Ibuprofen 17.85 2.22 7.15 19.36 
Aspirin 21.70 10.53 11.02 26.52 
 
2.3.3. Interaction Parameter and Strength of Interaction 
In a binary system involving two materials, A and B, there are two types of interaction:  
i) Inter (A-A) or (B-B), known as cohesive interactions 
ii) Intra (A-B), known as adhesive interactions. 
Based on the Leonard-Jones pair potential function, Rowe relates the strength of 
interaction ( in MPa) to the solubility parameters () of two surfaces63:  
BB = 0.25 B2  AA = 0.25 A2 AB = 0.25  AB Equation 2-8   
Where AB, the interaction parameter, is defined by the harmonic mean equation 
proposed by Wu63: 
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Quantities xd and xp are the fractional non-polarity and polarity respectively (xd + xp = 1) 
for each material, defined by the expressions 
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Where d is the dispersion or non-polar component of the Hansen three-dimensional 
solubility parameters. The parameters g1 and g2 can also be defined in terms of the 
solubility of the materials: 
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Where K is the constant and V is the molar volume of the material, i.e. its molecular 
weight divided by its density, assuming that the materials are supercooled liquids or 
amorphous polymers. Table 2-3 reveals the calculated value of selected API 
(paracetamol, ibuprofen and aspirin) with 4 chosen excipients. All the values were 
calculated as formula above explained. 
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Table 2-3: Interaction parameters and strength calculated of interactions of 
Paracetamol, Ibuprofen and Aspirin and potential excipients 
 Paracetamol-
P188 
Paracetamol-
P338 
Paracetamol-
P427 
Paracetamol-
PVP 
Interaction 
parameter () 
0.58 0.49 0.53 0.91 
Strength of 
interactions () 
98.82 83.34 87.30 137.40 
 Ibuprofen-P188 Ibuprofen-P338 Ibuprofen-P427 Ibuprofen-PVP 
Interaction 
parameter () 
0.36 0.31 0.33 0.95 
Strength of 
interactions () 
42.15 36.09 37.99 98.95 
 Aspirin-P188 Aspirin-P338 Aspirin-P427 Aspirin-PVP 
Interaction 
parameter () 
0.57 0.48 0.52 0.93 
Strength of 
interactions () 
91.65 77.42 81.10 132.69 
 
Table 2-3 shows that paracetamol, ibuprofen and aspirin have strongest interaction with 
PVP but least interaction with P338. PVP reveals the strongest interaction with 
paracetamol. The interaction of ibuprofen and all the excipients reveals the least. It also 
estimated that P188 shows the strongest interaction for the entire API with the strongest 
interaction with paracetamol. Therefore, from the above calculation the justification for 
the API and excipients chosen for the study was made.  
2.3.4. Poloxamer 
Poloxamers are nonionictriblock copolymers, commercially known as Pluronic (BASF), 
Poloxamer (ICI)64 or Synperonic. They were developed and first marketed by the BASF 
Corporation and differ from other polymeric surfactants in having both a hydrophobic 
and a hydrophilic end. The chemical structure of the polymer is shown in Figure 2-11 65. 
The hydrophobic polymer, polypropylene oxide is flanked by polyethylene oxide, which 
has the hydrophilic character that makes poloxamers non-ionic surfactants66. The EO and 
PO segments are joined by ether bonds67. The range of block numbers can be tailored 
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with the molecular weight64. The hydrophilic part maintains the polymer’s solubility in 
water, while the hydrophobic part provides associative behaviour in water.  
By popular convention, poloxamer P188, for example, indicates the prill form of 
the compound (designated by the initial P), while 18 (the first two digits) multiplied by 
100 gives the molecular mass of the PO and 8 (the last digit) multiplied by 10 denotes the 
percentage of EO. A prill is a dry sphere of solid formed by cooling the molten form. It is 
a solid at room temperature and a low viscosity liquid when melted. All forms of 
poloxamer can been differentiated by the ratio of EO to PO, marked as n and m in Figure 
2-10. This ratio will affect the physical surface-active properties. It also corresponds to 
physicochemical characteristics such as the melting point, cloud point and hydrophilic-
lipophilic balance. The phase (liquid, flake or prill) is indicated by L, F or P in the names 
of the different forms shown in the Pluronic grid (Figure 2-10), which is based on a 
mapping of the percentage of hydrophile as a function of the hydrophobe molecular 
weight. 
 
Figure 2-10: Pluronic Grid presented the percent of Polyoxyethylene and 
Polyoxypropylene and physical forms exist for Poloxamers. (L = liquid, P = prill, F = 
flake). 
 
In the Pluronic grid (Figure 2-10), the nomenclature is given by multiplying the 
PO axis by 300 and giving the molecular mass of PO. Multiplying the last number by 10 
gives the percentage of EO. For instance, F68 is the flake form of the poloxamer 
containing PO of molecular weight 1800 and 80% EO. Table 2-4 gives examples of 
poloxamer m and n values with the molecular weights and phases as appropriate. 
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According to the hydrophile-lipophile balance (HLB) system designed for categorizing 
non-ionic surfactants, the higher the portion of n (the hydrophilic part) in the Poloxamer 
structural formula, the higher the HLB value of the poloxamer and the more soluble it is 
in aqueous solution46.  
 
Figure 2-11: Chemical structure of Poloxamer 
Table 2-4: Examples of some poloxamers properties indicated by their names 
Poloxamer Name Physical form m n Molecular weight 
L124 Liquid 12 20 2090-2360 
P338 Solid 141 44 12700-17400 
P188 Solid 80 27 7680-9510 
P407 Solid 101 56 9840-14600 
P237 Solid 64 37 6840-8830 
 
Higher values of EO segments, (n segment as in Figure 2-11), indicate that 
poloxamer compounds can be dissolved in water at room temperature. As the temperature 
increases, water becomes a progressively poorer solvent for the PO segment, (m segment 
in Figure 2-11), leading to micelle formation and the creation of a gel phase. The two 
identity characteristics of poloxamers are known to be thermoreversible, which means 
that at low temperatures a solution is formed, while at higher temperatures a gel phase 
occurs. Rheological and diffusion studies indicate that the two phases occur because at 
low temperature and concentrations below 12.5%, the micelles are well separated and the 
poloxamer system displays Newtonian behaviour. However, at concentrations higher than 
12.5% and high temperatures, the micelle volume fraction approaches close packing68.  
Studies of physical mixtures of paracetamol and poloxamer P188 are not 
common. However, the interaction through hydrogen bonds of ibuprofen and poloxamer 
* 
O
O
O * H
H O
n  nm
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has been proposed by several studies69. Poloxamer conformation has been known with 
the PO block acting as anchor, while the EO block acts as a ‘brush’ at the surface of the 
mixture particles70. Poloxamers have demonstrated effective steric stabilisation, thought 
to arise from anchoring of the hydrophobic PO chain to the particle surface and 
subsequent stabilisation by the protruding EO chains. The capacity of charge reduction by 
poloxamers has also been shown to be greater than for other polymers71. 
Poloxamers are widely used as wetting and solubilising agents and surface 
adsorption excipients72. Their amphiphilic structure makes them useful in pharmaceutical 
applications, where they can be used to increase the water solubility of hydrophobic, oily 
substances as well as modelling systems in drug delivery applications. Their tendency to 
aggregate into micelles also makes poloxamers appealing candidates for the 
encapsulation and delivery of hydrophobic drugs67. In biomedical applications, 
poloxamers are applied as modifiers in drug delivery, in situ generated implants, gene 
expression, modelling membranes, including solubilisation of the membrane, alteration of 
membrane rigidity and soft tissue injury treatment73. Additionally, poloxamers are 
popular because of their incorporation in creams and aqueous suspensions as dispersion 
stabilisers and flocculants. They are also used as surface modifiers in organic distribution 
of colloidal particles. Poloxamers are also popular as surface active agents in ophthalmic 
delivery systems because they are less toxic, less homolytic and less irritating to the 
ocular surface and because they tend to maintain near physiological pH values when in 
solution46. Poloxamer188 was used as an emulsifier in Lipomul® IV, a product that was 
given to patients unable to ingest food taken orally, and to emulsify a volatile anaesthetic, 
methoxyflurane. Poloxamer188 was found to be effective in dogs in preventing the 
formation of fat emboli in prolonged cardiopulmonary bypass65.  
Several techniques have been employed to study poloxamers, including viscometry, 
light scattering, nuclear magnetic resonance (NMR), phase diagram determination, 
gelation mechanism, UV-VIS absorption, surface tension, electron spin resonance (ESR), 
small angle neutron scattering, fluorescence, Raman spectroscopy and ATR 
spectroscopy64. The adsorption of poloxamers on a hydrophobic surface was examined by 
AFM, and in situ experiments by surface plasmon resonance (SPR) spectroscopy 
revealed the brush conformation of poloxamer adsorbed on a gold surface66. The study 
also showed that the amount of poloxamer adsorbed reached a maximum near the critical 
micelle concentration and that the process was only partially reversible.  
Chapter 2  Materials, Method and Techniques 
62 
 
2.4. X-ray Photoelectron Spectroscopy (XPS) 
X-rays are a form of electromagnetic radiation whose wavelength is from 10 to 0.01 nm, 
with energies from 120 eV to 120 keV. They may be soft or hard. Soft X-rays are those 
with wavelengths ranging from 0.12 to 3 keV, while those of hard X-rays range from 3 to 
120 keV, the latter having greater penetrative ability. 
 
Figure 2-12: Schematic diagram of X-ray photoelectron spectrometer. 
XPS works by irradiating a sample with a quantity of photons given by Equation 
8 below, to produce large numbers of photoelectrons, then comparing the kinetic energy 
with the initial energy of the photons. Figure 2-12 is the schematic diagram of an 
experimental XPS unit74. The absorption of high energy photons causes the ejection of 
electrons from tightly bound core levels or from more weakly bound valence levels. Each 
element produces a characteristic set of XPS peaks at characteristic binding energies. 
These EB values directly identify each element present in or on the surface of the material 
being analysed. These characteristic peaks correspond to the electrons within the atoms. 
The number of electrons detected in each of the characteristic peaks is directly related to 
the amount of the element within the area (volume) irradiated.  
The magnitude of electron attraction towards the nucleus is the atom binding 
energy and the quantity of energy that the particle loses in transit from the sample to the 
analyser is known as the work function. The kinetic energy difference is stated as 
Equation 2-13. The work function is consistent for each sample in a specific XPS 
analyser. However, in XPS survey analysis, every atom has its own range of binding 
energies used for element recognition. A subset of elemental analysis is high resolution 
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analysis. The different types of chemical bond will affect the appropriate EB, creating a 
‘chemical shift’ which affects high resolution analysis. For instance, the C 1s EB for the 
methyl environment is at 284.7 to 285 eV, while N-C=O has a higher EB of 288 to 289 
eV.  The energy of the photon is  
E = hν         Equation 2-13 
where h is the Planck constant (6.62 x 10-34 J/s) and ν is the frequency. The kinetic 
energy, EK, of the excited electron is related to the atom binding energy, EB, by the 
following equation: 
Ek= hν – EB        Equation 2-14 
The photon energy, hv, probes the sample with energy Ei. The photon emissions to the 
sample surface will ionise the sample to Ef. Therefore, the energy equation can be written 
as: 
Ei + hv = Ef +Ek       Equation 2-15 
 
2.4.1. Instrumentation 
The basic layout of an XPS machine is as presented in Figure 2-12. Throughout the 
studies, the X-ray source is an X-ray tube. Commonly, the anode is made from 
aluminium (Al) or magnesium, at 1486.7 eV and 1253 eV respectively. In this study, Al 
was preferred, because monochromatic AlK X-radiation could be used to improve 
spectral resolution74. A high sensitivity instrument such as an XPS must be operated 
under ultrahigh vacuum, i.e. at a pressure of 10-6 to 10-9 Pa, in order to reduce the amount 
of noise in the spectrum and to avoid any surface contamination by residual gas which 
would alter the surface composition. In addition, to count the number of electrons at each 
value of kinetic energy with the minimum of error, XPS must be performed under UHV 
conditions, as this will help to prevent accumulation of gaseous contaminants onto the 
sample surface and reduce photoelectron-gas collisions, which are typically understood in 
terms of the inelastic free mean path (IMFP) concept. UHV is defined as < 10-8 mbar. 
The minimum pressure needed for the photons to reach the sample surface and reduce 
collisions with gas molecules is 10-5 mbar. The relation of kinetic theory of gases and the 
Chapter 2  Materials, Method and Techniques 
64 
 
rate, r, of gaseous molecules arriving at the surface (assuming they stick and are 
incorporated) is: 
r = 3.51 x 1022 P / (TM)½      Equation 2-16 
Where P is the pressure in torr, T is the temperature in K and M is the molecular weight 
of the gas, where 1 Torr = 1.33 mbar. For example, for N2, where M is 28, P is 1 Torr and 
T is 298 K, the rate will be 3.88 x 1020 molecules cm-1 s-1. Assuming a monolayer 
~ 2x1015 atom cm-2 (a typical number of atoms at the surface is 1x1015 cm-2), the time 
needed for N2 coverage is 2.6 x 10-6 s at 1 Torr, 2.6 s at 10-6Torr and 44 minutes at  
10-9Torr. In order for relatively low contamination within the timescale of an experiment, 
the pressure should ideally be lower than 10-9 Torr. The UHV is obtained by means of 
several pumps, viz. diffusional, ion, mechanical, adsorption and turbomolecular pumps, 
each of which operates at a different pressure, as listed in Table 2-5.  
 
Table 2-5: Vacuum stage and type of pump used to required pressure (Pa) 
Vacuum Stage 
Low vacuum 
Medium vacuum 
High vacuum 
Ultra high vacuum 
 
Monochromators of various types are used in XPS for electron focusing. A 
magnetic monochromator allows double focusing. The first XPS instrument using the 
monochromatic principle was developed by Siegbahn’s team74. Serial XPS spectrometers 
commonly use electrostatic monochromators, which are small and can increase the 
electron intensity. Their use is necessary to narrow the XPS peaks.  
In order to resolve 1000 eV electrons to ± 0.5 eV, an analyser would be required 
with a slit plate width of 1 mm and radius of 1.2 metres. Therefore, it is convenient to 
retard the incoming electrons so that they have lower energy when passing through the 
analyser. A lens system is needed to focus the electron energy of the sample to increase 
the throughput. Focused electrons are then passed through the main part of the XPS 
equipment, the hemispherical analyser. Generally, there are two modes of hemispherical 
analyser, one known as fixed analyser transmission (FAT) or constant analyser energy 
Diffusion Pump 
TurbomolecularPump 
Ion Pump 
Titanium SublimationPump 
102 
10-1 
10-4 
10-8 
10-11 
Pressure (Pa) Types  of Pumps needed 
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(CAE) and the other as fixed retard ratio (FRR) or constant retard ratio (CRR). In CAE 
mode the pass energy of the analyser is held at a constant value and it is entirely the job 
of the transfer lens system to retard the given kinetic energy channel to the range 
accepted by the analyser. The CAE mode is commonly used in XPS instruments. The 
higher the pass energy applied, the lower the peak resolution. 
The parameters at which the XPS analysis is set will affect the spectrum produced. 
The full width half minimum (FWHM) of the spectrum is affected by the analyser 
diameter, pass energy and the spread of energies in the X-ray source. The consideration 
of localised charging may broaden the XPS lines. Therefore, the charge neutralisation 
setting is vital in XPS experiments.  
2.4.2. Quantification of Surface Atomic Composition 
Background Subtraction 
Inelastic collisions of the electrons emitted on the sample surface may alter the number of 
electrons recorded by the detector. The energy loss processes will result in some 
modification to the spectrum background. There are three types of XPS background 
subtraction: linear, Shirley and Tougaard. The Tougaard background is the most 
complicated because it removes all the inelastic processes, while linear background is the 
simplest. Shirley background subtraction assumes that each unscattered electron is 
associated with a flat background of losses; the background intensity at a point is 
proportional to the intensity of the total peak area (above background at any point)75. Due 
to the shape of the most of the spectra of paracetamol and of paracetamol and excipient 
mixtures, the Shirley background was chosen to be used in all the XPS analyses.  
Relative Sensitivity Factor  
In XPS the detected photoelectron current is linearly related to the detected atom density. 
Mathematically, the idealisation of the sample intensity is difficult; the XPS data are 
quoted in terms of atom fractions. Therefore, the relative sensitivity factor (RSF) is used, 
where one elemental peak is taken as the standard to which other peaks are referred. In 
polymer analysis the standard is commonly C1s. 
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Sample charging 
Electrons at the sample surface will be lost during photon bombardment. On a metal 
surface, the loss of electrons is compensated by the grounding abilities of the metal itself: 
new electrons move to the surface continuously to compensate the electron loss at the 
surface region. However, for organic or insulating samples, the rate of photo-electron loss 
is greater than the electron replacement from within the specimen, which leads to the 
creation of a positive surface potential. Electrons from the bulk of the sample cannot 
compensate for this loss and this reduces the field at the surface. As a result, the peaks 
will shift due to the reduced kinetic energy of the ejected electrons (Figure 2-13). 
Therefore, some adjustment has to be made during the experiment and to the XPS 
spectrum. A ‘flood gun’ of low energy electrons (0-5 eV) can be utilised to supply more 
electrons to the sample surface. Furthermore, the correction of lines with reference to 
adventitious C is needed before any fitting of the organic spectrum.  
 
Figure 2-13: Schematic illustration of electrons at a conducting and an insulating 
surface during photoemission 
 
XPS Spectra 
There are two types of XPS spectra, viz. survey spectra and high resolution XPS spectra, 
which are distinguished by the pass energy utilised during the analysis. Survey spectra 
are generated by scanning over the whole available energy range, which requires higher 
pass energy to increase analysis sensitivity, while high resolution analysis is obtained 
from lower pass energy during XPS analysis. The spectra are detailed enough to allow 
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peaks to be deconvoluted as differences in the chemical environment of an atom and 
observed as shifts in EB.  
Binding Energy 
Using XPS, chemical shift is detected from the value of EB. The exact value of the 
binding energy of the core electrons of a given element depends on their atomic 
surroundings. The energy of an electron in a tightly bound core state is determined by the 
attractive potential of the nuclei and the Coulomb interaction of the repulsive core with 
all the other electrons. A change in the chemical environment of a particular atom 
involves a spatial rearrangement of the valence charges of this particular atom and a 
different potential created by the nuclear and electronic charges on all the atoms in the 
compound. This mechanism, called chemical shift, involves charge transfer to or from the 
core ionised atom. The second factor involves the electric field caused by the effective 
charges of the surrounding atoms76.   
The transfer of charge to an atom and neighbouring electronegativity will lead to 
shifts in the core level EB of an atom, which can be used to distinguish between different 
functional groups and oxidation states. Reducing the electron density of the system and 
the formation of a cation environment leads to the shifting of EB to a higher value, 
whereas the addition of electrons and anion formation in the system will lower the EB. In 
other words, the value of EB rises in proportion to the positive state of element oxidation 
in the compound, while in a negative oxidation state, the shift is towards smaller EB 
values (negative shift)74. This is based on the increasingly electronegative pull of 
neighbouring electron density away from the element of interest. As a result, the element 
holds onto its remaining electrons more tightly, making it harder to remove an electron 
and thus increasing the EB. Chemical shift can also be perceived by the changes in 
nuclear shielding, including core hole relaxation, where the electrons move closer to the 
hole in order to shield it from the positive nucleus.  
Shake Up 
When a core electron is photoejected, the Coulombic potential of the outer shell electrons 
is suddenly altered. The immediate change may induce the shake-up transition of a 
valence electron to a higher, previously unoccupied orbital. Shake-up peaks always 
appear at high EB values77. The existence of shake up makes the kinetic energy decrease, 
distinguishing this from other molecules in which shake up do not occur. A weak shake-
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up line is typical of aromatic carbon and conjugated systems. The relative area of the 
different components of XPS lines reflects the relative concentration of the corresponding 
atoms78, 79.  
EB shake up = EB + E                     Equation 2-17 
 
 
 
 
 
 
 
Figure 2-14: Schematic illustration of the effect of shake up electron excitation on an 
XPS spectrum 
 
Figure 2-14 shows the shakeup phenomenon and the relationship is translated as 
Equation 2-17.  
 
Valance band 
The variation in the number of valence bands (VB) in samples is attributed to changes in 
the conformational structure of the molecules80. It provides information about the 
electrons contributing to the chemical bonding, as they are involved in delocalised or 
bonding orbitals. VB spectra with specific patterns indicate different chemical states.  
Inelastic Mean Free Path 
IMFP and attenuation lengths are two important parameters in XPS and quantitative 
surface analysis81. IMFP can be obtained from theory and certain types of experiment, 
whereas attenuated length (AL) is obtained from overlayer film experiments and by the 
use of a model which ignores electron scattering effects82. The IMFP begins when X-rays 
penetrate the sample surface to a depth of twice the mean free path and produce electron 
emissions (Figure 2-15). The electrons emitted with a certain kinetic energy, EK, will 
travel an appropriate distance before reaching the sample surface. In XPS, the kinetic 
energy of such electrons is interpreted as indicating the chemical state of the atom. The 
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average distance covered by an electron between two inelastic shocks is called the mean 
free path, λ. The inelastic shock distance will vary from larger to smaller values. Any 
electron which undergoes a shock will experience random energy changes, meaning the 
loss of energy, so that the detected energy, E, will be lower than the initially emitted 
energy, Eo. Those electrons having reached the surface without any inelastic interaction 
will contribute to the background spectrum peak, while those which leave the material 
without inelastic shock or energy loss will form an XPS peak (Figure 2-15). 
 
 
Figure 2-15: IMFP mechanism in XPS. (a) X-ray photoelectron emission of the atom 
at depth 2λ. (b) X-ray causes emission of 4 electrons: 2 (blue) will reach the surface 
without losing energy, while 2 (grey) undergo inelastic collision with other particles 
and lose energy. (c) The blue electrons form the XPS peak and the grey electrons the 
background peak in the XPS spectrum.  
The IMFP depends upon two main factors, which are the kinetic energy, EK, of the 
electron and the nature of the solid. Most organic solids have very similar IMFP energy 
relationships. Therefore, the nature of the solid is needed to recognise the behaviour of 
the chosen organic solid. The IMFP value is important in the calculation of layer 
thickness. Figure 2-16 illustrates layers of two compounds: compound B is a substrate on 
which compound A is layered at thickness t. The XPS emission intensity without A is Io, 
while the emission intensity with A has changed to I. Therefore, the thickness of layer A, 
t, can be calculated from the Equation 2-18. 
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I = Io (-t/ λ)        Equation 2-18 
Where t = layer thickness, I = intensity with two layers, Io=intensity without layer A, λ = 
IMFP. 
 
Figure 2-16: Illustration for the effect of XPS emission intensity on two compounds, 
A and B 
Several researchers have made extensive attempts to calculate the IMFP,, value 
for organic and inorganic compounds83, 84 by plotting the IMFP graph of kinetic energy 
(EK) as a function of IMFP depth. Two methods can be used to calculate the IMFP: 
experimental determination and theoretical prediction. Recently, IMFP values have been 
provided by the National Institute of Science and Technology (NIST). There is a simple 
equation for IMFP estimation, as follows:84 
λd = 
૝ૢ
ࡱࡷ
૛ + 	૙.૚૚	ඥࡱࡷ       Equation 2-19 
This gives the IMFP, , value in mgm-2, therefore to convert the value to nm the 
following equation is implemented:84 
λd = λn /ρ         Equation 2-20 
From Equations 2-19 and 2-20, the C 1s, O 1s and N 1s IMFP values can be estimated, 
as listed in Table 2-6. 
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Table 2-6: Elements, C, O and N approximation data of EB, EK and estimation value 
IMFP for Paracetamol. 
Orbital Binding Energy 
(EB) 
Kinetic Energy 
(EK) 
IMFP (nm) 
C 1s  ~ 280 eV  ~ 1207 eV 4.83 
N 1s  ~ 400 eV  ~ 1090 eV 4.59 
O 1s  ~ 530 eV  ~ 960 eV 4.30 
The formula for estimating the thickness of a surface layer using the ratio of intensities 
from the layer and substrate is as follows85:  
ܔܖ ቂ
ࡵ࢒ࢇ࢟ࢋ࢘
ࡵ࢙࢛࢈࢙࢚. + 	૚ቃ = 	 ࢚ࣅ	∙	ܛܑܖࣂ      Equation 2-21 
Where Ilayer is the intensity of the peak arising from the surface layer, Isubst. is the intensity 
of the peak arising from the substrate, t is the thickness of the surface layer, λ is the IMFP 
of electrons in the surface layer and θ is the angle at which the electrons exit the surface. 
 
2.4.3. Method 
The samples were analysed using a Kratos Axis Ultra 86 XPS instrument with a 
monochromated AlK source, a hemispherical analyzer with a hybrid (electrostatic and 
magnetic) lens system, charge neutralization by filament-generated, magnetically 
channelled low-energy electrons and a delay line detector (DLD). Throughout the study, 
two types of tapes used for samples mounting; double-sided adhesive carbon disks and 
double-sided tape. Only samples named Poloxamers and EtSingle used double sided 
tapes while others of XPS samples measurements used double-sided adhesive carbon disk 
(12 mm diameter double-sided carbon disks were cut into half for samples mounting).  
Samples were spread over double-sided tape for the XPS analysis, and care was taken to 
ensure that powdered samples particles completely covered the tape.   
The analysis was conducted at a pressure below 10-8 mbar (UHV) with X-ray 
operating source power of 180 W (15 kV and 12mA). The instrument was operated in 
CAE mode. The CAE survey scans were conducted at an energy level of 80 eV and high 
resolution scans at 20 eV of photoemission from individual core levels. Surveys were 
measured in steps of 0.5 eV and 300 ms dwell time per data point.  
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C 1s high resolution spectra were measured at 0.1 eV steps and 300 ms dwell time 
per data point. O 1s dwell time was 400 ms per data point. Radiation-damaged samples 
were analysed by repeating the sample scans. The intensity/ energy response was 
calibrated with clean gold, silver and copper surfaces in accordance with the National 
Physical laboratory (NPL) procedure, an absolute reference obtained from the gold 
spectrum and compared with  a clean gold surface to obtain the transmission function and 
appended to the data file86. Surveys were measured from 1100 to -5 eV with 0.5 eV steps 
and 300 ms dwell time. High resolution spectra were measured around the area of 
interest, with 0.1 eV steps and 300 ms dwell time per data point for C1s, 400 ms for O1s, 
and 500 ms for N1s spectra. Repeats were carried out to check for radiation damage. XPS 
data were analysed using the Casa XPS software.  
A Shirley background was used in all curve fitting due to the. The binding energy 
scale was referenced to adventitious carbon hydrocarbon contamination at 285 eV, at 
which a separate peak was clearly visible. A lineshape GL(30) (70 % Gaussian, 30 % 
Lorentzian using the Gaussian/Lorentzian product form) was employed for C 1s spectra. 
For the O 1s spectra, an exponential tail GL (55) was used, as there appeared to be some 
asymmetry towards higher binding energy. Samples naturally containing C-C 
environments were referenced to adventitious hydrocarbon contamination at 285 eV. 
Samples without C-C environments were referenced to the lowest EB photoemission; 
those paracetamol samples containing aromatic ring were referenced to C=C at 284.7 eV. 
Chemical environments/functional groups with position different ± 0.5 eV, two peaks 
were used to represent both environments for clarity and eased of discussion.  
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Figure 2-17: An example of an XPS instrument, a Kratos Axis Ultra at The 
University of Manchester, showing the X-ray source and monochromator (centre), 
electron analyser (top), loading chamber (left) and vacuum/pressure controls (right). 
 
2.5. X-ray Diffraction 
In 1913, English physicists WH and WL Bragg developed a theory to explain why the 
cleavage faces of crystals appear to reflect X-ray beams at a certain angle of incidence, 
known as theta (θ). In XRD, the basic variables are the distance, d, between atomic layers 
in a crystal bombarded by the incident X-ray beam of wavelength, λ, multiplied by an 
integer, n. XRD is a non-destructive technique utilised to define the geometry and 
structure of crystalline materials. The diffraction of incident X-rays is based on the elastic 
scattering of the electron clouds in an atom of the material. An electron in an alternating 
electromagnetic field will oscillate with the same frequency as the field. When an X-ray 
beam hits an atom, the electrons around the atom start to oscillate with the same 
frequency as the incoming beam. In almost all directions, the interference will be 
destructive, because the combining waves are out of phase, so there will be no resultant 
energy leaving the solid sample. However, the atoms in crystals are arranged in regular 
patterns and in a very few directions there will be constructive interference: the waves 
will be in phase and a well defined X-ray beam will leave the sample in these directions.  
The X-ray diffraction principle starts with the incident beam at parallel atomic 
planes, separated by the interplanar distance, d. In Figure 2-18 below, the incident X-ray 
Chapter 2  Materials, Method and Techniques 
74 
 
beams are coming from the left and reflecting from the planes. The beam will be 
diffracted by an angle θ from the plane.  
Figure 2-18: Schematic diagram of X-ray diffraction between planes in XRD 
Figure 2-18 shows the relation of the reflected plane, the interplanar plane distance, d 
and θ in Bragg’s Law87. Trigonometry is used to relate d  and  at the distance AB + BC. 
The distance AB is opposite  thus88 
sin dAB          Equation 2-22  
ABn 2         Equation 2-23 
Substituting Equation 2-22 in Equation 2-23 we obtain 
 sin2dn          Equation 2-24 
Where n is an integer,   is wavelength, d  is the interplanar spacing in Å,  is the 
diffraction angle in degrees. For the general case for plane hkl, Equation 2-24, which is 
known as Bragg’s Law, can be rewritten as Equation 2-25: 
hklhkld  sin2        Equation 2-25 
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Instrumentation 
An X-ray diffractometer consists of three main elements: an X-ray tube, a sample and an 
X-ray detector (Figure 2-19). First, the X-rays are generated by the bombardment of 
electrons from the tungsten filament of a cathode tube on a metal target acting as anode. 
Different metal targets will be characterised by specific wavelengths. Some common 
metal targets are Cu, Fe, Mo and Cr, with Cu being the most common target material for 
single crystal diffraction; in this case, the value of K is 1.5406 Å. At sufficient electron 
energy to dislodge inner shell electrons of the target material, characteristic X-ray spectra 
are produced. These have several components, the most common being K and K. The 
high intensity K consists in part of K1 and K2, where K1 has a slightly shorter 
wavelength and twice the intensity of K2. Because the wavelengths characteristic of K1 
and K2 are close, the average of the two intensities is used in the XRD patterns. This X-
ray generating mechanism occurs in a device known as a scintillating tube. The X-rays 
are then collimated and directed onto the sample by slits. As the sample and detector are 
rotated, the intensity of the reflected X-rays is recorded. When the geometry of the 
incident X-rays colliding with the sample satisfies the Bragg equation, constructive 
interference occurs and there is a peak in intensity. The detector records and processes 
this X-ray signal and converts it to a count rate, which is then output to a device such as a 
computer monitor. 
 
 
Figure 2-19: Schematic diagram of an X-ray diffractometer 
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2.6. Prediction of Crystal Morphology 
Crystal morphologies were predicted using the Material Studio Simulation package from 
Accelrys89. 
 
Figure 2-20: BFDH calculations adapted from Material Studio for the prediction of 
crystal facet indexing and number 15 facet has been predicted as (010) facet (shown 
from  sign).  
 
The package incorporates three methods for crystal morphology prediction from crystal 
structure data, which were in this work obtained in CIF format from the Cambridge 
Structural Database (CSD). The three methods are89 
1. The Bravais-Friedel Donnay-Harker (BFDH) method, which uses the crystal lattice 
and symmetry to generate a list of possible growth faces and their relative growth 
rates 90, 91. Faces with lowest attachment energy are the slowest growing and 
therefore have the most morphological importance. The attachment energy is the 
energy released on attachment of a growth slice to a growing crystal surface.  The 
attachment energy is calculated by combining the Donnay-Harker rules, which 
identify the (h k l) indices of likely growth planes, with the Bravais-Friedel rules, 
which deduce relative growth rates by assigned center-to-face distance of each 
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face. The combined information is then used to construct the morphology with a 
Wulff construction. 
2. The growth morphology method, which assumes that the growth rate of a crystal 
face is proportional to its attachment energy (the energy released on attachment of 
a growth slice to a growing crystal surface)2, 92 
3. The equilibrium morphology of a crystal, which is determined by the minimum of 
the surface energies for all relevant crystal faces at zero Kelvin 93. 
Using these methods, the relationship of external morphology and internal crystal 
structure allows the prediction of crystal shape, the development of tailor-made additives 
and the control of solvent and impurities effects. It can be rationalised with Material 
Visualiser which provides all of the graphical tools for constructing models of molecules, 
crystalline materials, surfaces, polymers and mesoscalestrutures. The integrated model 
building and editing tools can be manipulated, view and analysed in an asymmetric unit 
or structures of crystallisation solids 89. 
These methods are suitable for organic molecule system under the assumption that the 
surface is a perfect termination of the bulk structure and that no surface relaxation takes 
place. Surface relaxation is not significant for organic materials. The latter restriction is 
important for crystal structures that do not have a centre of inversion. Finally, the 
equilibrium morphology method calculates the surface energy using a predefined finite 
and fixed slab thickness at a temperature of 0 K. It is assumes the surface energy is an 
average between the surfaces with Miller indices {h k l} and {-h –k l}. The most features 
of Material Studio stimulation is the predicted morphology is related to experiment, 
enabling indexing of experiment data 89. Therefore, Material Studio Stimulation is 
suitable for the big crystal facets indexing due to the instruments restriction by XRD 
goniometer or optical microscope.  
2.7. Attenuated Total Reflection Infrared (ATR-IR) 
Infrared (IR) spectroscopy is a popular quantitative technique to measure the vibration 
frequency and mode of the molecules vibration. The vibrational frequencies of a 
molecule are characteristic of the bonds between its constituent atoms and correspond to 
certain frequencies of infrared light. The IR technique uses light radiation from 4000 to 
400 cm-1, known as mid-infrared. In pharmaceutical analysis, IR is used to assess purity 
via the existence of moisture on the surface and to determine functional groups in 
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conjunction with the molecular bonds. IR is a popular technique for hydrogen bond 
determination.  
ATR-IR spectroscopy, invented in the 1960s, is an enhancement of IR which uses 
the reflection of an IR beam to determine molecular vibration. Three popular types of 
reflection IR are internal reflection spectroscopy (ATR), external reflection spectroscopy, 
otherwise called specular reflection and typically used for smooth surfaces, and a 
combination of internal and external reflection spectroscopy, known as diffuse reflection 
spectroscopy (DRIFT), which is useful for rough surfaces. It is a versatile and non-
destructive technique of sample analysis and can be used to analyse a variety of materials, 
including powder, rubber, thin film, pharmaceuticals and even liquid samples. The 
concept is based on the total reflection of the IR beam when it comes into contact with 
the sample (Figure 2-21). The beam is directed onto an optically dense crystal with a 
high refractive index at a certain angle to obtain reflection. The sample is clamped above 
the crystal, so that when the beam reflects through the crystal it penetrates the sample to a 
finite depth along the top surface of the crystal via evanescent waves. An evanescent 
wave is produced each time the infrared beam is reflected from the inside surface of the 
crystal. These evanescent waves penetrate the sample at each reflection point at a 
distance z. The altered (attenuated) energy from each evanescent wave is passed back to 
the IR beam, which exits the opposite end of the crystal and is directed to the detector of 
the IR spectrometer. The detector records the attenuated beam as an interferogram signal, 
which can be used to generate the IR spectrum. The crystals used are varieties which may 
affect the spectral range of the analysis and the depth of the penetration. Typically, the 
crystals used are zinc selenide (ZnSe), Germanium (Ge), silicone (Si) and diamond.  
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Figure 2-21: Schematic Diagram of Attenuated Total Reflection Infrared (ATR-IR) 
Spectroscopy functions. 
 
2.8. Differential Scanning Calorimetry (DSC) 
Differential Scanning Calorimetry (DSC) is a technique developed by Watson and 
O’Neill in 1960 and commercially introduced in 1963. The instrument illustrated in 
Figure 2-22 below measures energy directly and allows precise measurements of heat 
capacity. DSC works by measuring the difference in heat energy absorbed and released 
by a sample, as compared to an inert reference (empty pan), when both are heated, cooled 
or held at a controlled temperature. The temperature of the sample pan increases linearly 
as a function of time, while the reference pan should have a well-defined heat capacity 
over the range of temperature scanned. For example, as a solid sample reaches its melting 
temperature, Tm, and changes to a liquid, it will require more heat flowing to it to 
increase its temperature at the same rate as the reference. The absorption of heat by the 
sample indicates the endothermic phase transition from solid to liquid. However, at the 
crystallisation temperature, Tc, for instance, less heat is needed to raise the sample 
temperature, as the process is exothermic. At more subtle phase changes, DSC can be 
applied to observe the glass transition temperature, Tg, of a polymer sample. DSC is 
widely used in research and industrial settings as a quality control instrument due to its 
applicability in evaluating sample purity and for the determination of polymer curing.  
The DSC analysis is depicted in a graph of heat flux as a function of time or 
temperature. The DSC instrument will interpret exothermic reactions by producing 
positive or negative peaks, depending on the manufacturing technology. For a specific 
mass undergoing an endothermic or exothermic process, the enthalpy transition can be 
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calculated and related to the wider thermodynamic determination. The enthalpy of 
transition, H, can be expressed by the integral of the curve, given by the Equation 2-26. 
H = KA        Equation 2-26 
Where H is the enthalpy of transition, K is the calorimetric constant and A is the area 
under the curve. The calorimetric constant varies from instrument to instrument and can 
be determined by analyzing a well characterized sample with known H. 
 
Figure 2-22: Schematic diagram of Differential Scanning Calorimetry 
instrumentation 
DSC is a popular technique for phase diagram studies of samples. The most 
common theoretical DSC curves are those observed for fusion, crystallization and glass 
transition temperatures. For instance, at increased temperature, amorphous 
semicrystalline solid molecules will become less viscous and have enough freedom of 
motion to rearrange the molecular structure spontaneously into crystalline form. The 
value of crystallisation temperature, Tc, indicates this as an exothermic process. 
Conversely, as the temperature increases to melting temperature, Tm, the sample will 
have enough energy to melt, indicated as an endothermic curve. Similarly, glass transition 
temperature, Tg, will be reached as the temperature of an amorphous solid increases. On 
the DSC curve, Tg appears as a step in the baseline of the recorded DSC signal.  
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3. CHAPTER 3: CRYSTAL CRYSTALLISATION 
3.1. Objectives 
The objectives of the work described in this chapter were:  
i) To differentiate the crystal habits obtained by using three different solvents: 
acetone, ethanol and methanol.  
ii) To obtain high quality single crystals of at least 1 cm diameter by slow cooling 
crystallisation. 
3.2. Crystallisation Techniques 
The cooling process affects the growth rate and the size of crystals. Rapid cooling will 
reduce crystal size due to the incomplete growth of a large number of small crystals1. 
While overly slow cooling may also cause incomplete growth due to the very long time 
required to complete growth,2 theoretically, through slow cooling, all solute molecules 
(unit cells) will become aligned and a regular crystal shape will be obtained. This is 
illustrated in Figure 3-1, where hexagons represent the solute and triangles the 
impurities. If the hot solution is left to cool slowly, the impurities may settle briefly in the 
growing crystal lattice, but after a time they will move out and a regular crystal geometry 
of hexagon shapes will be formed. In rapid cooling, by contrast, the impurities will be 
trapped in the crystal units and irregular shapes obtained (Figure 3-2). 
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Figure 3-1: Schematic illustration for crystallisation of pure product during slow 
crystallisation 
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Figure 3-2: Schematic illustration for formation of impure product during fast 
crystallisation induced by rapid cooling 
 
Slow evaporation, in which the temperature of the solution is increased slowly over time, 
is among the easiest and best known of the crystallisation techniques. It is very sensitive 
to the choice of solvent and a major disadvantage is that the crystals tend to adhere to the 
glass walls, which can make it more difficult to retrieve them without damage3.  
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3.2.1. Vapour Diffusion 
A method which is suitable for milligram amounts of material is vapour diffusion, shown 
in Figure 3-3. A solution of the substance is prepared using first solvent S1 and placed in 
test tube T. A second solvent, S2, is placed in a closed beaker, B. S2 is chosen such that 
when it is mixed with S1 the solute will become less soluble. The test tube containing S1 
is then placed in the beaker and the beaker is sealed. The slow diffusion of S2 into test 
tube T and S1 out of T will cause crystals to form. If S2 is more volatile than S1, the 
solvent level will increase and prevent microcrystalline crusts from forming on the sides 
of T3, 4.  
 
 
 
 
 
 
 
 
Figure 3-3: Schematic diagram of vapour diffusion crystallisation technique. S1- 
first solvent, S2- second solvent, T- test tube 
 
A crucial step in the vapour diffusion technique is the selection of the solvents: S2 must 
have a lower melting point than S1.  
3.2.2. Paracetamol Solubility 
In the present study, paracetamol (monoclinic, form I) was prepared using several 
different solvents. An understanding of the crystallisation process is essential to the 
preparation of single crystals. Figure 3-4 shows the paracetamol solubility curve for all 
three solvents, using solubility data from the literature5.  
 
S2 
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T 
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Figure 3-4: Solubility curves of paracetamol in different solvents 
 
These solubility curves were used to prepare single paracetamol crystals with three other 
solvents: ethanol, methanol and acetone. Table 3-1 below shows the paracetamol mass of 
20 mL solvents calculated from the solubility curves (Figure 3-4). 
Table 3-1: Mass of paracetamol (PA) for 20 mL solvent calculated from the 
solubility data. 
Temperature 
(oC) 
g PA/ 20 mL 
MeOH g PA/ 20 mL EtOH g PA/ 20 mL Acetone 
10 3.79 2.46 1.09 
15 4.20 2.70 1.23 
20 4.71 3.01 1.38 
25 5.25 3.31 1.57 
30 5.88 3.67 1.76 
 
 
Solubility curve of Paracetamol for Different Solvents
* Adapted From: J.Chem.Eng.Data 1999, 44,1391-1395
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3.3. Preparation of Monoclinic Single Paracetamol Crystal by Slow Crystallisation 
Prior to preparation of paracetamol single crystal, two types of apparatus cleaning were 
conducted.  
i) First, the container was washed with a 2% solution of ammonium 
peroxydisulphate (APS) in 99% sulphuric acid. The APS solution was 
prepared by a lab technician immediately prior to the cleaning process. After 
this acid wash, the container was thoroughly rinsed with tap water, followed 
by deionised water. The apparatus was then dried in an oven at 60 °C.  
ii) The second method of cleaning was using a high temperature furnace, in 
which the apparatus was heated to 450 °C for 2 hours to eliminate all organic 
particles sticking to the apparatus wall. The heating method is normally used 
for big glass cleaning.   
Pure paracetamol single crystals were prepared using three types of solvent: absolute 
ethanol, acetone and methanol. The acetone and methanol were HPLC grade (99.9% 
purity). Ethanol (20 ml) in the jacketed vessel was held at a temperature of 20 °C. 
Paracetamol powder was weighed as calculated on Table 3-1. The saturated solution was 
prepared by dissolving all the powder in ethanol at a temperature of 23 °C. After a clear 
solution was achieved, its temperature was reduced to 20 °C, producing a supersaturated 
solution, which was stirred for 24 hours at 20 °C, when it was assumed that the solubility 
limit of the solution had been achieved. The magnetic stirrer was then removed from the 
vessel and the bath temperature decreased by 0.10 °C per day to 19.80 °C, when a single 
crystal seed was placed in the solution. The seed was prepared by evaporating the 
saturated solution in a small crystallisation disk for 1 day. The circulating bath (Thermo 
Scientific NESLAB Digital Plus RTE 7, refrigerated bath chiller circulator) was then 
programmed to reduce the temperature by 0.50 °C per day until last temperature was 
16.3oC.  The crystallisation was terminated approximation for 7 days. Care was taken that 
the crystallisation setup should not be affected by any vibration, stirring or disturbance 
until a sufficient size of single crystal was obtained. The crystal was then removed from 
the vessel by means of a Büchner filter.  
 
3.4. Preparation of a Single Orthorhombic Paracetamol Crystal  
Form II (orthorhombic) paracetamol is very sensitive to the presence of any 
contamination during the crystallisation process. Any impurities or debris present in the 
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crystallisation vessel will lead to recrystallisation to form I. Therefore, all the glassware 
was cleaned in APS prior to the experiment. 
12.50 g of pure paracetamol was dissolved at 40 °C in 500 ml of deionised water in a 
conical flask. The solution was then heated to boiling point and kept boiling for 15 
minutes to ensure that all the powder had fully dissolved, before being filtered and 
transferred to a jacketed vessel where it was kept at 40 °C for 24 hours. Next, the solution 
was cooled at a rate of 3 °C per day until it reached the appropriate saturation temperature 
of 4 °C6, 7, when the seed was introduced into the vessel. This had been prepared by 
melting form I paracetamol powder at 175 °C. The crystallisation process took 15 days.  
3.5. Sample Preparation and Characterisation 
The single crystals prepared as above were ground prior to characterisation by ATR-IR 
and XRD analysis. An amount sufficient for the analysis, approximately 1-2 mg, was 
ground in a mortar until a homogenous powder was formed. The ground crystal analysed 
by XRD and ATR-IR were labelled as AceGround (single crystal grown in acetone), 
EtGround (ground single crystal grown in ethanol), MeGround (ground single crystal 
grown in methanol). For single crystal XRD analysis, a single seed crystal of less than 
0.25 mm was selected for the unit cell and indexes. No further treatment was done. Single 
crystal X-ray diffraction data were collected at 100 K with an Oxford Diffraction X-
Calibur 2 diffractometer utilising Mo K radiation (λ = 0.71073 Å) and an Oxford 
Cryosystems cryostream Controller 700. Data were recorded with the X-ray source 
operating at 50 kV and 40 mA. Data reduction, cell refinement, and multi-scan absorption 
corrections were carried out using the program Crysalis RED (Oxford Diffraction Ltd., 
version 1.171.32.24, 2008). The X-ray powder diffraction patterns were collected using a 
Rigaku Miniflex instrument utilising Cu K radiation (1.5406 Å), operating over 5-40o 2θ 
at 1.5o min-1 with a 0.03o step, 30 kV voltage, and 15 mA current. Typically 5 mg of 
sample was placed on a sample attachment and smoothed to achieve a level surface. 
ATR-IR spectra were obtained with a ThermoNicolet Avatar 360 ESP FT-IR 
spectrometer with a Specac Golden Gate ATR attachment. A background spectrum was 
taken before each session of characterisation. Spectra were recorded over the range 4000-
400 cm-1. Spectra were analysed using Nicolet OMNIC E.S.P.5.1 software.  
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3.6. Results and Discussion 
3.6.1.  Paracetamol crystal 
Many authors report the preparation of single paracetamol crystals by the solvent 
evaporation technique7, 8 with a seed. However, the technique chosen for use in this study 
was slow cooling with a seed as a precursor because of the good outcomes in terms of the 
single crystals produced (Figure 3-5a). The slow cooling crystallisation would produce 
larger crystals and good temperature control led to the production of clear single crystals. 
Crystal growth is very sensitive to temperature, environment, the cleanliness of the 
container and vibration. Therefore, a programmed circulating bath was used in the 
crystallisation process. The solubility curve shows that at 20 °C a saturated solution of 
paracetamol becomes supersaturated; therefore the ideal temperature to introduce the 
seed was considered to be 19.80 °C. Two different types of crystallisation solution are 
compared in Figure 3-5. The photographs were captured to differentiate the arrangement 
of crystal in solution. Figure 3-5 (a) formed a single crystal at the bottom of jacketed 
vessel at the end of crystallisation period. However, Figure 3-5 (b) resulted no single 
crystal formed at the end of crystallisation period (attempt had been made until 2 months, 
the single crystal was not appeared at the end of the period).  
  
(a)                                                                       (b) 
Figure 3-5: Comparison of two crystallisation solutions. (a) Solution which 
crystallised to single crystals (b) Non-crystallised solution which would not formed 
single crystal. 
 
.  
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Figure 3-6: Paracetamol single crystal (a) From acetone solution where the 
crystallisation apparatus was washed with APS (b) Ethanol single crystal where the 
apparatus was cleaned with detergent and water. 
 
All the apparatus for the crystallisation experiment must also be very clean and the 
solvent used must be absolute or HPLC grade. Figure 3-6 shows images of two single 
crystals produced in apparatus (a) cleaned in APS and (b) cleaned with detergent then 
rinsed with deionised water. The figures show that the clarity of single crystal prepared 
was affected by the cleanliness of the crystallisation containers.  
3.6.2. X-ray Diffraction  
The single crystals of polymorph form I and form II diffraction patterns prepared were 
ground and analysed with powder XRD. Figure 3-7 compares XRD patterns of the two 
forms according to the Crystal Database Structure (CDS) data, while Figure 3-8 
compares experimental spectra for the two forms obtained from the prepared crystals. 
The results show that the main difference between forms I and II is visible at 2θ values of 
25.32° and 25.62°, for CDS data and experimental data respectively. The XRD 
diffraction patterns thus indicate that the paracetamol prepared was of polymorph forms I 
and II.  
Because the single crystal XRD (SXRD) diffractometer was restricted to 
characterising the structure of single crystals up to 0.2 mm, only seed crystals were used 
for the confirmation of form I paracetamol. Figure 3-9 depicts the SXRD analysis at 
different face orientations, showing measurements of the cell angles: α was at 90°, β at 
97.75° and γ at 90°, while the a axis was 7.14 Å, b was 9.34 Å and c was at 11.69 Å. It 
was confirmed that the crystal was monoclinic  with a cell volume of 772 Å3. These 
(a) (b) 
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results are in agreement with values given in the literature of α = 90°, β = 97.82° and γ = 
90°; length a = 7.09 Å, b = 9.23 Å and c = 11.62 Å. The reference CDS crystal cell 
volume was 753.94 Å3 and the dominant facets were at (0-1-1), (10-1) and (1-1-1).  
 
Figure 3-7: XRD paracetamol diffraction patterns for form I and form II from the 
CDS database. 
 
 
Figure 3-8: PXRD Paracetamol diffraction patterns for form I and form II from the 
prepared crystals 
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Figure 3-9: Single crystal- XRD (SXRD) facet analysis of paracetamol at two 
different orientations 
 
3.6.3. Attenuated Total Reflection -IR 
ATR-IR was utilised to test whether the prepared crystal had similar functional groups to 
those of powdered paracetamol. Figure 3-10 shows the spectra of powdered paracetamol 
and of ground paracetamol obtained from acetone crystal, ethanol crystal and methanol 
crystal. 
Table 3-2: Wave numbers of paracetamol (powder and ground crystal) functional 
groups 
Functional group Powder AceGround EtGround MeGround 
N-H (cm-1) 3312.93 3316.19 3318.58 3318.06 
C-OH (cm-1) 3162.64 3162.44 3166.76 3158.51 
N-C=O (cm-1) 1645.85 1649.96 1650.09 1649.84 
C=C (cm-1) 1560.78 1562.88 1561.70 1562.07 
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Figure 3-10: ATR-IR spectra of all the ground crystals and powder. AceGround- 
Single Crystal grown in acetone, MeSingle- Single Crystal grown in Methanol, 
EtSingle-single Crystal grown in Ethanol 
 
The sharp absorption (Table 3-2) at the higher wavenumbers of 3312 cm-1 and 3162 
cm-1 in all the spectra was due to the N-H amide group and the C-OH stretching group. 
The N-H and C-OH peaks of ground paracetamol crystals were more intense than those 
of the powdered form. The high intensity of the ground crystal C-OH peak is an 
indication of free hydroxyl groups in the molecules, while the broadness of the powdered 
paracetamol C-OH peak is characteristic of hydrogen bonds of paracetamol molecules. 
The high intensity of the asymmetric N-C=O peaks at 1650 and 1610 cm-1, especially in 
EtGround and MeGround, reveals the interaction of paracetamol N-C=O and solvent 
molecules. The reduced intensity of the C=O peak of the ground acetone crystal was most 
probably caused by the C=O acetone dipole moment with the paracetamol solute. The 
prominent peaks at 1560 and 1510 cm-1 are characteristic of the aromatic C-C stretching 
bands of paracetamol. The C-N stretching band was detected at 1220 cm-1 and the methyl 
(CH3) group of paracetamol was characterised by a vibration at 1432 cm-1. 
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3.6.4. Paracetamol vapour pressure 
XPS cannot be applied when the vapour pressure of a sample is high enough to cause 
significant sublimation under ultra-high vacuum conditions. The vapour pressure of 
paracetamol Form I increases from 2.2×10-5 Pa at a temperature of 40 °C to 0.0671 Pa at 
74 °C, with an enthalpy of sublimation of 238.85 kJ/mol9. Form II was reported as 
thermodynamically unstable10, 11. XPS experiment on Form II were attempted but was 
failed due to the high vapour pressure of the solid and sublimation during analysis. 
3.6.5. Paracetamol crystallisation with acetone, ethanol and methanol 
The crystal habit results from the relative growth rates of parent molecule surfaces in 
different directions. Therefore, preferential growth inhibition of different crystal faces 
changes the shape of the crystal. The interaction between crystal surfaces and the solvent 
or impurities will result in variations of crystal habit12. Paracetamol crystals were 
prepared in three ways, using acetone, methanol and ethanol as solvents respectively. In 
each case, many attempts at crystallisation were made and similar habits were observed 
for all types of solvent used. Two habits were observed: pinacoidal and prismatic. The 
results (illustrated in Figure 3-11), indicate that the choice of solvents in the present work 
did not influence the paracetamol crystal habit.  
 
 
Figure 3-11: Crystal habit for crystals growth in three different solvents. (a) Crystal 
growth in acetone, (b) crystal growth in ethanol, (c) crystal growth in methanol  
 
(a) (b) 
(c)   
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The selection of seed was very important for the final habit of the paracetamol single 
crystal. When a needle-shaped seed was chosen instead of a prismatic one, the resultant 
single crystal would have a pinacoidal habit, as shown in Figure 3-11. Figure 3-12 
shows an EtSingle sample with a diameter of 1.5 cm (a) and 1.0 cm (b).  
 
 
   
 
Figure 3-12: EtSingle. (a) Single crystal from needle seed (b) single crystal from 
prismatic seed 
 
3.7. Conclusions 
Paracetamol single crystals were successfully grown by slow crystallisation from acetone, 
ethanol and methanol solutions, using seed crystals and the slow evaporation technique. 
Paracetamol form II was prepared and characterised by PXRD analysis, as indicated by 
agreement of the diffraction pattern with CDS reference data. The monoclinic (form I) 
single crystal was characterised by single crystal PXRD, confirming that it had the same 
structural parameters as previously reported for its crystal structure. ATR-IR results 
support the PXRD findings, with very similar spectra for powdered paracetamol and 
ground crystals grown from acetone, ethanol and methanol solutions. The ATR-IR results 
revealed a broadened C-OH peak in powdered paracetamol, which is an indication of 
hydrogen bonds. The choice of solvent did not influence the paracetamol crystal habit. 
 
 
 
 
(a) (b) 
1 cm 
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4. CHAPTER 4: POLOXAMER CHARACTERISATION 
4.1. Objectives 
The objectives of the works described in this chapter were:  
i) To analyse surface degradation of three different composition of Poloxamers 
using X-ray Photoelectron Spectroscopy (XPS) 
ii) To differentiate the surface composition of three different Poloxamers 
composition using XPS. 
 
4.2. Introduction 
Effective tableting or compaction of pure drugs or active pharmaceutical ingredients may 
require the inclusion of excipients in the formulations. An excipient is an inactive 
ingredient that often helps to bind a dose of API. Other excipients may improve 
bioavailability, release or stability of a drug. Excipients in drug formulations are normally 
inert materials. However, polymer excipients can initiate, propagate or participate in 
chemical or physical interactions with the drugs. In the case of chemical interaction this 
may lead to the degradation of the API and so reduce the amount available for therapeutic 
effect or compromise the safety of the medication, while physical interaction may affect 
the rate of dissolution, uniformity of dose or ease of administration of the drug1. 
Nonionic surfactants with polyoxyalkane chains are often used as excipients even 
though they are quite sensitive to autoxidation2. The autoxidation process leads to the 
formation of hydroperoxides and free radicals, which are responsible for the degradation 
and ageing of pharmaceutical formulations. Poly(ethylene oxide)-poly(propylene oxide)-
poly(ethylene oxide) triblock copolymers of the ABA type, often denoted PEO-PPO-PEO 
or (EO)a(PO)b(EO)a and commercially known as Poloxamers, Pluronics or Synpronics, 
are nonionic macromolecular surface active agents3 with a and b are Poloxamers 
repetition units. 
Poloxamers differ from classic many other surfactants through their molar mass, 
which ranges from 1000 to 15,000, whereas other commonly used surfactants often have 
lower molar masses. The chemical structure of poloxamers consists of two different 
blocks of ethylene oxide (EO) and propylene oxide (PO) (Figure 4-1).  
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Figure 4-1: Chemical structure of poloxamers (m and n are the Poloxamers 
repetition unit) 
 
The two outer blocks are the same size, synthesised from ethylene oxide, monomer and 
constitute the hydrophilic components of the molecule, while the inner block is 
constructed from propylene oxide, and represents the hydrophobic moiety4. The sizes of 
the blocks are varied to provide the molecule with a range of surface activity.  
Poly(oxyethylene), EO, is very sensitive to photoxidation, as it can absorb 
radiation with wavelengths below 300 nm. Its degradation can be initiated particularly by 
chromophoric impurities which absorb UV light and produce radicals5. The presence of 
oxygen in the polyethylene oxide, EO, facilitates autoxidation of EO. The EO chain 
undergoes oxidation more rapidly than poly(oxypropylene), PO. EO degradation starts 
with the formation of radicals by hydrogen abstraction on the polymeric backbone,5 then 
the reaction of these free radicals with oxygen produces peroxy radicals or 
hydroperoxides at the α-carbon atoms of ethylene chains 2, 5. EO chains degrade to low 
molecular weight products 2. It has been shown2, 5 that the main mainly C-cleavage of 
poloxamers takes place. In response to their high sensitivity to autoxidation, poloxamer 
manufacturers add butylated hydroxytoluene (BHT) as an antioxidant. The BHT 
concentration in the formulation varies from one poloxamer product to another, so the 
rate of poloxamer degradation varies as a function of BHT concentration 1.  
Poloxamer thermoxidation studies showed that PO blocks were thermally less 
stable than EO blocks, due to the rapid formation of radicals on the tertiary carbon of PO 
2. The thermoxidation of PO at 125 °C resulted in the formation of acetate, formate and 
ketone chain ends from the decomposition of hydroperoxides formed on the backbone 
during oxidation 1. Other studies using the MALDI-TOF technique have shown that at 
155 °C the thermoxidation pathways of PO were at the secondary alkoxy radical 2, 6. An 
NMR study at 150 °C showed that the oxidation of EO blocks produced formate end 
groups through intramolecular decomposition and esterification of hydroxyl chain ends, 
*
O
O
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while the PO tertiary alkoxy radical was predominant at the beginning of the polymer 
breakdown 7. The chain breaking stages of thermoxidation were -scission and cage 
reactions 8. The thermoxidation product was confirmed as acetaldehyde, which was 
oxidised to acetic acid. The acetic acid then esterified 1,2-propanediol, 2 formate into 1,2-
propanediol, 1-acetate, 2 formate. PO exposed to radiolysis revealed the formation of CO 
and OH groups on the polymer chains 1, 9. It has been shown that the radiolysis of 
ethylene-propylene copolymers caused the rupture of C-C bonds and the formation of 
primary radicals 10.  
To date, no XPS study of poloxamer degradation has been carried out. Also, the 
NIST binding energy data applies only to poly(ethylene oxide) and poly(propylene 
glycol) as separate species, so no data on the pure copolymer has been recorded in the 
XPS database. Before analysing paracetamol/poloxamer formulations an XPS study of 
poloxamers and their degradation was undertaken. 
4.3. Experimental 
Poloxamer samples Poloxamer188 (P188), Poloxamer338 (P338) and Poloxamer407 
(P407) were obtained from two main sources. Aged samples (analysis after 24 months  
storage in the laboratory ) were obtained from Sanofi and their properties were not found 
due to the lost of MSDS. These samples had been stored in transparent glass containers. 
The other set of samples were freshly obtained from BASF and stored in opaque plastic 
containers in a dark place, thus having no exposure to light. Samples analysed were: 
i) Three aged samples, P188, P338 and P407 aged after 24 months stored. No 
notes had been found stated the manufacturing date of the sample. 24 months 
was duration of the sample delivered from the manufacturer. 
ii) Three fresh samples, P188, P338 and P407 freshly from supplier and stored as 
advised by MSDS sheet. No data of manufacturing date was found. 
As mentioned above, poloxamers degrade in air; therefore, in the manufacturing 
process an antioxidant, BHT, had been added. The concentration of BHT in each of the 
fresh poloxamer samples was as presented in Table 4-1 according to the MSDS from 
BASF. 
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Table 4-1: Butylated hydroxytoluene content in poloxamers 188, 338 and 407 
Poloxamers BHT (ppm) 
P188 100 
P338 100 
P407 82.4 
 
The samples were used as provided by the supplier. During the XPS mounting, 
samples were spread on double-sided tape and care was taken to ensure that poloxamer 
particles covered the tape entirely. Exposure of the samples to the laboratory ambient 
conditions before analysis was minimised to within approximately 10 minutes. The 
chemical structures and formulas of all the poloxamers used are illustrated in Figure 4-2. 
P188 and P338 had the same percentage of EO block (80%) but different molecular 
weights (MW) of PO block.  
 
Poloxamer 188  
 
Poloxamer 338 
 
Poloxamer 407 
Figure 4-2: Chemical structure of the poloxamers used in this study. 
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From Figure 4-2, the ratio of EO to PO block of P188 and P338 is approximately similar; 
5.00 and 4.74 respectively while P407 has lowest value of 2.93. The ratio indicated that 
P407 had the highest PO segment to EO, while P338 had the lowest PO content relative 
to EO.  
4.4. Results and Discussion 
4.4.1. ATR-IR 
The initial interest of the Poloxamers degradation analysis was IR comparison of fresh 
and aged P188 ( 3 years after manufacturing). The existence of a C=O peak at 1738.03 
cm-1 from aged P188 indicated that degradation had taken place. P188 chemical structure 
reveals no C=O bond, as shown in Figure 4-3. 
 
Figure 4-3: Comparison spectra of aged and fresh P188. Red circle reveals the C=O 
peak from aged P188. 
 
4.4.2. Survey Spectra 
Survey XPS spectra of all poloxamers are shown in Figure 4-4, illustrating the C 1s and 
O 1s photoelectron lines. Analysis of the emission intensities in the survey (Table 4-2) 
revealed that the C 1s intensities were higher than expected from the poloxamer 
stoichiometry, while O 1s concentrations were lower than expected. The existence of a 
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C=O peak in the analysis of C 1s high resolution data (see section 4.4.4) indicated that 
the deviations in carbon and oxygen content in the survey spectra stemmed from the 
formation of oxidised degradation products.  
 
Figure 4-4: Survey spectra of analysed Poloxamers 
In line with this, after the carbonyl percentage from high resolution analysis had 
been subtracted from the carbon and added to the oxygen composition in the survey 
spectra, the carbon and oxygen composition data were much more in line with the 
expected stoichiometry (Table 4-2). Significantly, removal of the C=O contribution 
allows distinguishing between the stoichiometries of P188, P338 and P407, especially for 
the fresh poloxamers.  
 
 
 
C  O 
O KLL C KLL 
Poloxamer 407- new 
Poloxamer 338- new 
Poloxamer 188- new 
Poloxamer 407- old 
Poloxamer 338- old 
Poloxamer 188- old 
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Table 4-2: Stoichiometrically expected and experimental elemental composition of 
P188, P338 and P407 including removal of C=O contamination specified in the C 1s 
high resolution data  
Types & age of 
Poloxamers C(%) O(%) 
C(%) 
Removing 
C=O 
O% 
Removing 
C=O 
P188calculated 
P188agedexp  
P188freshexp 
P338calculated 
P338agedexp  
P338freshexp  
P407calculated 
P407agedexp 
P407freshexp 
68.4 
71.7 
71.6 
 
68.5 
72.3 
72.1 
69.3 
73.0 
73.2 
31.6 
28.3 
28.4 
 
31.5 
27.9 
27.9 
30.7 
27.0 
26.8 
- 
68.4 
69.5 
 
- 
70.3 
69.7 
- 
69.9 
71.9 
- 
31.6 
30.5 
 
- 
29.7 
30.3 
- 
30.1 
28.1 
 
4.4.3. High Resolution C 1s and O 1s analysis without C=O 
 
Figure  4-5: C1s spectra of Poloxamers fitting without fixing C=O groups. 
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In the C 1s spectra (Figure 4-5), C-C-O units were found between 286.4 and 286.6 eV, 
while C-C contributions were found between 285 and 285.2 eV.  The results (Table 4-3) 
were in agreement with the presence of EO segments; the C-C-O EB was at 286.4 eV, and 
the PO contribution was clearly visible through emission from a C-C environment. 
Table 4-3: Calculated, experimental, binding energy and FWHM data for C-C-O 
and C-C environments fitted without C=O for all aged and fresh poloxamers 
Types of 
Poloxamers 
Atomic 
Concentration  
Atomic 
Concentration 
Binding 
Energy [eV] 
 
[C-C]cal% [C-C]exp % C-C FWHM 
  Aged Fresh Aged  Fresh Aged Fresh 
Poloxamer188 14.3 10.1 10.3 285.0 285.0 0.8 0.8 
Poloxamer338 14.8 12.1 11.4 285.0 285.0 0.8 0.9 
Poloxamer407 20.3 13.8 16.1 285.0 285.0 0.8 0.9 
 [C-C-O]cal. % [C-C-O]exp % C-C-O [eV] FWHM 
  Aged       Fresh Aged  Fresh Aged Fresh 
Poloxamer188 85.7 89.9 89.7 286.4 286.5 1.1 1.1 
Poloxamer338 85.2 87.9 88.6 286.4 286.5 1.1 1.1 
Poloxamer407 79.7 86.2 83.9 286.4 286.5 1.2 1.1 
 
Table 4-3 shows the concentration of all the C 1s poloxamers in comparison with 
the expected concentrations, indicating that all the aged poloxamers (P188, P338 and 
P407) had enhanced concentrations of C-C-O, while the C-C concentration were too low. 
It has been stated that exposure of chain termination leads to the formation of more C-C-
O chains at the surface. Previous reports suggest that the aged poloxamer samples were 
prone to coupling termination of radicals, rather than disproportionation termination 5, 11.  
A similar phenomenon was detected in the fresh poloxamer C-C and C-C-O 
chains. This result, in agreement with a previous study 5, 7, 12-15 shows that there was chain 
scission of the C-C chain and formation of the alkoxy radical from natural degradation, 
allowing the fixing of the oxygen to another polymeric chain after the abstraction of 
hydrogen for the radical reaction and further oxidation, yielding aldehyde or ketone, or 
ester end group compounds. The bond dissociation energies associated with these bonds 
(C-C-O and C-C) are approximately at 360 kJ/mol and 347 kJ/mol respectively 1. It is 
indicated dissociation of C-C-O bond needs higher energy than C-C which reveals to 
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bond breaking the C-C-O is harder than C-C. Concurrent with results, C-C-O was high 
concentration on the surface distinguish with C-C. No significance difference reveals on 
the binding energy of all the samples.  
The greatest difference between expected results and experimental data (Table 4-3) 
for C-C and C-C-O environments was found in both aged and fresh samples of P407, 
while the smallest differences were found in aged and fresh P338. This can be explained 
by the higher PO molecular weight of P407, influencing the rate of degradation. At low 
temperature, the PO block would degrade faster than the EO block,1, 16 because of the 
greater radical formation at tertiary carbon as opposed to secondary carbon. On top, P407 
(Table 4-3) showed the greatest difference between calculated and experimental results, 
due to its lower BHT content (see Table 4-1). These results were in agreement with a 
previous study which found that poloxamers with lower BHT content degraded faster 1. 
4.4.4.  High resolution C 1s and O 1s analysis with C=O fitted 
The analysis reported in this section will be divided into three sub-sections. First, 
comparison between fresh and aged Poloxamers based mainly on C 1s data will be 
carried out. Then the relationship between C=O (C 1s) related to O-H (O 1s) binding 
energy and composition concentration will be analysed, distinguishing between aged and 
fresh Poloxamers through O 1s data. Finally, a possible degradation mechanism 
compatible with the obtained data will be suggested.   
Table 4-4: Binding energy (eV) and atomic concentration percent of the poloxamers 
for the C 1s peak components  with C=O fitted  
C environment P188aged P188fresh P338aged P338fresh P407aged P407fresh 
C-C-Oexpected 
 
(286.1-286.8) eV 
Mean: 286.4 eV 
C-C-Oexp. [eV] 
[C-C-O]% 
286.4 
86.6 
286.5 
85.6 
286.4 
82.5 
286.5 
84.5 
286.5 
79.3 
286.5 
80.0 
C-Cexpected 
 
(285.0-285.2) eV 
Mean: 285.1 eV 
C-Cexp.[eV] 
[C-C]% 
285.0 
9.1 
285.1 
12.2 
285.1 
13.8 
285.1 
13.3 
285.1 
17.4 
285.1 
18.4 
C=Oexpected 
 
(286.9- 291.7) eV 
Mean: 289.3 eV 
C=Oexp[eV] 
[C=O]% 
288.1 
4.3 
287.8 
2.2 
287.8 
3.7 
287.8 
2.2 
287.8 
3.3 
287.9 
1.6 
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Figure 4-6: Poloxamers C 1s spectra representing XPS fitting with C=O group 
 
Table 4-4 gives the C1s binding energy data for all poloxamers detected by XPS, 
analysed by CasaXPS with C=O fitting, while Figure 4-6 and 4-7 (C=O peaks) represent 
the C=O peak. The data reveal that all C-C-O and C-C EB values were similar and in the 
range expected and reported in the literature. The C 1s emission from all poloxamers 
indicated the existence of C=O species (Table 4-4) at a binding energy ranging from 
287.8 eV to 288.1 eV. The binding energy of 287.5 to 287.9 eV (Table 4-4) is related to 
the carbon environment of several compounds such as formaldehyde, acetaldehyde, 
formate or alcohol ketone polymer. The peaks support the effect of formaldehyde or 
acetaldehyde or ketone on the degradation of poloxamers. However, other analysis is 
needed to certain weather aldehyde or ketone was detected due to the weakness of XPS in 
detected hydrogen atomic concentration. 
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Figure 4-7: C=O emission intensity peak from high resolution C1s Poloxamers  
The aged P338 and P407 samples, with C=O EB values at 287.8 eV (Table 4-4), 
had pronounced formaldehyde, acetaldehyde, hemiacetal or ketone peaks. In some 
studies, acid formation has been found on the degradation of EO or PO blocks 1, 13, 17. The 
absence of a C-OOH peak above 288.5 eV 18 indicates that no carboxylic group of formic 
acid was detected on the surface of any poloxamer samples.  
Analysis of the aged samples of P188 showed a chemical shift of C=O towards a 
higher binding energy of 288.1 eV compared to fresh P188 at 287.8 eV. The difference 
(0.3 eV) was significant. The 288 eV peak also appeared clearly in previous PO block 
analysis 12, 13 (the analysis was only on Poly (propyleneoxide, PPO) but to date, no 
explanation of the peak has been reported. The O-H peak in the O 1s environment was 
detected at 534 eV (Table 4-5). The high O-H (water) concentration of O 1s (Table 4-5) 
of aged P188 distinguishes it from other poloxamers and may cause the existing 
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formaldehyde to react with water molecules to form a new chain of poly(oxymethylene) 
glycol (Figure 4-8), for which a peak was detected at 288.1 eV of aged P188.  
However, C=O (C1s, Table 4-4) concentration of fresh P188 was not reveals 
significance different with fresh P338, while O-H concentration (O1s, Table 4-5) of P188 
reveals the lowest value among all the fresh poloxamers. The highest O-H concentration 
of fresh Poloxamers was P407 and P338. Both P407 and P338 have high PO percent. The 
explanation is that the PO (particularly on fresh P407) block was actively degraded at the 
initial stage, then after some time the EO (referred to aged P188) block was more actively 
degraded, with the absorption of moisture from the environment 1. 
 
 
Figure 4-8: Chemical reaction of formaldehyde and water to produce poly 
(oxymethylene) glycol 
 
Table 4-5: Binding energy (eV) and atomic concentration (%) for the O 1s peak 
components of the poloxamers 
O environment P188aged P188fresh P338aged P338fresh P407aged P407fresh 
C-C-Oexpected (532.5-532.8) eV 
C-C-Oexp 
[C-C-O] 
532.7 
88.5 
532.6 
96.3 
532.7 
93.1 
532.8 
94.8 
532.8 
90.4 
532.7 
95.3 
O-Hexpected (533-535) eV 
O-Hexp 
[O-H] 
534.3 
7.6 
534.7 
1.2 
534.2 
3.2 
534.3 
2.7 
534.2 
6.0 
534.2 
2.7 
C=Oexpected (532.3-532.4) eV 
C=Oexp.[eV] 
[C=O] 
532.4 
4.0 
532.1 
2.5 
532.4 
3.7 
532.4 
2.5 
532.4 
3.6 
532.3 
2.0 
 
Table 4-5 presents the data of O 1s fitting with the O-H peak. The asymmetrical 
tailing in the O 1s spectra (Figure 4.9) of all samples at both ends of the spectra needs 
fitting to support the existence of C=O and a suggested O-H peak. Peaks of both C=O 
C
O
H H
+ OH H HO(CH2O)nH
Formaldehyde Poly(oxymethylene) glycol Water 
Chapter 4  Poloxamer Characterisation 
116 
and O-H were detected, at 532.1 to 532.4 eV and at 534.1 to 534.7 eV. The ether O peak 
of the poloxamers was defined between 532.4 and 532.8 eV. Among aged samples, the 
O-H concentration was highest for P188 and lowest for P338. The difference in PO block 
concentration between aged P188 and aged P338 had an effect on the O-H concentration. 
Interestingly, aged P407 was found to have a higher concentration of O-H than aged 
P338. The most probable explanation for the high O-H concentration in high MW 
poloxamers (P407) is the active neutralisation of the PO hydroperoxide charged at 
tertiary carbon by a proton-forming tert-alcohol 12.  
 
Figure 4-9: O1s spectra for all analysed Poloxamers  
It is evident that radical formation over a period of two years had degraded P188, 
P338 and P407 by autoxidation or photoxidation to produce such impurities as esters, 
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aldehydes, ketones and water17, 19. As indicated above, the formation of poloxamer 
radicals may have been initiated by the presence of oxygen, heat, pressure or a catalyst 
that had been used during a previous experiment. The abstraction of hydrogen from EO 
or PO blocks produces hydroperoxide. As suggested previously,1,5,14,16 tertiary 
hydroperoxide is prone to be formed on the PO block, while secondary hydroperoxide 
would form on the EO block. Decomposition of the hydroperoxides produces alkoxy and 
hydroxyl radicals, formed on both EO and PO blocks. With time, alkoxy radicals lead to 
the formation of more hydroperoxide from both blocks. The formation of C=O (Table 4-
4) at 287.5 eV to 288.1 eV results from the breaking of peroxy chains. These chains can 
be cleaved through -scission in several ways to produce aldehyde, ketone and alkoxy 
radicals. It is evidence that the O 1s spectra of all aged poloxamers had been shifted to a 
higher binding energy. C-O-C and O-H peaks were higher in aged than fresh samples. 
Spectrum tailing indicated the O-H environment. Figure 4-10 and 4-11 show the 
mechanisms of radical formation and chain scission for EO and PO blocks proposed by 
several studies 1,5,7,14,16,17. 
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Figure 4-10: Polyoxyethylene (EO) and Polyoxypropylene (PO) block degradation 
mechanism 
 
4.5. Conclusions 
The XP spectra of aged and fresh poloxamers of three different types have been 
investigated. The stoichiometry of each type of poloxamer could be determined from a 
combination of survey and high resolution analysis. During ageing, oxidative degradation 
leads to the formation of carbonyl functional groups and absorption of moisture from the 
environment leads to the formation of water on the polymer surface. The concentration of 
C=O and water content was related with the Poloxamers EO and PO percent. It is also 
evident that the BHT concentration influences the rate of Poloxamers degradation.  
 
hCH
C H3
CH2
CH3
O CH2 CH
CH3
CH2
CH3
O CH2C C
O2,
CH3
CH2
CH3
O CH2C
OOH
C 
OOH
*
O
O
O * H 
HO
H+
h
CH2CH2 O CH2 CH2 CH2 O CH2CH CH
O2,
CH 2 O C H2C H
OOH
CH
OOH
H+
CH2 O CH2CH
O
CH
O
H O + 
PEO PEOPPO aa b
CH2 O CH 2C 
O
C 
O
HO +
C H3 CH3
A: General Poloxamer chemical formula 
B: EO radical degradation mechanism 
C: PO radical degradation mechanism 
Chapter 4  Poloxamer Characterisation 
119 
 
 
 
Figure 4-11: Scissions of Polyoxyethylene (EO) and Polyoxypropylene (PO) block 
radicals 
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5. CHAPTER 5: POLYCRYSTALLINE PARACETAMOL 
CHARACTERISATION 
5.1. Objectives 
The objective of this chapter is to examine the possibility to detect differences in local 
interactions within different forms of paracetamol by core level spectroscopy. 
5.2. Introduction 
X-ray photoelectron spectroscopy (XPS) is a well-established technique for elemental 
analysis at surface and for the determination of the chemical state of atoms at surfaces. 
The technique has been used extensively for surface science studies of single crystal 
surfaces, adsorbed molecules and thin films, including studies of their growth and of 
surface reactions.1 Over the last decade or so the technique has also been established in 
studies of biomaterials,2-5 where it has proved useful especially for the determination of 
thin films and overlayers of functionalised organic moieties anchored at surfaces. 
In the context of pharmaceutical research XPS has mostly been used in studies of 
controlled release drug delivery systems, especially in the context of active 
pharmaceutical ingredient (API) absorption and adsorption on drug delivery carrier 
materials, including particulates6-17 and films18-22. Already in 1991 Buckton introduced 
the idea to correlate XPS–determined surface chemical compositions with the wettability 
of API surfaces ,23 but this experimental approach was subsequently taken up only 15 
years later, in studies addressing the crystal facet anisotropy of wetting behavior 24-26 and 
the wetting of polycrystalline powder samples 27-29. Very recently, the technique has also 
been applied to detect free base segregation at the surfaces of an API salt powder30 
because the free base layer impacted on the flowability of the milled drug. The ability of 
XPS to sensitively probe inter- and intramolecular proton transfer in organic solids can be 
applied to distinguish between salts and co-crystals of APIs with a nitrogen proton-
acceptor group 31-33, establishing the technique as complementary to X-ray diffraction and 
solid state NMR characterization of proton transfer. 
While proton transfer leads to sizable chemical shifts in high resolution XP spectra, it 
is currently not clear whether XPS is also sensitive to more subtle variations in local 
structure in molecular organic solids, for example due to polymorphism, disorder or 
crystal facet specific termination effects. In the absence of strong electronic interactions 
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due to, e.g., inter- or intramolecular - interactions or electron transfer, the expected 
effects on the core level binding energies probed by XPS should be small, because the 
cohesive energy of molecular crystals derives typically from relatively weak dipole, van 
der Waals and London interactions. However, no systematic studies of their effects have 
been performed.  In the following the issue is directly addressed through a study of a 
number of polycrystalline paracetamol samples that were obtained by different 
preparations routes. They include commercial Form I paracetamol powder, a different 
polymorphic form (Form III) of paracetamol, and various quench-cooled melts and ball-
milled paracetamol samples with varying degrees of disorder. Paracetamol was chosen 
because it represents one of the few compounds for which literature data already exist.26 
  
5.3. Experimental Section 
5.3.1. Materials 
Seven paracetamol powder and blends were prepared for the comparative analysis. 
i) Untreated paracetamol powder (Form I), as received from Sigma Aldrich, UK. 
ii) Ground paracetamol obtained by grinding material i) using a mortar and pestle. 
iii) Milled paracetamol, obtained by milling i) in a Retsch MM200 mixer mill at a 
rate of 30 Hz, using 5 mL stainless steel jars, each containing one 7 mm 
diameter stainless steel ball mill. The milling time was 5 min. 
iv) A liquid nitrogen (LN2) quench-cooled melt of paracetamol 34-36. Powdered 
paracetamol i) was melted in an aluminium foil envelope and immediately 
immersed in liquid nitrogen (LN2). 
v) 5 min milled LN2-quench-cooled paracetamol, obtained by milling an aliquot 
of sample iv) in a Retsch MM200 mixer mill at a rate of 30 Hz, using 5 mL 
stainless steel jars, each containing one 7 mm diameter stainless steel ball mill. 
vi) 15 min milled LN2-quench-cooled paracetamol, obtained by milling an aliquot 
of sample iv) in the same way as v). 
vii) Glassy paracetamol obtained through a DSC heat-cool cycles (see section on 
DSC results below) performed under a flow of N2 gas. 
 
Besides XPS characterization all the above samples were investigated by PXRD and 
DSC. Due to the difficulties of obtaining sufficient sample from the small pans used in 
DSC, no characterisation of the DSC-derived sample vii) by ATR-IR could be performed. 
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5.3.2. X-ray Powder Diffraction (PXRD) 
PXRD reference patterns of untreated paracteamol and aged samples were collected on 
a PANalytical X'Pert Pro Multipurpose Diffractometer (MPD) in transmission Bragg-
Brentano geometry with a Cu anode operating at a power of 1.6 kW (40 kV, 40 mA). 
Polycrystalline samples were mounted as received on XRF grade Mylar film and rotated 
at 0.5 Hz. The incident beam was conditioned with a focusing mirror, 0.04 rad Soller slits 
and a 0.5° antiscatter slit. The diffracted beam passed through 0.04 rad Soller slits and 
0.5° antiscatter slit before entering the PIXcel detector operating in scanning mode with 
an effective step size of 0.013° between data points and a dwell time of 18.69 s per data 
point. 
PXRD patterns of solidified melts and milled samples were recorded immediately after 
preparation using a Rigaku Miniflex Instrument utilizing CuKα radiation (1.5406 Å), 
operating over 5-40° at 1.5° min-1 with a potential of 30 kV and current of 15 mA in steps 
of 0.03°. Typically 1 to 2 mg of sample was placed on the top holder and smoothed to 
achieve a level surface. 
 
5.3.3. Differential Scanning Calorimetry (DSC) 
Thermal analysis was conducted using a TA Instruments DSC Q100 with a low 
temperature attachment (Refrigerated Cooling System, TA Instruments) for subambient 
operation. The instrument was calibrated with high purity indium (Нfusion = 28.57 J g-1 
and Tm = 156.36 °C). The specific software of TA Universal Analysis 2000 was used for 
heat capacity calculations in the study. All scans were conducted at 10°C/min with 
nitrogen purge to minimise oxidative decomposition. A sample (5-12 mg) was weighed 
and crimped in the DSC pan, which was weighed again to ensure that the sample had not 
spilled out during the crimping process. Each of the samples was programmed to the 
methods needed. Most of the samples were analysed more than twice. A few samples 
were run more than once, as good thermograms were obtained. 
5.3.4. X-ray Photoelectron Spectroscopy (XPS) 
XPS spectra were recorded with a Kratos Axis Ultra instrument employing a 
monochromatic Al K source (1486.69 eV), a hemispherical analyser with a hybrid 
(electrostatic and magnetic) lens system, charge neutralization by filament-generated, 
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magnetically channeled low-energy electrons37, and a delay line detector (DLD). The 
powder samples were spread over double-sided tape for the XPS analysis, and care was 
taken to ensure that the sample particles completely covered the tape. However, 
throughout the study, measurement and analysis was not ruled out for the tape 
contribution affected the samples composition or element (C, O and N). Experiments 
were performed while operating the X-ray source with a power of 180 W (15 kV and 12 
mA), with the pressure below 108 mbar during analysis. 
The instrument was operated in CAE (constant analysis energy) mode, with a pass 
energy of 80 eV for survey scans, and 20 eV for high resolution scans of the 
photoemission from individual core levels, with a calibrated intensity/energy response 
and transmission function38. Surveys were measured in steps of 0.5 eV, with 300 ms 
dwell time per data point. High resolution spectra were measured within the spectral 
range of interest ( 20 eV around the core level emission peaks of interest), with 0.1 eV 
steps and 300 ms dwell time per data point for C 1s, 400 ms for O 1s, and 500 ms for N 
1s spectra. Repeats were carried out to check for radiation damage.  
Analysis of the data was carried out with Casa XPS software39. A Linear background 
was used in all curve-fitting along with a GL(30) lineshape (70% Gaussian, 30% 
Lorentzian using the Gaussian/Lorentzian product form39) and samples were referenced 
to adventitious hydrocarbon contamination at 285 eV. Positions of photoemission peaks 
assigned to chemical environments are in agreement with the ranges commonly reported 
for similar chemical environments1,40. Individual chemical environments/functional 
groups often exhibit similar ranges of binding energy values where the bonding or 
electronegativity is similar, thus where peaks arising from photoemission from different 
chemical environments occurred at the same position or within ±0.1 eV, a single peak 
was used to represent both environments for clarity and ease of discussion. The elemental 
compositions were calculated using an O 1s relative sensitivity factor (RSF) of 2.52 
relative to C 1s, using the Scofield values corrected for angular anisotropy of 60, and an 
inelastic mean free path energy dependency of 0.66. Repeatability of the binding energy 
measurements was 0.1 eV, while repeatability for the elemental composition values was 
within 1.0%.  
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5.4. Results and Discussion 
5.4.1. DSC of Untreated Form I Powder 
To establish that the supplied paracetamol Form I powder followed the established 
phase behavior36,41-44 it was analysed by DSC (Figure 5-1). The first cycle of the 
thermogram indicates that melting of the Form I powder commences at about 169.4°C, 
and that the phase transition rate goes through the maximum at 171.7°C. After cooling 
this melt to 10°C, the second thermogram follows closely the previously reported 
progression of phase transitions, including (i) crystallization of the glassy state of the 
solidified melt to paracetamol Form III (onset at 76.0°C, maximum at 82.3°C), (ii) 
recrystallisation of Form III to Form II (onset at 124.2°C, maximum at 128.5°C), and (iii) 
melting of Form II (onset at 157.0°C, maximum at 159.8°C). 41 The Tg of the solidified 
paracetamol melt was at 24.6°C, which is also in agreement with previous observed 
values.41 
We also investigated the milled sample iii) by DSC. It exhibited a weak and broad glass 
transition at a slightly higher Tg value of 42.9°C, indicating that the amorphous 
component introduced by milling was non-uniform and not as strongly disordered as the 
solidified melt. Evidence for Forms III and II was not observed; only melting at the 
temperature characteristic for form Form I was observed. Subsequent cooling and re-
heating resulted in the same behavior as for the unmilled sample. 
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Figure 5-1:. DSC curve of the untreated commercial Form I paracetamol powder, 
indicating how the glassy paracetamol as well as Forms II and II are obtained by 
heating a melt of Form I 
 
5.4.2. PXRD 
Powder diffraction patterns were generated from the DSC-melted sample as well as 
from the samples obtained by milling directly after preparation. The patterns are 
displayed in Figure 5-2. All patterns exhibit strongly broadened lines, indicating the 
presence of significant disorder. Comparison with calculated reference diffraction 
patterns of Form I45, Form II46 and Form III47 (Figure 5-2) reveals that the composition 
of the solidified melt obtained from the DSC experiment is dominated by a disordered 
Form III component, but some disordered Form I component is present as well. 
Disordered Form I dominates the composition of the milled samples. Unfortunately the 
pattern of the LN2-quenched sample could not be reliably acquired due to instrument 
failure. 
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Figure 5-2: X-ray powder diffraction patterns for the non-crystalline samples 
compared to calculated patterns for Form 1, Form 2 and Form 3 of paracetamol. 
Data acquired with a Rigaku benchtop XRD system. 
 
Untreated paracetamol exhibited the expected diffraction pattern of Form I with a high 
degree of crystallinity and phase purity (Figure 5-3). Figure 5-3 also displays the 
diffraction patterns of the LN2-quenched sample alongside two milled samples after 
storage for 8 months. It can be seen that the broadening of the diffraction lines observed 
directly after preparation (Figure 5-2) has given way to sharp diffraction lines 
characteristic for Form I of paracetamol. Clearly re-crystallisation of the disordered 
phases to Form I take place at a significant rate. These data were acquired with a rotating 
capillary powder sample holder, allowing identification of preferred orientation effects 
through the intensity distribution of the diffraction peaks. It can be seen that the LN2-
quenched sample exhibits a strong reflection at 2θ = 36° (CDS: plane of (132)), 
indicating that it has recrystallised to crystallites with strongly preferred orientation of the 
crystal planes. No such strong preferred orientation effects were observed for the milled 
samples.  
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Figure 5-3: X-ray powder diffraction patterns of untreated paracetamol (Form I) 
compared to for milled samples compared to the pattern of untreated paracetamol. 
Data acquired with a rotatingcapillary in the Philips Panalytical XRD system 
approximately 8 months after measuring the data displayed in Figure 5-2. 
 
5.4.3. XPS Survey Data 
Survey spectra (Figure 5-4) show the 1s photoemission from C, O, and N for all 
samples and their KLL Auger peaks. The elemental composition of the sample region 
probed by XPS can be determined from the survey spectra (Table 5-1). It can be seen that 
the C, O, and N percentages are close to those expected from the stoichiometry of a pure 
paracetamol sample, but an excess of C intensity at the expense of O and particularly N 
intensity suggest the presence of significant contributions from adventitious hydrocarbon 
contamination on all samples. An excess of C is also borne out by the higher than 
expected C:O and C:N intensity ratios (Table 5-1). The observed level of contamination 
indicated by these data is similar to that commonly observed in studies of inorganic 
materials handled in a laboratory environment1. In recent studies of other molecular 
materials with the same XPS instrument 31,32,38 similar levels were also observed. 
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Figure 5-4: XPS survey spectra of all paracetamol powder samples. 
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Table 5-1: Comparison of expected elemental composition of pure paracetamol with 
the composition actually determined from the XPS survey data. 
 C O N C:O C:N O:N 
Paracetamol, expected 
(atom%) 
72.7 18.2 9.1 4.00 8.00 2.00 
Untreated powder (%) 
EB (eV) 
76.55± 0.64 
284.7 
15.69 ± 0.58 
532.2 
7.76± 0.06 
400.0 
4.88 9.86 2.02 
Milled powder (%) 
EB (eV)) 
73.91   
284.7 
18.53   
531.7 
7.56  
399.7 
3.99 9.77 2.45 
Ground Powder (%) 
EB (eV) 
76.65 
284.7 
15.52   
532.7 
8.13   
400.2 
4.94 9.43 1.91 
DSC (%) 
EB (eV) 
75.09 
284.7 
17.07 
532.7 
7.84 
400.2 
4.40 9.58 2.18 
LN2 quenched 
EB (eV) 
76.65 
284.7 
15.74 
532.7 
7.67 
400.2 
4.87 9.99 2.05 
Ground LN2 quenched 
EB (eV) 
76.58 
284.7 
15.55 
532.7 
7.88 
400.2 
4.92 9.72 1.97 
5 min milled LN2 
quench 
EB (eV) 
74.04 
 
284.7 
17.60 
 
532.2 
8.36 
 
400.2 
4.21 8.86 2.11 
15 min milled LN2 
quench 
EB (eV) 
74.84 
 
284.7 
17.28 
 
532.2 
7.88 
 
400.2 
4.33 9.50 2.19 
 
5.4.4. XPS High Resolution Data 
For the discussion of the chemical shifts in the high resolution data we recall the 
numbering of the various atom species in paracetamol in Figure 5-5. 
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Figure 5-5: Numbering of atoms in paracetamol, C8H9NO2 
 
C1s 
The photoemission from the C 1s core level of paracetamol reveals three clear peaks. 
Peaks of increasing EB are assigned to the carbon environments with increasing 
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electronegative neighbours (decreasing electron density on carbon), with the lowest EB 
peak at 284.7 to 285.4 eV; two deconvoluted C environments were fitted: C=C (C2, C3, 
C5, C6) and C-C (C8). The shoulder peaks ranging from 285.76 to 286 eV arise from 
C-OH (C4) and C-N (C1). The well resolved peak at 287.92 to 288.02 eV arises from 
carbon in the amide group, N-C=O. The aromatic structure of paracetamol results in a 
broad -* shake-up satellite at high EB values around 291 eV. 
 
Figure 5-6: C1s photoemission spectra of some paracetamol powdered samples. 
 
Visual inspection of the C 1s data displayed in Figure 5-6 already indicates that 
variations between the samples are only minor. The vertical lines drawn through the 
spectra show that the chemical shifts in the binding energies of the various carbon 
moieties are negligible. The relative intensities of the three fitted curves under each 
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spectrum are comparable as well. The numerical results of the curve fitting analysis 
(curves displayed in Figure 5-6) underline these observations (Table 5-2, and Figure 5-
7). Most interestingly, the intensity of the N-C=O (amide) group of paracetamol does not 
vary very much across the various preparations (Table 5-2, Figure 5-7). This is 
interesting, because the strongly chemically shifted C1s emission from the amidic carbon 
atom is specific for emission from paracetamol because adventitious carbon 
contamination does not contain amide species. The reduction of the amide emission is for 
all samples approximately 30-40%, which is too large to be compatible with a reduction 
due to crystal facet orientation effects, because the C1s signal escapes from a depth of a 
few nm,48 i.e., from a region in the crystal that is significantly larger than the thickness of 
a single molecular layer. Moreover, the amide emission is unaffected by either crystal 
structure, crystallinity or preferred orientation of the crystallites in the powder samples. 
This suggests that the observed variations relate predominantly to the presence of 
adventitious carbon contamination species at the surface, a conclusion that is also in line 
with the elemental analysis data derived from the survey spectra (see Figure 5-4). 
Finally, the C1s emission contributions from the C=C/C-C=O and C-N/C-OH groups 
support this conclusion as well, because a lower than expected intensity value for C=C/C-
C=O groups was associated with an increased concentration of C-N/C-OH (Table 5-2). 
This trend was observed for all the samples. A quantitative interpretation of the C-N/C-
OH enhancement is not entirely straightforward because the intensities of all peaks in the 
C 1s data are affected by the presence of the shake-up peak at higher binding energy. It is 
not clear how its intensity is related to the intensities of the three main peaks in the 
spectra. However, in a first approximation, the magnitude of the enhancement in the C-
N/C-OH component of the C1s emission is around 10% (Table 5-2), indicating that the 
adventitious carbon contamination contains significant concentrations of functional 
groups with C-O bonds. 
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Table 5-2: Results of quantification of the C1s emission by curve fitting analysis. 
The emission intensities [%] do not add up to 100% because of the presence of the 
shake-up peak in the spectra. 
Samples C=C C-C=O C-N C-OH N-C=O 
Expected (%) 50.0 12.5 12.5 12.5 12.5 
Untreated powder 
EB (eV) 
49.3 
284.7 
12.3 
285.4 
12.3 
285.7 
12.3 
286.2 
8.0 
288.1 
5 min milled powder 
EB (eV) 
48.1 
284.7 
12.1 
285.2 
12.0 
285.7 
12.0 
286.3 
12.0 
288.0 
Ground powder 
EB (eV) 
50.9 
284.7 
11.4 
285.4 
12.4 
285.8 
12.4 
286.2 
8.7 
288.1 
DSC 
EB (eV) 
49.1 
284.7 
12.3 
285.0 
12.3 
286.0 
12.3 
286.0 
8.5 
288.0 
Untreated LN2  
EB (eV) 
49.1 
284.7 
12.4 
285.4 
12.4 
285.8 
12.4 
286.3 
8.3 
288.1 
Ground LN2 
EB (eV) 
48.1 
284.7 
12.0 
285.3 
12.0 
285.8 
12.0 
286.3 
9.3 
288.1 
5 min milled LN2 
EB (eV) 
47.4 
284.7 
11.9 
285.1 
11.9 
285.8 
11.8 
286.2 
11.8 
288.0 
15 min milled LN2 
EB (eV) 
48.4 
284.7 
12.1 
285.1 
12.1 
285.8 
12.1 
286.2 
12.1 
287.9 
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Figure 5-7: Plot of the intensities of the C 1s emission components for all samples. 
The concentrations [%} do not add up to 100% because of the presence of the 
shake-up peak in the spectra. 
 
O1s 
Paracetamol is characterized by two O 1s emission peaks, a carbonyl oxygen 
component at 531.3 eV and a hydroxyl emission at 532.76 eV (Figure 5-8, Table 5-3). 
The results of the curve fitting analysis of the O 1s data of all samples are summarized in 
Table 5-3. The binding energies are compatible with previously observed values for these 
functional groups,40 and there is little variation between the samples. From the 
stoichiometry of paracetamol one would expect intensities of the two peak components to 
be in a ratio of 1:1. In contrast to this expectation the data in Figure 5-8 are characterized 
by generally stronger emission from the OH than the carbonyl component. This is clearly 
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borne out by the results of the quantitative curve fitting analysis (Table 5-3), which 
indicates that on average 59% of the O 1s emission stems from the OH region of the 
spectrum. A very similar enhancement of the OH concentration has previously been 
reported for individual facet surfaces of paracetamol.26 The inelastic mean free path of 
the O1s electrons is on the order of 2.9 nm,48 indicating that the surface region probed by 
the O 1s signal is several nm. This length is too large to be compatible with an enhanced 
OH concentration due to crystal facet termination effects, which would be restricted to a 
surface region with a thickness similar to a C-OH bond (~0.3 nm). It is more plausible to 
assume that OH groups from the adventitious carbon contamination cause the observed 
enhancement of the OH signal. The observed enhancement of the O 1s signal is on the 
order of 10% of the signal expected for the two oxygen atoms in paracetamol. We noted 
above that the observed attenuation of the C1s signal from the paracetamol amide group 
was about 30-40%, indicating that the adventitious carbon contaminations contains 
approximately one oxygen atom for every four carbons atoms. 
Table 5-3: O 1s high resolution binding energy analysis of all the samples 
Samples OH (eV) C=O (eV) 
Expected (%) 50 % 50 % 
Untreated powder 
EB (eV) 
57.36% 
532.8 
42.64% 
531.3 
Milled powder 
EB (eV) 
55.06% 
532.8 
44.94% 
531.3 
Ground powder 
EB (eV) 
57.72% 
532.8 
42.28% 
531.3 
DSC 
EB (eV) 
57.06% 
532.7 
42.94% 
531.3 
Untreated LN2  
EB (eV) 
58.27% 
532.8 
41.73% 
531.3 
Ground LN2 
EB (eV) 
56.10% 
532.8 
43.90% 
531.3 
5 min milled LN2 
EB (eV) 
59.61% 
532.8 
40.39% 
531.3 
15 min milled LN2 
EB (eV) 
63.73% 
532.8 
36.27% 
531.3 
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Figure 5-8: O1s photoemission spectra of all paracetamol samples. 
 
 
Figure 5-9: O 1s analysis of tested samples 
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N1s 
For all samples only one peak of N was observed in the N 1s emission, with a binding 
energy of approximately 400 eV, which is compatible with the N-C=O amide species. 
Table 5-4 summarises the N 1s (bottom) high resolution binding energy analysis of all 
the samples. No additional quantitative information can be derived from the high 
resolution N1s data, which are therefore not displayed here. 
 
Table 5-4: Results of N 1s high resolution binding energy analysis of all the samples 
Samples N-C=O (eV) 
Untreated powder 400.2 
Milled powder 400.0 
Ground powder 400.2 
DSC 400.2 
LN2 without ground 400.2 
LN2 ground 400.2 
LN2 milled 5 minutes 400.1 
LN2 milled 15 min 400.0 
 
5.5. Discussion 
The first high resolution XPS data of paracetamol reveal that the C 1s and O 1s 
photoemission spectra contain a number of emission features that have previously not 
been observed in XPS data obtained with a non-monochromatised X-ray source.26 
Especially the well resolved C 1s and O 1s emission features from the amide group of 
paracetamol can be used to characterize surface cleanliness, phase purity and local 
structure. However, the XPS examination of a number of paracetamol powder samples 
with different degrees of crystallinity, crystal structure or preferred orientation of the 
crystallites produced very similar results for all samples. Most notable is a significant 
attenuation of the signal from the paracetamol amide group, which is evident from the 
elemental analysis, from the analysis of the high resolution C 1s emission data and from 
the hydroxyl/carbonyl intensity ratio of the O 1s emission. The surface sensitivity of XPS 
is not sufficient48 to explain this attenuation through structural variations in the top layers 
due to facet specific crystal surface terminations or reconstructions. It is more likely that 
the observed amide attenuation and the associated variations of the sample composition 
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within the near-surface region probed by XPS are due to contamination acquired by the 
samples during preparation and handling in the laboratory environment. This so-called 
adventitious carbon and oxygen contamination is a well known phenomenon in surface 
analysis1 and very difficult to avoid unless samples are prepared under conditions of 
cleanliness that cannot be achieved without very considerable effort (for example 
evaporation and sublimation under ultra-high vacuum conditions). However, no 
measurement on the effect of tape was done due to the constaint of instrument availability 
and analysis cost. This explanation of the observed variations is given particular 
credibility by the fact that amides are not a common component in adventitious surface 
contamination layers. The well resolved features of the amide group in the C 1s, N 1s and 
O 1s emission from paracetamol thereby provide a reliable means for determining the 
amount of contamination on the surface. The quantitative analysis of the data suggests 
that the adventitious contamination layer constitutes about 30-40% of the carbon content 
within the near-surface layer probed by XPS, and that it contains carbon and oxygen 
approximately in a ratio of 4:1. These substantial amounts of surface contamination are 
likely to have a pronounced effect on commonly used macroscopically observable surface 
parameters such as contact angles. 
 
5.6. Conclusions 
The reported study of polycrystalline paracetamol samples underlines the fact that 
extreme care must be taken when surface properties are determined by surface sensitive 
techniques that do not permit insight into the chemical composition of the top molecular 
layers.  
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6. CHAPTER 6: SINGLE CRYSTAL PARACETAMOL 
6.1. Objectives 
The objectives of the studies reported in this chapter were twofold: 
i) To examine the possibility that XPS can establish the chemical composition of 
paracetamol facets by determining the elemental composition and the chemical 
state of the elements at selected crystal facets  
ii) To examine the surface chemical composition as a function of solvent used during 
crystal growth.  
 
6.2. Introduction 
The affinities of a crystal depend on the presentation of its facets, and the surface 
properties of a particular crystal facet will be governed by the molecular functionalities at 
the surface. The dominant facets of a crystal will influence its physical and chemical 
interfacial properties, including the wettability, surface energy and chemical 
composition1. The crystal structure determines the macroscopic crystal shape. Therefore 
the knowledge of crystal structure at a molecular level is a prerequisite to the 
understanding and potential control of pharmaceutically important bulk properties of 
crystalline pharmaceutical solids.  
The most prominent characteristic features of an individual crystal are its facets 
and the angles between them2. The Miller indices of the crystal facets are associated with 
surface coverage by characteristic functional groups, which depend on conformation of 
molecules in the crystal structure and the chemical composition determined by the crystal 
termination. The crystal system, structure and Miller indices of the prominent facets can 
often be determined by powder XRD, and always by single crystal XRD techniques. 
Scanning electron microscopy (SEM) has been used as well, especially in early work in 
conjunction with computer programs based on geometric considerations3. The Cambridge 
Structural Database acts as a repository of small molecule crystal structures, so data 
needed for crystal structure visualization, analysis and structural knowledge can be 
obtained without experiments4. There have been numerous studies of paracetamol, whose 
crystal structure was first studied by Haisa5, followed by studies of electron density6, the 
 
Chapter 6  Single Crystal Paracetamol 
145 
 
interaction of paracetamol solute with crystallization solvents and density functional 
theory (DFT), including electronic distribution 7. 
Paracetamol was chosen for the X-ray Photoelectron Spectroscopy study in this 
thesis for three main reasons. Firstly, there have to date been no detailed studies of single 
paracetamol crystals using high resolution XPS analysis. Secondly, paracetamol crystals 
are sufficiently stable under UHV conditions compared to other available API such as 
ibuprofen and aspirin. Thirdly, only one study has previously addressed the composition 
of single crystal facets, but without reference to the solvents used for crystallisation. XPS 
analysis will also provide an opportunity to gain information on the influence of 
contaminants in the crystallization process and of the solvents used during crystallization.  
BFDH (Bravais-Friedel-Donnay-Harker) theory was applied to identify the 
orientation of paracetamol crystal facets. BFDH theory was developed in the first half of 
the 20th century as a tool for the prediction of crystal morphology. The basis of BFDH 
predictions is the assumption that the morphological importance, which encompasses 
both facet size and the statistical frequency of facet occurrence, of an (hkl) facet increases 
with the interplanar distance dhkl between the (hkl) lattice planes8, 9. The dhkl values must 
also be corrected for the selection rules for each of the 230 space groups, which can be 
found in the International Tables for X-ray Crystallography 10. A high frequency of facet 
occurrence and/or facets with large surface areas are typically associated with slowly 
growing facets, which leads to the application of BFDH theory in crystal morphology 
prediction by associating higher growth rates of an (hkl) face with lower dhkl values, and 
vice versa. In the 1950s, Hartman and Perdok developed theoretical methods for the 
prediction of crystal growth and morphology that put BFDH theory on a sounder physical 
foundation by calculating relative facet stability based on a consideration of nearest 
neighbour bonds in the crystal2. 
6.3. Experimental 
6.3.1. Preparation of Single Crystal and Ground Crystal Paracetamol  
i) AceSingle1 (single crystal grown in acetone #1). HPLC grade acetone was used 
in the crystallisation experiment. The apparatus was cleaned and dried at 400°C for 
2 hours in the oven before use. A single acetone crystal was prepared by the slow 
cooling crystallisation technique. A saturated acetone-paracetamol solution was 
prepared by dissolving paracetamol in 20 mL acetone at 20°C. The experiment was 
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performed in a 50 mL jacketed vessel connected to a programmable circulating 
water bath, model RTE 740 (Thermo Neslab Digital Plus). The temperature was 
raised to 23°C in order to form a supersaturated solution for 1 hour, after which the 
temperature was reduced gradually over 1 hour to 20 °C. During this process the 
solution was stirred constantly using a magnetic stirrer at scale 4. The solution was 
kept at 20°C with stirring for 2 hours. Some of the solution was then taken for seed 
preparation, stirring ceased and the temperature was reduced by 0.1°C per day until 
it reached 19.8°C, when single crystal nucleation was induced by the addition of 
seeds. After the initiation of seeding, the bath temperature was reduced by 0.2 °C 
per day until it reached 16°C. The crystal was dried under ambient conditions 
before further analysis. The paracetamol weight used in the saturated solution was 
based on reading the reference solubility curve 10 at a temperature of 20°C. The 
paracetamol molar concentration was calculated at 0.01 mol in 20 mL of acetone 
(0.45M).  
 
ii) AceSingle2 (single crystal grown in acetone #2): A single acetone crystal was 
prepared by the slow cooling technique described above, the only difference being 
in the cleaning of all the apparatus in detergent, after which it was thoroughly 
rinsed in deionised water. No further cleaning was done. 
 
iii) EtSingle (single crystal grown in ethanol): A single ethanol crystal was prepared 
by slow cooling crystallisation. All of the apparatus was first cleaned in detergent 
and rinsed with deionised water. No further cleaning was done. The only ethanol 
solvent used was absolute ethanol. A saturated ethanol-paracetamol solution was 
prepared by dissolving paracetamol in 20 mL ethanol at 20°C. The following steps 
as stated in AceSingle (in section i). 0.019 moles were added to 20 mL of ethanol 
giving 0.98M of paracetamol solution.  
 
iv) MeSingle1 (single crystal grown in methanol #1): All the apparatus used was 
washed in APS two days before use, then dried in an oven at 60°C and covered 
with Parafilm until the crystallisation experiment. The methanol solvent used was 
HPLC grade. The crystallisation procedure was similar to that described for acetone 
crystal preparation. 0.03 moles were added to 20 mL of methanol giving 1.55M of 
paracetamol solution. 
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v) MeSingle2 (single crystal grown in methanol #2): Before the experiment all the 
apparatus was prepared as for the acetone crystal experiment. The crystallisation 
technique was similar to that used in the acetone experiment.  
vi) Powder:  Powdered paracetamol was used without any treatment or modification 
for XPS analysis. 
 
6.3.2. XPS Analysis 
Facets of these crystals were analysed by XPS to examine the near-surface stoichiometry. 
The single crystals were analysed as a function of facet orientation and indexed with 
Materials Studio using BFDH calculations 11 (see also Introduction and Chapter 2).  
XPS was carried out as described in Chapter 2. As given in the table in the previous 
section, three groups of paracetamol single crystals were analysed: prepared from 
saturated solutions of paracetamol in acetone, ethanol and methanol respectively. For 
each single crystal a different number of facets, and in some cases various spots on a 
facet, were chosen for analysis, depending on facet size, ability to neutralise built-up 
charges, and the accessibility of under the geometric constraints of the XPS apparatus. 
The XPS analysis was in two mode; 4 peaks of fitting and 6 peaks of fitting for C1s and 
O 1s data.  
Some of the crystal facets underwent visible beam damage during the XPS 
investigations, while others were not affected. These observations were as follows: 
i) AceSingle1 and AceSingle2: No colour change on the sample surface. The crystals 
were observed to be unchanged during the XPS analysis. 
ii) EtSingle: The sample surface became yellowish after the XPS experiment. 
iii) MeSingle1 and MeSingle2: Sample surfaces were observed to be unchanged after the 
XPS analysis. No colour change was observed. 
iv) Ground crystals: All the ground crystals kept their original colour. No colour change 
to the powder surface was observed. 
 
6.3.3. BFDH Assignment of Crystal Facet Orientation 
The AceSingle (Figure 6-1) crystal was analysed at four spots, but only two could be 
used due to excessive charging during the measurements at the other spots. 
Chapter 6  Single Crystal Paracetamol 
148 
 
 
Figure 6-1: (a) Photograph of AceSingle crystal with areas of XPS small spot 
analysis indicated by numbers; spot 1: (0-20)-facet; spot 2: (0-1-1)-facet; spot 3: (-1-
10)-facet, spot 4: (1-10)-facet; (b) BFDH construction that formed the basis for facet 
orientation assignment.  
 
The EtSingle sample was analysed at 23 spots on a large single facet. The crystal image 
and schematic BFDH diagram are illustrated in Figure 6-2.  
 
1
4
2
3
1 cm 
(a) 
(b) 
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Figure 6-2 (a) Photograph of EtSingle crystal with areas of XPS small spot analysis 
indicated by numbers; spot 1: (0-1-1)-facet; spot 2: (-1-1-1)-facet; spots 3-20 & 22: 
(00-1)-facet, spot 21: (01-1)-facet; (b) BFDH construction that formed the basis for 
facet orientation assignment; bottom: sketch of single crystal superimposed over 
BFDH construction. 
 
Paracetamol crystallisation from methanol (MeSingle1) generated the highest 
quality crystals with clear facets (Figure 6-3). The BFDH-derived orientations of the 
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facets were for this crystal independently confirmed through a Laue single crystal 
orientation (see next section below for details). 
 
 
       
Spot 1 Spot 2 Spot 3 Spot 4 
 
Spot 1- facet 
 
Spot 2- facet 
 
Spot 3- facet 
Spot 5 Spot 6 Spot 7 
Spot 1- plane Spot 2- plane Spot 3- plane Spot 4- plane 
Spot 7- plane Spot 6- plane 
(a) 
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Figure 6-3: (a) Photographs covering 0.8 cm2 around the XPS analysis spots on the 
MeSingle1 crystal; images were acquired in situ in the XPS analysis chamber; the 
XPS small spot analysis was taken in the central area of each photograph; Four 
spots, labeled 1 to 4, were chosen on the main (-101) facet, two spots, labeled 5 and 6, 
on the (011) facet and one spot (7) on the (11-1) facet. Spots 1 and 2 were in the 
middle of the (-101) facet, while spots 3 and 4 were at its edge. Tilting the holder at 
approximately 45° exposed facet (011) of the crystal. Only one spot (7) was analysed 
on facet (11-1) because of the geometric constraints on the detection of 
photoelectrons in that position. (b) photographs of the MeSingle1 crystal; (c) BFDH 
construction that formed the basis for facet orientation assignment, with sketch of 
single crystal superimposed over the BFDH construction.  
 
Similarly, from the methanol-derived MeSingle2 crystal a total of 8 spots on 3 
main facets were analysed, as shown in Figure 6-4.  
(b) 
(c) 
0.7 cm 
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Figure 6-4: (a) Sketch of MeSingle2 crystal with areas of XPS small spot analysis 
indicated by numbers; spots 1: (1-11)-facet; spot 2: (20-1)-facet; spots 3,4: (00-1)-
facet; spot 21: (01-1)-facet; (b) BFDH construction that formed the basis for facet 
orientation assignment; (c) sketch of MeSingle2 (1-10)-facet with areas of XPS small 
spot analysis indicated by numbers 5-8; (d) BFDH construction that formed the 
basis for facet orientation assignment.) 
 
All orientations of investigated facets are summarised in Table 6-1. The scheme in 
Figure 6-5 summarises which facets were examined by XPS. 
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Table 6-1: Orientation of all analysed facets of paracetamol single crystals as 
determined by BDFH analysis  
Type of Single Crystal Spots Facets orientation 
AceSingle 1 
2 
3 
4 
(0-20) 
(0-1-1) 
(-1-10) 
(1-10) 
EtSingle 1 
2 
3-20 &22 
21 
(0-1-1) 
(-1-1-1) 
(00-1) 
(01-1) 
MeSingle1 1-4 
5 &6 
7 
(-101) 
(011) 
(11-1) 
MeSingle2 1 
2 
3-4 
5-8 
(1-11) 
(20-1) 
(00-1) 
(1-10) 
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Figure 6-5: Summary of the facets of the single crystals prepared which were 
analysed 
 
6.3.4. Laue Orientation of MeSingle1 Crystal Facet Orientations 
The single crystals were generally too large for orientation in the X-ray goniometer 
available to the local analytical SXRD service. However, for the methanol-derived 
crystal, MeSingle1, the structure and the Miller indices of the crystal facets could be 
checked by single crystal Laue XRD (SXRD). Single crystal X-ray diffraction data were 
collected at 100 K with an Oxford Diffraction X-Calibur 2 diffractometer utilising Mo K 
radiation (λ = 0.71073 Å) and an Oxford Cryosystems Cryostream Controller 700. Data 
were recorded with the X-ray source operating at 50 kV and 40 mA. Data reduction, cell 
refinement, and multi-scan absorption corrections were carried out using the program 
CrysAlis RED (Oxford Diffraction Ltd., version 1.171.32.24, 2008). The structure was 
solved with SHELXS-97 and refined on F2 against all reflections with SHELXL-97. All 
non-hydrogen atoms were refined by direct methods anisotropically; all hydrogen atoms 
(011)
AceSingle MeSingle1 EtSingle
(001)
EtSingle MeSingle2
(111) 
EtSingle MeSingle1 MeSingle2
(101) 
MeSingle1 MeSingle1 MeSingle1 MeSingle1 
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were located in different Fourier maps and refined isotropically. The CIF file containing 
full crystallographic details has been deposited with the Cambridge Crystallographic Data 
Centre (CCDC) as HXACAN01. 
The facets of the methanol-derived crystal were ascertained as (-101), (011) and 
(11-1), in line with the BFDH predictions (see above). 
6.3.5. Attenuated Total Reflection IR 
Bulk analysis of crystal purity was performed by grinding the single crystals to powders, 
which were analysed alongside as received powdered paracetamol by ATR-IR 
spectroscopy, using a Thermo-Nicolet Avatar Model 360 IR. A Golden Gate ATR 
sampling accessory was employed for the ATR-IR experiments. 1-2 mg of each sample 
was placed on the ATR sampling device (Ge crystal) and a torque of 20 cNm was 
applied. The IR spectrum was processed using the OMNIC ESP 5.1 software package. 
Ground crystal samples were used directly after preparation; no further treatment was 
needed before ATR analysis. For each experiment, the background was acquired before 
analysis of the sample. Each spectrum was measured twice for the purpose of monitoring 
reproducibility.  
6.4. Results 
Only monoclinic paracetamol single crystals could be analysed by XPS. As mentioned 
earlier, form II single crystals could not be analysed because their vapour pressure was 
too high, so that significant sublimation took place in the XPS analysis chamber. 
6.4.1. ATR-IR Analysis 
Figure 6-6 shows the ATR-IR spectra of ground crystals and powder paracetamol. The 
spectra of EtGround, MeGround and paracetamol powder were very similar, while 
AceGround was characterised by some significant differences in the spectrum, mainly at 
the C-OH peak of 3163 cm-1, indicating that significant amounts of an OH-bearing 
contaminant were presented in the sample. This peak was much weaker in the spectra of 
EtGround, MeGround and powder. The C-N peak at 1223 cm-1 wavenumber was broader 
than those of other samples. The C=O characteristic peak was observed at 1651 cm-1. 
Lower C=O indicates the amide group with lowest intensity on AceGround. No 
wavenumber shift was observed for any of the samples.  
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Figure 6-6: ATR-IR spectra of all the tested ground crystal samples compared with 
powdered paracetamol 
 
6.4.2. PXRD Ground Crystals 
PXRD characterisation was used to further examine whether there were any differences 
between the samples. A comparison by reference to the commercial powder is shown in 
Figure 6-7. Again, the acetone-derived crystal stands out by exhibiting significant 
evidence for lower crystallinity (less pronounced diffraction reflexes at higher 2 values), 
while the ethanol derived sample exhibits evidence for preferred orientation or 
texturisation particularly through the high intensity peaks at about 40.5° and around 48°. 
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Figure 6-7: PXRD patterns of paracetamol powder and all the ground types of 
paracetamol crystal 
 
6.4.3. XPS Survey Analysis 
Figures 6-8 to 6-11 show the variations of atomic concentration to the selected facets as 
determined from the intensity of the C1s, N1s and O1s emission lines in XPS survey 
scans. The bar charts indicate that there were no major differences between single crystal 
types (AceSingle, MeSingle1, MeSingle2 and EtSingle) for either the (011), (001), (111) 
and (101) facets. For all samples, the C concentration was significantly higher than 
expected from the paracetamol stoichiometry (72.7%) while the concentrations of O and 
N were lower. This observation was broadly in line with previously reported results by 
Heng et al. who also reported higher than expected C 1s signals and lowered N 1s 
intensities; their results for O 1s emission intensities indicated near-stoichiometry for the 
(201), (001) and (011) facets, and reduced intensities for the (110) and particularly the 
(010) facets. 
The magnitude the enhancements in C 1s intensities was in line with a number of 
previous studies of organic substances with our instrument (including the powder data 
reported in chapter 5), which have consistently indicated the presence of excess C on 
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crystalline organic substances12-16. Since it was well known that surfaces exposed to 
ambient atmosphere exhibit adventitious C contamination17; we have previously 
attributed these slight enhancements to the presence of such contamination. We will 
discuss below to what extent crystal facet-specific variations in the surface stoichiometry 
or matrix effects affecting the electron emission process may contribute to these 
variations. 
 
 
Figure 6-8: Survey elemental analysis of C, O and N elements on (011) facet 
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Figure 6-9: Survey elemental analysis of C, O and N elements on (001) facets 
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Figure 6-10: Survey elemental analysis of C, O and N elements on (111) facets 
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Figure 6-11: Survey elemental analysis of paracetamol crystal (101) facets  
 
The paracetamol molecule is composed of carbon, hydrogen, oxygen and nitrogen 
atoms. Hydrogen cannot be detected by XPS because of its low photoelectron cross 
section. Typical survey spectra are shown in the Appendix 1 and Appendix 5 illustrating 
the C, O and N 1s photoelectron lines and their KLL Auger peaks of three different single 
crystal differentiated by solvents used during crystallisation. Figure 6-5 shows the chart 
of paracetamol facets analysed at various crystallisation solvents such as acetone 
(AceSingle), ethanol (EtSingle) and methanol (MeSingle). The stoichiometric ratio for C, 
O and N expected from the elemental composition of the molecule is 8:2:1. Table 6-2 
summarises the results for the average concentration of spots analysed; the standard 
deviation was found to be 0.2 to 0.8.  
It can be seen (Table 6-2; column 2) that the C concentration was a little higher 
than the expected value for all crystal types. It is likely that the excess C concentration, 
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which reduced the corresponding O and N percentages (Table 6-2; column 3 and 4), 
represents hydrocarbon contaminants on the crystal surface12. The enhanced C to O ratio 
is therefore likely also due to contamination with adventitious carbon (hydrocarbon) 
contamination. Table 6-2; column 5, shows that for all samples the results were not 
significantly different. 
Examining the O/N concentration ratio revealed a trend. Because most solvents 
and common contaminants dissolved in solvents tend to contain a significant amount of 
oxygen-bearing functional group the O/N ratio was particular instrumental for identifying 
whether crystallisation solvents generated clean paracetamol surfaces. Both acetone-
derived crystals (AceSingle1 and AceSingle2) were characterised by the highest value of 
the O/N ratio, suggesting that deposition of contaminants from acetone solutions was 
particularly strong. The lowest O/N ratio was obtained for untreated powder paracetamol, 
indicating that the supplied material had overall higher surface cleanliness than the single 
crystals. Methanol- and ethanol-derived crystals had intermediate O/N ratios. 
Table 6-2: Elemental analysis of single crystals and powder crystals of paracetamol. 
 %C %O %N C:O C:N O:N 
Stoichiometric 
composition 72.7 18.2 9.1 4.00 8.00 2.00 
AceSingle1 
Experim – 
Stoichiom* 
76.14 ± 0.47 
3.44 (+5%) 
17.03 ± 0.20 
-1.17 (-6%) 
6.83 ± 0.28 
-2.27 (-25%) 
4.47 
0.47 
11.15 
3.15 
2.49 
0.49 
AceSingle2 
Experim – 
Stoichiom* 
75.03 ± 0.59 
2.33 (+3%) 
17.76 ± 0.16 
-0.44 (-2%) 
7.21 ± 0.76 
-1.89 (-21%) 
4.22 
0.22 
10.41 
2.41 
2.46 
0.46 
EtSingle 
Experim – 
Stoichiom* 
74.92 ± 0.57 
2.22 (+3%) 
17.14 ± 0.21 
-1.06 (-6%) 
7.92 ± 0.58 
-1.18 (-13%) 
4.37 
0.37 
9.46 
1.46 
2.16 
0.16 
MeSingle1 
Experim – 
Stoichiom* 
74.21 ± 0.58 
1.51 (+2%) 
17.76 ± 0.74 
-0.44 (-2%) 
8.03 ± 0.22 
-1.07 (-12%) 
4.18 
0.18 
9.24 
1.24 
2.21 
0.21 
MeSingle2 
Experim – 
Stoichiom* 
75.28 ± 0.74 
2.58 (+4%) 
16.99 ± 0.88 
-1.21 (-7%) 
7.73 ± 0.17 
-1.37 (-15%) 
4.43 
0.43 
9.74 
1.74 
2.20 
0.20 
Powder 
Experim – 
Stoichiom* 
75.33 ± 0.54 
2.63 (+4%) 
16.74 ± 0.21 
-1.46 (-8%) 
7.93 ± 0.32 
-1.17 (-13%) 
4.50 
0.50 
9.50 
1.50 
2.11 
0.11 
* Absolute differences between experimental results and expected stoichiometry are reported alongside (in 
brackets) the relative deviation (in %). 
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6.4.4. C 1s 
High resolution spectra of all the samples are presented in the Appendix 2, 6.9-11. All 
spectra have three peak regions: two low intensity peaks at high binding energies and one 
main peak at lower binding energy with a complex shoulder.  
The C 1s spectra were fitted with six carbon signals to accommodate the six 
chemical environments in the paracetamol molecules. They first include the aromatic 
carbon (C=C) between 284.7 eV to 284.8 eV; second, the carbonyl (C–C=O) contributed 
at 285 4 eV to 285.2 eV; third, the phenolic C (C-OH) at binding energies between 286.0 
eV and 286.3 eV; fourth, the C-N emission at higher binding energy between 285.9 eV 
and 285.7 eV, all in accordance with the increasing electronegativity of the environment 
around the emitting carbon atom; fifth, the amide N-C=O or C=O group was fitted within 
288-288.3 eV13 (Table 6-3); sixth, the low intensity peak at the high binding energy 
above 290 eV is a -* shake up satellite, which is related to the presence of the aromatic 
ring14. 
Table 6-3: C 1s values of binding energy (EB) and expected atomic concentration % 
C 1s No % Range (eV) 
C=C (Aromatic) 4 50 284.7 to 284.8 
C-C=O 1 12.50 285.2 to 285.40 
C-N (Aromatic) 1 12.50 285.9 to 286.7 
C-OH (Aromatic) 1 12.50 286.0 to 286.3 
N-C=O 1 12.50 288.0 to 288.3 
Shake-up 2  289 and above 
 
 
During fitting the binding energy was constrained to within ±0.2 eV of EB values 
previously reported for C 1s and O 1s 15. Relative intensities and peak positions were 
allowed to vary with a permitted residual standard deviation (RSD) from the ideal 
paracetamol stoichiometry of 0.9 to 1.3. For instance, from stoichiometry calculations the 
expected N-C=O concentration was 12.5%, but for an RSD below 1.3 the best fitted N-
C=O percentage was only 10.5%. The C=C binding energy was fixed at 284.7 eV and the 
overlapping peaks in its shoulder fitted applying the above constraints. The peak of N-
C=O at 288 eV was separated enough in EB to not suffer from interference of other peaks 
during fitting and needed no restraints or constraints. The shake-up peak intensity was 
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about 5-8% of the whole spectrum and was also fitted without any EB or fwhm 
constraints. The overall spectral shapes obtained from all types of single crystal facets 
and powder paracetamol were much more similar to each other than in the previous study 
by Heng et al.16 No shake up peaks were apparent in previously reported results (Figure 
6-12) in contrast to the data for two of the facets reinvestigated here [(011) and (001)]. 
The reason for the dissimilarities of the results may lie in a different background 
subtraction method, the use of a non-monochromated MgKα source, the use of higher 
detector pass energy of 40 eV or different charge neutraliser settings. 
 
Figure 6-12   : C 1s spectra at 5 facets obtained from previous study by Heng 
 
6.4.5. O1s 
The O 1s spectra for all samples revealed similar spectral envelopes. Two peaks were 
assigned as C-OH and C=O at 531.3 eV and 533 eV, respectively (Appendix 3, 7, 12-
14).  
6.4.6. N 1s 
The N 1s spectra (Appendix 4, 8, 15-17) exhibit a single peak at 400.1 eV, due to one 
type of nitrogen environment assigned as amide, N-C=O. The narrow fwhm of 1.2 eV 
provides strong evidence that for fitting a second peak within the envelope was not 
necessary. 
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6.5. Discussion 
6.5.1. Probing Depth and Attenuation of C 1s, N 1s, and O 1s Emission Signals 
While some aspects of the probing depth of XPS on organic substrates have been touched 
upon in earlier chapters it still seems worthwhile to delve more into the quantitative 
aspects of XPS analysis before considering the physical significance of the acquired XPS 
data. This will facilitate a more meaningful discussion of the data. 
Using the TPP-2M formula for the inelastic mean free path (IMFP) of electrons 
with kinetic energies below 2 keV in organic matter18, the expected depth attenuation of 
emission intensities from a semi-infinite sample slab at normal emission can be predicted 
at least semi-quantitatively. The IMFPs predicted by this method for C 1s, N 1s and O 1s 
photoelectrons excited by Al K are 33.1 Å, 30.6 Å and 27.5 Å, respectively18. Facet-
specific properties on clean single crystal surfaces are predominantly caused by variations 
in crystal structure termination in the topmost layer of molecules. We are therefore 
predominantly interested in this surface region of the crystal, where elastic scattering 
effects can, in a good first approximation, be neglected because elastic scattering does not 
influence the depth attenuation of electrons near the surface as strongly as for deeper sub-
surface regions of a crystal19. 
Assuming exponential attenuation and the above IMFP values, the resulting depth 
distribution functions (DDFs) of C 1s, N 1s, and O 1s electrons can be predicted. They 
are presented in Figure 6-13. It can be seen that with the increasing binding energy (i.e., 
decreasing kinetic energy) of the electrons from C 1s to O 1s the depth attenuation of the 
signal becomes slightly stronger, but variations between the three signals at no depth 
exceed differences of more than 10%. 
The size of a paracetamol unit cell is, in any direction in the crystal, 
approximately 10 Å. Assuming a clean stoichiometric single crystal facet of paracetamol, 
the numbers of atoms of each element probed by an XPS signal from within the 10 Å 
nearest to this surface must therefore add up to the stoichiometric composition. 
Consequently, variations of the XP emission intensity from the three elements due to 
crystal facet-specific molecular orientations principally cannot exceed approximately the 
fraction of emission intensity coming from the topmost 10 Å of the sample. 
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Figure 6-13: Depth distribution functions of the photoemission signals from C 1s, N 
1s and O 1s at normal emission, estimated using the TPP-2M formula for the 
inelastic mean free path of electrons in paracetamol 20. The dashed lines indicate 
that only about 28% of the signals arise from a depth within about 10 Å near the 
surface. 
Hypothetically contrasting the two most extreme cases, namely all nitrogen 
moieties exposed right at the surface vs. all nitrogen moieties pointed as far away from 
the surface as possible into the crystal bulk, the calculated DDFs in Figure 6-13 indicate 
that the variation of the N 1s emission could therefore become at most approximately 
30%, including an up to 15% enhancement of the N 1s emission intensity relative to 
paracetamol bulk stoichiometry in the case of N moieties exposed at the surface and a 
corresponding 15% reduction in the case of N moieties oriented towards the bulk. In 
reality of course, the variations in molecular orientation as a function of surface 
termination are much more subtle (see for example the molecular models for the (010) 
and (001) surfaces presented by Heng et al 21) and will therefore be much less 
pronounced. It would seem that a consistent reduction of the N 1s emission by more than 
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about 10% relative to bulk stoichiometry would therefore almost certainly indicate that 
the composition of the near-surface region probed by XPS deviates so much from the 
bulk stoichiometry as to make the surface non-representative of a clean crystal facet. 
Measurable interfacial properties of such a surface would probably not be representative 
of a clean equilibrium facet of a paracetamol crystal. 
An additional physical factor that may alter depth distribution functions in 
practice somewhat may be the so-called matrix effect22, which arises as a result of 
emission asymmetry caused by direction-dependent variations in crystal composition. 
Most importantly, the density of crystal lattice planes varies significantly as a function of 
direction in the crystal. As a result the XPS probing depth at a surface terminating a 
crystal along a direction with large interplanar lattice spacing will be generally larger than 
at a surface terminating a direction with low interplanar spacings. Near-the surface, 
significant additional variations can arise due to reconstruction and lattice relaxation 
effects. However, the surface tension, and therefore the thermodynamic driving force for 
the occurrence of surface reconstructions and sub-surface relaxations, of molecular 
crystal surfaces tends to be much lower than in metallic, covalent and ionic crystals, 
which are held together by much stronger bonding than the dipole, van-der-Waals, - or 
London forces in molecular crystals. As a result, the mass density of paracetamol is likely 
to remain reasonably isotropic even in the near-surface and surface region, so relatively 
weak variations of matrix effects arising from lattice plane variations would be expected. 
Moreover, because only low-Z atoms are present the differences in inelastic and elastic 
scattering cross sections as well as forward and backscattering matrices will be similar 
throughout the crystal structure, with matrix induced differences probably most likely as 
a result of molecular orientation effects. 
That matrix effects are unlikely to have a decisive influence on the C 1s, N 1s and 
O 1s intensity variations observed is suggested by the quantitative analysis of all XPS 
survey data, which revealed that deviations from stoichiometric composition do not 
follow a monotonic trend as a function of photoelectron kinetic energy; consistently, an 
enhancement of C 1s intensities (highest photoelectron kinetic energy) was observed, 
while a much stronger decrease of N 1s intensities (somewhat lower kinetic energy) was 
followed by relatively small deviations (usually a slight enhancement) from bulk 
stoichiometry for the O 1s emission (lowest kinetic energy). Such strong non-monotonic 
variations of emission intensities as a function of electron kinetic energy are unlikely due 
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to matrix effects because both the magnitudes and angle-dependencies of scattering and 
energy loss cross sections do not exhibit such non-monotonic trends. 
Finally, it should be considered that the presence of significant contamination by 
solvent molecules or other contaminants in the bulk of the crystals may play a role in 
determining some of the observed variations. FTIR data did indeed indicate that the 
acetone-derived crystals may perhaps contain some NH or OH-bearing contaminants, 
which were not detectable for the ethanol- and methanol-derived single crystals. 
Interestingly, the acetone derived crystals also do exhibit evidence for much stronger N 
1s attenuation than the methanol and ethanol-derived crystals, which exhibited N 1s 
attenuation similar to the pure starting material powder. These results for the alcohol-
derived crystals in conjunction with the consistent good quality of the powder diffraction 
patterns of ground crystals and of the single crystal pattern of the methanol-derived single 
crystal indicate that strong bulk contamination of the crystals is absent. 
6.5.2. Attenuation of the N 1s Emission from the Amide Group 
 The signals associated with the amide group of paracetamol are most diagnostic 
for the assessment of surface properties because N is an element absent from practically 
all environmental contaminants commonly found on surfaces handled in a laboratory 
environment. The N atoms therefore provide us with the most reliable searchlight for 
examining the effects of surface termination, facet orientation or surface contamination 
and shall be examined in more depth. The results of the elemental analysis from the 
survey spectra (Table 6-2) indicated that the N 1s emission intensities were always 
reduced, between 12% and 25% relative to bulk stoichiometry, depending on facet 
orientation and solvent used for the preparation of the crystals. Crystallisation from 
acetone led to the most pronounced suppression of N 1s intensity. All N 1s intensity 
results obtained in this study are listed once more in Table 6-4 below. It can be seen that 
not a single measurement revealed any enhancement of N 1s intensity relative to bulk 
stoichiometry. If facet–specific molecular orientation effects were the cause of the 
observed N 1s intensity variations then at least some preparations of facets should exhibit 
N 1s intensities above or near the stoichiometric value. These results indicate strongly 
that surface contamination effects have a decisive influence on the measured data, 
masking any facet-specific molecular orientation effects in the XPS data of the surfaces. 
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Table 6-4: Experimental XPS-derived N stoichiometries and the relative deviation 
from paracetamol bulk stoichiometry (9.1%) classified by facet orientation. 
(011) (001) (111) (101) 
Experim. 
[%] 
Deviation 
from 
Stoich. 
Experim
. 
[%] 
Deviation 
from 
Stoich. 
Experim. 
[%] 
Deviation 
from 
Stoich. 
Experim. 
[%] 
Deviation 
from 
Stoich. 
8.04 -11.6% 8.44 -7.3% 7.45 -18.1% 8.41 -7.6% 
7.46 -18.0% 8.16 -10.3% 7.32 -19.6% 8.2 -9.9% 
6.24 -31.4% 7.85 -13.7% 7.79 -14.4% 7.76 -14.7% 
6.92 -24.0% 8.31 -8.7% 
  
7.77 -14.6% 
  
7.89 -13.3% 
    
  
8.22 -9.7% 
    
  
8.62 -5.3% 
    
  
8.68 -4.6% 
    
  
8.21 -9.8% 
    
  
7.87 -13.5% 
    
  
8.22 -9.7% 
    
  
8.63 -5.2% 
    
  
8.09 -11.1% 
    
  
7.86 -13.6% 
    
  
8.55 -6.0% 
    
  
8.3 -8.8% 
    
  
7.81 -14.2% 
    
  
8.65 -4.9% 
    
  
8.19 -10.0% 
    
  
7.85 -13.7% 
    
  
7.99 -12.2% 
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As can be seen by consultation of the signal depth distribution functions in Figure 
6-13, the presence of the commonly observed thin surface contamination layer of 
adventitious carbon equivalent to a thickness of a few Å would be sufficient to explain 
the observed reductions in N 1s intensity by typically up to 15%. As argued above, facets 
exhibiting even higher levels of N 1s emission intensity reductions are almost certain to 
be highly non-stoichiometric within the depth probed by XPS. That the observed N 1s 
deviations are for many preparations, especially the methanol and ethanol-derived 
crystals, weaker than or about the same as the value of –13% observed for the untreated 
powder (Table 6-2) suggests that the cleanliness of the starting materials, the preparation 
vessels and the media was good. Because of the much lower surface area of the 
macroscopic crystals one would otherwise expect higher surface concentrations of 
surface-active contaminants. 
6.5.3. Intensity of the C 1s and O 1s Components from the Amide Group 
The amide component in the C 1s emission spectra was well resolved and its intensity 
could thereby be quantitatively analysed relative to the total intensity of the C 1s 
emission, and the stoichiometry of the surface region probed by the C 1s emission 
thereby independently double-checked. There is an additional systematic uncertainty in 
the relative error of about ±5% in these data because of the presence of the shake-up 
losses in the C 1s spectra, for which it is not entirely clear how they will affect the 
intensities of the various emission components. Moreover, the C 1s emission is slightly 
less surface-sensitive than the N 1s emission (the signal depth distribution functions in 
Figure 6-12 suggest an about 5% absolute enhancement of C 1s intensity), so the amide 
component should be slightly less sensitive to surface contamination than the N 1s 
emission. 
The expected bulk-stoichiometric C 1s contribution from the amide group is 
12.5% (one C in eight). The results of the quantitative analysis of the C 1s spectra are 
documented in Figures 6-14 to 6-22 below. They show that the N-C=O (amide) 
intensities were very similar for all facets, around 9 ± 0.5%, equivalent to a reduction of 
amide concentration by about 28% ± 4%. This reduction is much stronger than that 
observed in the N 1s analysis, and certainly much stronger than those that facet-specific 
variations of crystal surface terminations could cause. The EB of the N-C=O emission 
was consistently at about 288 eV to 288.1 eV, indicating that no significant variation of 
the structural environment around the amide group takes place between the samples. The 
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most plausible explanation for the very strong attenuation of the amide stoichiometry is 
again the suggested presence of a significant adventitious carbon contamination layer, 
which would enhance especially in the C=C regions of the C 1s spectra, which is exactly 
the observation borne out by the C=C intensity values reported in Figures 6-14 to 6-22 
below. The C=C intensity should be significantly reduced from its stoichiometric value of 
50% (four out of eight C atoms) due to the shake-up losses in the aromatic system, but 
the data indicate for most samples intensities of more than 45%. The remaining C 1s 
contributions from the other functional groups (expected value: 12.5%, one out of 8 C 
atoms), while spectroscopically not as well resolved from each other as the amide 
contribution, are also close to expected bulk stoichiometry, supporting the view that 
adventitious carbon contamination accounts for most of the observed weakening of the 
emission from the amide group. 
 
Figure 6-14: Methanol Single Crystal (MeSingle1) analyses for C 1s at all analysed 
facets 
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Figure 6-15: Methanol Single Crystal (MeSingle2) analyses for C 1s at all analysed 
facets 
 
 
Figure 6-16: N-C=O concentration on MeSingle1, MeSingle2 and EtSingle at all 
facets analysed 
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6.5.4. Spatial Variations Across Single Facets 
Finally, a few comments shall be made on results examining spatial variations of 
emission intensities on the crystal facets. For example, spots in the middle and edge of 
facets were analysed for the purpose of examining the uniformity across a facet. Spot 3 
(101), 4 (101) and 6 (011) were at the edge of crystal (refer to Figure 6-3), while spot 1 
(101), 2 (101) and 5 (011) were on the middle of the MeSingle1 crystal. Figure 6-14 thus 
reveals a trend: the C=C concentration was high at the edge of crystal but C-N, C-C=O, 
C-OH concentrations were smaller in the edge area. Facet (011) shows high concentration 
of C=C but significantly low concentration of C-N and C-OH relative to (101) facet. 
However, the O 1s C=O and C-OH (Figure 6-23) were not showed a significant 
different. Reconfirmation of the analysis by MeSingle2 (different crystal) was made. At 
facet (001) and (110) of spot 3, 6 and 8 (refer to Figure 6-15) high concentration of C=C 
were obtained. Those spots were at the edge of the crystal facet. Consistently, all these 
data indicate that an enhanced concentration of C=C species is presented at the edges 
compared to the middle of the facets. 
Further analysis focused on the (011) facet, as presented in Figure 6-17 (this 
analysis was based on the fitting without FWHM and EB constraints for all C 1s 
components) and Figure 6-18 (this analysis was based on the fitting with FWHM and EB 
constraints of six C 1s components representing all C moieties with different chemical 
environments). The corresponding O 1s data are presented in Figures 6-23 and Figures 
6-24. This examination was carried out to reconfirm whether the presence of solvent was 
influential on the crystal surface. The difference between EtSingle/MeSingle to 
AceSingle results can be seen on the C=O (Figure 6-18), C=O/C=C (Figure 6-17), C-
OH (Figure 6-17) and C-N/C-OH results (Figure 6-18). Similarly, Figure 6-24 and 6-25 
reveal no systematic trend of C=O and C-OH between MeSingle1, EtSingle or AceSingle 
of O 1s analysis. For both types of analysis (FWHM and EB constrained 6-component vs 
unconstrained 4-component) there were significant differences observed only between 
spots 5 and 6 of MeSingle1 (Figure 6-23), which may well be related to the extreme 
positioning of spot 6 on the edge of a crystal facet. The trend observed on the facet (111) 
(Figure 6-29) indicates that for EtSingle and MeSingle, the cleanest systems investigated 
here, C=O and C-OH concentrations do not vary significantly. Unfortunately, due to the 
constraints in tilting the crystal to certain facets in the XPS analysis chamber, other facets 
were not investigated in similar detail. 
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Figure 6-17: (011) facets analysis for three different single crystal at different C 
environment (4 peaks fitted during CasaXPS fitting) 
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Figure 6-18: (011) facets analysis for three different single crystal at different C 
environment (6 peaks fitted during CasaXPS fitting) 
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Figure 6-19: (101) facets analysis for three different area of MeSingle1 at different C 
environment (6 peaks was fitted during CasaXPS fitting) 
 
Figure 6-20: (101) facets analysis for three different area of MeSingle1 at different C 
environment (4 peaks was fitted during CasaXPS fitting) 
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Figure 6-21: (111) facets analysis for three different single crystal at different C 
environment (4 peaks was fitted during CasaXPS fitting) 
 
Figure 6-22: (111) facets analysis for three different single crystal at different C 
environment (6 peaks was fitted during CasaXPS fitting) 
0
5
10
15
20
25
30
35
40
C=C/C-C=O N-C=O C-N/C-OH Shake Up
C
on
ce
nt
ra
tio
n 
[%
]
EtSingle MeSingle1 MeSingle2
Chapter 6  Single Crystal Paracetamol 
178 
 
Figure 6-23: Methanol Single Crystal (MeSingle1) analyses for O 1s at all analysed 
facets 
 
Figure 6-24: (011) facets analysis for three different single crystal at different O 
environment (4 peaks fitted during CasaXPS fitting)  
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Figure 6-25: (011) facets analysis for three different single crystal at different O 
environment (6 peaks fitted during CasaXPS fitting) 
 
 
Figure 6-26: (101) facets analysis for three different area of MeSingle1 at different O 
environment (4 peaks fitted during CasaXPS fitting) 
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Figure 6-27: (101) facets analysis for three different area of MeSingle1 at different O 
environment (6 peaks fitted during CasaXPS fitting) 
 
 
Figure 6-28: (111) facets analysis for three different single crystal at different O 
environment 
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Figure 6-29: (111) facets analysis for three different single crystal at different O 
environment 
 
6.6. Conclusions 
All the results discussed in the previous sections indicate that the prepared single crystal 
paracetamol specimens at the level of cleanliness one would expect of samples obtained 
by carefully conducted ‘wet chemistry’ in the laboratory. Though adventitious carbon 
contamination levels are clearly evident there was no indication that they were excessive 
relative to those commonly observed in surface science studies of materials prepared in 
the laboratory. 
The interactions of the solvent and solute (paracetamol) during crystallisation may 
in principle influence the composition of C 1s or O 1s. Solvent adsorption and that of 
dissolved solvent contaminants on the crystal surfaces may also affect the concentration 
of functional groups 23, 24. The ATR-IR spectra (Figure 6-5) include an N-H peak at 
3300 cm-1, with the O-H groups visible at 3163 cm-1, but revealed no major differences 
between functional group signatures for all the single crystals. Only small differences of 
peak intensity are observable, particularly for the N-C=O vibration at 1650 cm-1, 25 which 
indicate that the preparations carried out in acetone medium may be more prone to 
leading to enhanced contamination levels than the preparations in the alcohol media. 
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The PXRD results (Figure 6-6) for AceGround, EtGround and MeGround reveal no shift 
of diffraction peaks relative to powder paracetamol. This indicates that the solvents used 
in the crystallisation are not decisively influencing the bulk paracetamol composition or 
local interactions in the crystal structure. 
N-related signals (N 1s, amide component of C 1s, C=O component in O 1s) will 
only source from paracetamol molecules rather than impurities on the surfaces and their 
analysis leads to the conclusion that the C 1s, O 1s and N 1s XP emission intensity data, 
and the elemental analyses derived from them, can be interpreted through a model 
incorporating an adventitious hydrocarbon contamination layer (somewhat oxygenated) 
on the surface and a stoichiometric composition of the underlying on the crystal surfaces. 
However, reconfirmation due to the C:H:N elemental analysis was not done throughout 
this study. Untreated paracetamol powder had one of the lowest ratios of O to N 
concentrations, suggesting that some solvent may be present at the surfaces of the single 
crystals. It was observed that both AceSingle1 and AceSingle2 had the highest O/N 
ratios, followed by MeSingle1 and MeSingle2 and EtSingle. Elemental analysis of some 
of the crystals should perhaps be carried out to confirm their stoichiometry. 
What this study shows is that the use of very pure methanol (HPLC grade) and 
consistently cleaning the apparatus with APS and drying in the oven at 60°C prior to use 
allows to preparations of crystal facets with a high degree of cleanliness, though still 
contaminated by the adventitious carbon contamination layers expected for materials 
handled in a laboratory environment. The challenge for experimental surface science is 
now to find additional methodologies for reducing the surface contamination levels 
further, by reducing contamination levels introduced during crystallisation further and/or 
handling samples under cleaner (glove box, clean room, special UHV compatible 
crystallisation chamber) conditions during transfer from solution medium to XPS analysis 
vacuum. 
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7. CHAPTER 7: PARACETAMOL AND POLOXAMER MIXTURE 
7.1. Objectives 
The objectives of the work described in this chapter are:  
 To determine the optimum composition of Poloxamer188 required to coat the 
paracetamol surface by grinding and milling techniques.  
 To observe the changing of paracetamol/poloxamer188 surface composition 
induced by radiation at various mass percentages.   
7.2. Introduction 
Excipients are used in pharmaceutical formulations to enhance drug properties 
during processing or in the final product. For example, excipients attached by adsorption 
on the drug surface may provide many advantages. Recently, the adsorption of 
crospovidone onto the surface of carbamazepine has been proven to retard the 
crystallisation of the drug, thus enhancing its release properties1. In other work, it has 
been shown that polymer excipient adsorption can modify the electrostatic surface 
properties of a drug.2 The adsorption process can be affected by numerous parameters 
such as the molecular weight of the adsorbate, the number and position of functional 
groups, the power of the solvent, the physical and chemical properties of the adsorbent, 
such as shape, porosity, surface area, polarity and surface energy, including the 
electrostatic properties of particles.2 
Adsorption is accomplished by grafting a polyfunctional agent onto the surface, 
which increases the number of available reactive functional groups per unit surface area. 
The solid mixture can be categorised by bulk properties such as solubility, compactibility 
and elasticity, which are primarily dependent on lattice interactions, and surface 
properties such as interfacial tension, adhesion and cohesion, which are influenced by the 
surface chemistry and energy3 of excipients and drugs, through adsorption via 
electrostatic interactions4. The method may be due to the interdiffusion of the 
components, creating a zone of transition or interphase. It requires mutual solubility and a 
sufficient molecular solubility5. The adsorption of large linear polymer excipients is due 
to binding of particular sites. However, in practice the individual polymer molecules 
often adsorb to more than one site and interfere with access to unoccupied adsorption 
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sites6. The adsorption may occur by hydrogen bonding, van der Waals interaction, ion 
dipole interaction and the hydrophobic effect6, 7. The interaction of aniline – a compound 
similar to paracetamol with a different para-substituent group at the para position – with 
silicon surfaces is accompanied by the cleavage of either N-H or C-H bonds.8  
The binding of two molecules by physical interaction or physical forces is the 
regulating force in all natural and technological phenomena that do not involve chemical 
reactions and is thus very important in all branches of science and industry.9 The physical 
forces acting between molecules are essentially electrostatic or quantum mechanical and 
make a smaller contribution than gravitational forces due to mass attraction. Electrostatic 
forces are those between charges and dipoles or induced by dipoles. Quantum mechanical 
forces are known as dispersion and repulsion forces. In other terms, physical forces 
between molecules can be categorised as cohesion and adhesion forces. Cohesion 
describes physical interactions between molecules of the same type, whereas adhesion 
occurs when molecules of two different types interact. Molecular interaction forces apply 
at very small separations. Theoretically, they fall off exponentially as the distance 
between atoms increases. 
In the work reported in this chapter, powdered pure paracetamol and several 
excipients were physically mixed. Powdered materials represent complex systems for 
fundamental characterisation, being heterogenous in structure, composed of particles of 
different shapes and sizes with interparticular voids. As a result, powders contain a 
multitude of interacting surfaces, which leads to wide-ranging physicochemical and 
mechanical properties.10 It has been noted that milling, drying and crystallisation may 
influence the fundamental properties of powdered solids11. However, the physical 
interactions at molecular level are much less well understood12. Physical interactions 
between drugs and excipients are relatively common, because few chemicals are used 
during the process. Milling or comminution is a common operation employed to reduce 
particle size. The mechanical stress inherent in the process often produces structural 
changes in the milled crystalline API. It has been suggested that milling forms a thin 
amorphous surface layer on particles with disordering of the surface structure rather than 
the entire bulk 13.  
Physically, milling will reduce the particle size of a compound, enhancing the 
dissolution rate through an increase in the available surface area. However, some reports 
state that milling is accompanied by a disorder of the crystalline structure, leading to the 
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formation of amorphous regions, particularly at the surface14. These amorphous regions 
or crystal defects are unstable and can migrate, transform and change in nature13, 15.  In 
addition, they will create high energy sites at the surface and thus reduce the activation 
energy needed for dissolution relative to the more structurally ordered particle surface13.  
Understanding the interactions between polymers and crystal surfaces at the 
molecular level will make it possible to design polymeric additives to inhibit 
crystallisation more efficiently12. The surface properties of the mixture are determined by 
the structure and chemical composition of the outermost atomic layer. The effects of an 
excipient on a drug are linked to the interfacial area of contact between drug and 
excipient. The amount of excipient will affect the contact between them. Encapsulating a 
weak acid drug with a polymer excipient will cause polymer-induced degradation16. The 
adsorption of excipients on the layers at the interface was not always homogenous17.  
The adsorption of Poloxamer 188 on the Poly (d,L-lactic-co-glycolic acid), PLGA 
surface was driven by hydrophobic forces between PO of poloxamer and the adsorbent 
surface17. At the high concentration of Poloxamer and PLGA mixture, the adsorption 
behaviour of the system suggest a formation of surface Poloxamer aggregates17.  
Polymer adsorption on solid surfaces has been studied using a number of techniques, 
such as solid state NMR, FTIR, Raman, UV, electron spin resonance (ESR) and photon 
correlation spectroscopy (PCS), microcalorimetry and surface plasmon resonance (SPR) 
12. 
7.3. Experimental 
7.3.1. Materials 
Paracetamol powder and blends were prepared prior to the analysis.  Nine paracetamol 
powder and Poloxamer 188 blends were prepared for the comparative analysis. 
i) Untreated paracetamol powder (form I) as received from Sigma Aldrich, UK.  
ii) Untreated Poloxamer 188 as received from BASF, UK. No milled Poloxamer 
188 was characterized by XPS due to Poloxamer 188 data was only for 
comparison purposes. No calculation was involved. 
iii) Milled paracetamol powder obtained by milling in Retch MM200 mixer mill 
at a rate of 30 Hz, using 5 mL stainless steel jars, each containing one 7 mm 
diameter stainless steel ball mill. The milling time was 5 min. 
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iv) Ground paracetamol and poloxamer 188 at mass percent of poloxamer 188 10 
% w/w. Mixtures was ground by using a mortar and pestle.  
v) Ground paracetamol and poloxamer 188 at mass percent of poloxamer 188 50 
% w/w. Mixtures was ground as (iv). 
vi) Ground paracetamol and poloxamer 188 at mass percent of poloxamer 188 90 
% w/w. Mixtures was ground as (iv)  
vii) Milled paracetamol and poloxamer 188 at mass percent of Poloxamer 188 10 
% w/w. Mixture was milled as (iii). 
viii) Milled paracetamol and poloxamer 188 at mass percent of Poloxamer 188 50 
% w/w. Mixture was milled as (iii). 
ix) Milled paracetamol and poloxamer 188 at mass percent of Poloxamer 188 90 
% w/w. Mixture was milled as (iii). 
 
7.3.2. Differential Scanning Calorimetry (DSC) 
Thermal analysis was performed using a TA Q100 instrument with a low 
temperature attachment (refrigerated cooling system, TA Instruments) for sub-ambient 
operation. The specific software used for heat capacity calculations in the study was TA 
Universal Analysis 2000. All scans were conducted at 10 °C/min with a nitrogen purge to 
minimise oxidative decomposition. A sample (5-12 mg) was weighed and crimped in the 
DSC pan, which was re-weighed to ensure that no sample had spilled out during the 
crimping process. Most of the analyses were repeated once or more; a few samples were 
analysed only once or twice, when good thermograms were obtained in the initial runs. 
The strength of the interaction between drug and excipient was estimated using the 
Gordon Taylor equation, with the assumption that the mixtures were ideally mixed18, 
21
2211
Kww
TKwTw
T ggg 

  ,       Equation 7-1  
Where Tg1 is the glass transition temperature of the drug-polymer blend, w1, w2, Tg1, Tg2 
are the weight fractions and glass transition temperature of the drug and polymer 
respectively. The constant, K, is a measurement of the interaction between the 
components and can be approximated by using equation below. 
K 
22
11
g
g
T
T


         Equation 7-2 
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Where 1 and 2 are the true densities of the paracetamol and excipients respectively19, 20. 
Due to the limitations of the instrument, the true density of paracetamol (1.205 g/cm3) has 
been taken from the literature21, while the poloxamer (0.99 g/cm3) is the value provided 
by BASF. If the Tg of a blend was lower than predicted or calculated, the negative 
deviation from ideal behaviour was obtained. Gordon and Taylor explain such differences 
by the strength of intermolecular interactions between individual components of the 
mixture. The polymer will have a strong bond with the drug if the Tg obtained is higher 
than predicted, because stronger binding will lower the chain mobility. Conversely, if a 
lower Tg is obtained this indicates that polymer and drug are less strongly bound and 
prone to self-associate.  
 
7.3.3. Powder X-ray Diffraction (PXRD) 
PXRD patterns were recorded on a Rigaku Miniflex Goniometer at 30 kV and 15 
mA at steps of 0.01°. About 5 mg of each sample was placed in the top holder and rotated 
through the range of 5° to 40° at a rate of 3°/minute. The PXRD patterns were converted 
to the Excel program for further analysis.  
7.3.4. Attenuated Total Reflection Infrared (ATR-IR) 
ATR-IR experiment was held as stated on Chapter 6.  The estimation of 
crystallinity of physical mixtures by ATR-IR spectra was based on the measurement of 
two selected peaks area; known as intensity of the band and analytical band. Intensity of 
the band is the spectrum peaks which invariant with the changing of mixture crystallinity. 
Whilst, analytical band is the spectrum peak which is reduced or increased as the 
crystallinity of the mixture increased. The peak area percentage is plotted against the 
mixture compostion 22.   
 
7.3.5. X-ray Photoelectron Spectroscopy (XPS) 
Details of the XPS instrument and data acquisition were already are given in Chapter 2 . 
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7.4. Results 
7.4.1. Differential Scanning Calorimetry (DSC) 
The poloxamer 188 direct heating thermograms revealed two peaks appearing at 56 °C 
and 390 °C, indicating a melting temperature and a decomposition temperature, 
respectively. The heating and cooling thermograms showed poloxamer 188 to be a 
crystalline compound with the detection of melting and crystallisation peaks. The 
thermograms revealed a broad melting peak at 55.97 ± 0.05 °C (Table 7-1), shifting a 
little from the direct heating peaks. Hence, a broad peak associated with recrystallisation 
appeared at 32.21 °C and re-melting occurred at 52.99 °C.  
Table 7-1: Tm and the enthalpy change, , for different blends of paracetamol and 
poloxamer 188 
Poloxamer mass  
(%) 
Peak 1/ (°C) 
 [J/g] 
100 55.97 
( – 136.4) 
90 53.69 
( – 121.8) 
50 52.72 
( – 84.13) 
10 51.87 
( – 24.06) 
0 171.66 
( – 174.00) 
 
Table 7-2: Correlation between percentage of poloxamer, predicted Tg and 
experimental Tg 
Poloxamer 
(% w/w) 
Predicted Tg 
(based on Gordon Taylor 
Equation, °C) 
Measured 
Tg (°C) 
100 - 42.59 
90 38.53 36.33 
50 32.04 52.39 
10 26.90 65.35 
0 - 24.65 
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In order to understand the interaction of the paracetamol with poloxamer 188, an 
attempt was made to correlate the Tg of the mixture with the percentage of poloxamer in 
the mixture (Table 7-2). A positive deviation of the measured from the predicted Tg 
indicates the region of interaction between the constituents.  
7.4.2. Powder X-ray Diffraction (PXRD) 
The poloxamer 188 powder X-ray diffraction (PXRD) pattern was compared with 
that of the pure reference22 (Figure 7-1) for confirmation of compound purity. It was 
found that the experimental results agreed with the reference, showing 2 main peaks, as 
expected, at 2 values of 19° ( d spacing: 4.67) and 23° (d spacing: 3.85)23 
 
 
 
 
 
 
 
 
Figure 7-1: PXRD pattern of poloxamer 188 as in the literature14 
 
Figure 7-2 shows the PXRD patterns for mixtures of poloxamer 188 and 
paracetamol. The PXRD pattern of pure poloxamer 188 and paracetamol were compared 
with the blending peaks (Figure 7-2). At higher percentages of poloxamer, (90 % w/w), 
main peaks at 19° and 23.5° appear that can be assigned to poloxamer 188. It was 
observed that all the peaks of paracetamol and poloxamer 188 were present in the 
patterns of all blends. The paracetamol peaks appeared more clearly at lower 
concentrations of poloxamer 188.  For instance, the paracetamol double peaks at 23.57° 
and 24.14° were obvious and of high intensity only at 10 % w/w of poloxamer 188, while 
 
 
~17° 
~22° 
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in other blends these were presented as split peaks. It was observed that an increased 
proportion of poloxamer 188 would reduce the intensity of the paracetamol peaks. 
 
Figure 7-2: PXRD patterns for physical mixtures of paracetamol and poloxamer 188 
 
Figure 7-3: PXRD results for milled blends of paracetamol and poloxamer 188 
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Figure 7-3 shows the PXRD results for milled samples. For all blends, peaks exist 
indicating paracetamol and poloxamer 188. All the milled samples had similar peaks to 
those of the parent patterns, indicating that milling does not lead to the formation of new 
phases. Line broadening indicates reduced crystallinity as the poloxamer 188 
concentration is increased.  
7.4.3. Attenuated Total Reflection Infra Red (ATR-IR) 
 
 
Figure 7-4: Chemical structure of poloxamer 188 with a=70, b=30 
 
The ATR-IR spectrum (Figure 7-5) of the poloxamer 188 was found to have a 
strong C-C-O peak at 1039 cm-1 and one of medium intensity at 2890 cm-1, due to C-H 
aliphatic groups. The peaks at 841 and 949 cm-1 were characteristic of the PEO chain of 
poloxamer 24. The intense peak at 1100 cm-1 is the characteristic band of C-C-O and C-C 
stretching region24, while the band at 1341 cm-1 is characteristic of the wagging region of 
CH2 in the PEO chain24. In the ATR-IR spectrum of paracetamol (Figure 7-6), bands in 
the region of 560 cm-1 are characteristic of the C-H out-of-plane bending of the p-
substituted benzene ring, while the bands at 1651, 3108 and 3316 cm-1 represent C=O 
stretching, O-H stretching and N-H stretching respectively25.  
 
Table 7-3: Possible functional groups and wavenumbers of poloxamer 188 
Possible functional group Possible wavenumber (cm-1) Notes 
C-CH3 (methyl group) 2970-2850 
1383-1375 
Single methyl group 
on C atom 
C-O-C  1140-1110  strong 
C-H (aliphatic)  2970-2850 (strong) stretch 
O-H (deformation) 1640-1630 - 
C-H (methyl ether) 2832-2815 medium 
 
*
O
O
O * H
HO
75 7530
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Figure 7-5: ATR-IR spectrum of pure poloxamer 188 
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Figure 7-6: ATR-IR patterns of paracetamol and poloxamer 188 ground mixtures at 
wavenumbers 2000 cm-1 to 3500 cm-1 
 
The objective of ATR-IR analysis was to detect hydrogen bonds between 
paracetamol and poloxamer 188. It has been found that paracetamol molecules can have 
intermolecular hydrogen bonds in solid form through N-H...O and O-H...O bonds26. It is 
presumed that the O-H peak at 3108 cm-1 indicated a C-OH band. The existence of the 
peak in the blend indicated the formation of hydrogen bonds between paracetamol and 
poloxamer 188. At high poloxamer 188 concentrations, the absence of C-OH peaks 
indicated that poloxamer 188 did not form hydrogen bonds at the intermolecular level27.  
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Table 7-4: Analysis of ATR-IR functional groups of paracetamol and poloxamer 188 
mixtures 
PEO % 
w/w 
N-H 
(3500-3300) 
cm-1 
 
C-OH 
(3350-
3250) 
(1080-
1010) 
cm-1 
C-H 
(aliphatic) 
(2970-
2850) 
cm-1 
 
C=O 
(1710-1670) 
1665-1640) 
cm-1 
C-N or 
C-O 
(1340-
1020) 
cm-1 
 
C-H or 
CH3 
(benzene) 
(870-675) 
cm-1 
(Paracetamol + poloxamer 188) ground 
90 3307.81 (very 
weak) 
Not 
detected 2878.53 
1649.77 
(weak) 
1610.05 
(weak) 
1097.61 
839.44 
50 3315.84 3108.56 2880.32 1649.38 1609.48 1105.10 
836.82 
10 3314.27 3108.47 Not detected 1648.70 1223.65 
835.93 
Poloxamer Not detected  Not detected  2879.27 Not detected 1101.46 
841.25 
Paracetamol 3316.34 3108.67 Not detected 
1648.98 
1609.21 1223.01 
835.67 
681.45 
(Paracetamol + poloxamer 188) milled 
90 3319.09  (very weak) 
Not 
detected 2882.25 Not detected 1097.95 
840.96 
50 3317.40 3109.20 2883.54 1650.74 1610.28 1101.07 
837.97 
10 3317.01 3109.06 2882.85 1650.87 1610.30 1100.03 
838.15 
686.98 
  
Table 7-4 shows the analysis of the functional groups of paracetamol and 
poloxamer 188 mixtures, ground and milled. At high concentrations of poloxamer 188 
the N-H peak was found to be of very weak intensity and the C-OH peak was absent, 
while the benzene peak at 686 cm-1 (Figure 7-7) was observed at low poloxamer 188 
concentrations for both types of blend. Only a little shift observed of the blending 
discerned to the pure paracetamol and poloxamer 188. Conversely, at a low concentration 
of ground blends (Table 7-4) poloxamer 188 the C-H peak disappeared.  
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Figure 7-7 : ATR-IR spectra of paracetamol and  poloxamer 188 ground mixture at 
wavenumbers 700 cm-1 to 1700 cm-1 
 
The difference between milled and ground samples was most obvious in the 
spectrum of the blend with 10% w/w poloxamer (Table 7-4). The spectrum of the milled 
mixture had higher intensity peaks for poloxamer 188 than paracetamol, particularly at 
2800 cm-1 (Table 7-4), in the C-H aliphatic band. The ATR peak of 1100 cm-1 (Figure 7-
7) of CH3 was pointed as intensity of the band which did not change noticeably with the 
composition of the mixture. The 1648.9 cm-1 (Figure 7-7) peak was present only in the 
mixture of high crystallinity (low percentage of poloxamer 188). Therefore it was 
selected as intensity band.22 
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Figure 7-8: Estimation of crystallinity of paracetamol and poloxamer 188 mixtures 
using the ATR-IR spectra as reference 
 
Figure 7-8 above shows the ATR-IR analysis of the crystallinity of different types 
of mixture. All the samples revealed the same pattern of crystallinity, where an increase 
in the proportion of poloxamer 188 reduced the crystallinity of the mixture, as indicated 
by the fact that all the lines on the graph have negative slopes. The milled mixture had the 
best correlation value, R, of 0.98, while the physical mixture was 0.82 and the ground 
mixture was 0.72. The crystallinity of the milled mixture varied only slightly as the 
concentration of poloxamer 188 was increased, indicating that the blending of 
paracetamol and poloxamer 188 did not affect the crystallinity of the molecular structure.  
7.4.4. X-ray Photoelectron Spectroscopy (XPS)  
Table 7-5: Moles of paracetamol and poloxamer 188 at different mass percentages 
100% 10% w/w  
Poloxamer 188 
50% w/w 
Poloxamer 188 
90% w/w 
Poloxamer 188 
Mol 
paracetamol 
Mol 
poloxamer 
188 
Mol 
paracetamol 
Mol 
poloxamer 
188 
Mol 
paracetamol 
Mol 
poloxamer 
188 
Mol 
paracetamol 
Mol 
poloxamer 
188 
6.61 x 10-3 1.19 x 10-4 5.95 x 10-3 1.06 x 10-5 3.31 x 10-3 5.32 x 10-5 6.61 x 10-4 9.57 x 10-
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The XPS analysis technique was used to measure the composition of paracetamol 
and poloxamer 188 blends with surface sensitivity. Table 7-5 shows the number of moles 
of each ingredient in three blends. Estimated calculations of paracetamol and Poloxamer 
188 strength of interaction (in Chapter 2) predicted that paracetamol and poloxamer 188 
interacted, from the harmonic mean equation, with an interaction parameter of 98.82. 
Poloxamer 188 was predicted to have the strongest interaction among all the poloxamers 
calculated.  
7.4.5. Stoichiometry Analysis 
The C, O and N binding energy, EB, of all the samples was due to the C binding 
energy at 285.0 eV for the untreated powder, ground mixture and milled mixture. On the 
paracetamol and poloxamer 188 XPS fitting, the paracetamol C element was calibrated at 
285.0 eV. Table 7-6 below shows the elemental analysis of pure paracetamol and 
poloxamer 188 as well as ground and milled mixtures at three different ratios. Figure 7-9 
reveals that N emission intensity of pure paracetamol decreased as the poloxamer 188 
concentration increased. However, the C and O elements were changeable between them.  
Table 7-6 shows the theoretical and experimental elemental analysis values for the 
milled and ground mixtures, revealing similar trends: as the poloxamer 188 concentration 
increased, so did the C/N and O/N ratios. Since N is absent from the structure of 
poloxamer 188, the large differences in C/N and O/N ratios between experimental and 
calculated value reveals the loss of N concentration signal on the surface of the blends. 
However, for the C/O ratio, the experimental and calculated values show relatively little 
divergence at high milled poloxamer 188 concentrations. In addition, the ground mixture 
is characterised by a higher concentration of O than in the milled mixture. The high O 
concentration could be due either to surface oxidation 28 of paracetamol or poloxamer 188 
during grinding or, more likely, the uptake of humidity by the more highly dispersed 
material with freshly created, and therefore more reactive, crystal surface areas. 
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Figure 7-9: Survey spectra for pure paracetamol, poloxamer 188 and mixtures of 
various compositions, showing C, O and N elements 
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Table 7-6: Analysis of C, O and N elements, showing predicted elemental 
concentration and experimental data for pure paracetamol, poloxamer 188 and 
various mixtures of ground and milled compounds 
 C (%) O (%) N (%) C:O C:N O:N 
Calculated 
Paracetamol 72.70 18.20 9.10 4.00 8.00 2.00 
Poloxamer 188 68.42 31.58 -    
10% w/w 
Poloxamer 188 
71.53 19.19 8.19 3.73 8.73 2.34 
50% w/w 
Poloxamer 188 
66.99 23.23 4.56 2.88 14.69 5.09 
90% w/w 
Poloxamer 188 
62.29 27.22 0.91 2.29 68.45 29.91 
Experimental 
Paracetamol 76.55 15.69 7.76 4.88 9.86 2.02 
Milled 
paracetamol 
73.91 18.53 7.56 3.99 9.78 2.45 
Poloxamer 188 71.63 28.37 - 2.52 - - 
(Paracetamol + poloxamer 188)ground 
10% w/w 
Poloxamer 188 51.50 46.37 2.48 1.11 20.77 18.70 
50% w/w 
Poloxamer 188 50.20 48.82 0.98 1.03 51.22 49.82 
90% w/w 
Poloxamer 188 50.24 48.80 0.96 1.03 52.33 50.83 
(Paracetamol + poloxamer 188)milled 
10% w/w 
Poloxamer 188 72.19 26.54 1.27 2.72 56.84 20.89 
50% w/w 
Poloxamer 188 71.47 28.04 0.50 2.55 142.94 56.08 
90% w/w 
Poloxamer 188 72.15 27.41 0.43 2.63 167.79 63.74 
 
7.4.6. High Resolution 
C 1s 
Photoemissions from the C 1s core level of paracetamol and poloxamers produced 
two different spectra. Obviously, two of three paracetamol poloxamer 188 spectra 
revealed the absence of shake-up peaks. The shake-up peak is the characteristic peak of 
C=C, which is aromatic in nature. C=C peak was set at 284.7 eV. Three difference shapes 
of paracetamol poloxamer 188 high resolution spectra were observed (Figure 7-10). 
Seven deconvoluted peaks were fitted according to the paracetamol and poloxamer 188 
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functional groups. The C 1s binding energy was calibrated through the aliphatic C-C peak 
at 285.0 eV, due to the loss of the shake-up peak from the blend spectra. The peak at high 
EB is N-C=O (amide group of paracetamol) at a range of 287.9 to 288.3 eV. The high EB 
(289 eV and above) emission from paracetamol is due to the - * shake up satellite peak 
arising from the aromatic ring 5, 29. The adjacent high intensity peak was deconvoluted 
into three main peaks. The higher EB with two different electronegative neighbours, set at 
a range between 285.7 and 285.9 eV and 286.3 and 286.1 eV respectively, was due to C-
N and C-OH photoelectrons5, 30. The bare poloxamer 188 spectrum was deconvoluted 
into 2 peaks; the most electronegative neighbour of C-OH was assigned between 286.4 
and 286.5 eV with FWHM different of 0.2. Next to the C-OH peak, the deconvoluted 
peak of the bulk concentration of poloxamer 188 was a C-C-O peak between 286.4 and 
286.6 eV 30, 31. The hydrophobic poloxamer 188 part, which is C-C, has been assigned at 
285.0 eV. Table 7-7 shows the estimated value of each deconvoluted peak on the XPS 
spectrum according to the real structures of paracetamol and poloxamer 188. 
Table 7-7: Stoichiometrically numbers of C1s carbon environments for pure 
paracetamol, poloxamer 188 and mixture. 
Compound/s C-N/C-OH N-C=O C-C=O/C-C C=C  
Paracetamol 1/1 
(12.50% + 12.50% = 
25.00%) 
1 
(12.50%) 
1/0  
(12.50%) 
4  
(50.00%) 
Poloxamer 
188 
0/1 
(0.47) 
0 0/30 
(14.22) 
C-C-O 
180 (85.31%) 
Paracetamol + 
poloxamer 
188 
1/2  
(1.37%) 
1  
(0.46%) 
1/30 
(14.16%) 
 
C=C (4 = 1.83%) 
C-C-O 
(180 = 82.19%) 
 
The two components can be sdistinguished through the N-C=O and C=C emission 
from paracetamol, while the C-C-O and C-C peaks fitted was clearly part of the 
poloxamer 188 structure.  Poloxamer 188 differs from other poloxamer types in the ratio 
of ethylene oxide (EO) and propylene oxide (PO) blocks. Poloxamer 188 has 140 chains 
of EO divided into blocks of EO, giving 70 blocks for each EO, while the PO block is 
sandwiched between EO blocks and has only 30 chains. Therefore, the C-C-O percentage 
was indicated as the highest in the composition of the poloxamer 188 structure. Due to 
the size of poloxamer 188 relative to paracetamol and its known high surface activity; it 
was expected that emission from the C-C-O groups would dominate at any mixture 
composition. 
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Figure 7-10 shows the spectra of three milled blends and of pure paracetamol and 
poloxamer 188. Interestingly, for the 50% w/w mixture the poloxamer 188 spectrum 
dominates, with paracetamol only evident as a weak low-binding energy component and 
its shake-up peak as an extremely weak tail at higher binding energy. This indicates that 
paracetamol is entirely covered by poloxamer in this mixture. In contrast, a much 
stronger shake up peak was observed for 10 % w/w poloxamer 188 content. The shoulder 
at low EB and higher binding energy generally increased as the poloxamer 188 
concentration decreased and the C=C feature of paracetamol at 284.7 eV emerges more 
visibly. The increasing N-C=O contribution of paracetamol also becomes visible as a 
small shoulder at higher EB values.  
 
 
Figure 7-10: The C1s spectra of the three mixtures 
All carbon environments are coloured as indicated in the legend. 
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Table 7-8: Calculated atomic concentrations of C 1s for blends of paracetamol and 
poloxamer 188 proportional to the calculated moles 
 Mol paracetamol Mol poloxamer 188 
100% Paracetamol or 
Poloxamer 188 
6.61 x 10-3 1.19 x 10-4 
10% w/w Poloxamer 188 5.95 x 10-3 1.06 x 10-5 
50% w/w Poloxamer 188 3.31 x 10-3 5.32 x 10-5 
90% w/w Poloxamer 188 6.61 x 10-4 9.57 x 10-5 
 [C-N] [C-OH] 
10% w/w Poloxamer 188 11.25 11.29 
50% w/w Poloxamer 188 6.26 6.47 
90% w/w Poloxamer 188 1.25 1.63 
 [C=C]  
10% w/w Poloxamer 188 45.00  
50% w/w Poloxamer 188 25.04  
90% w/w Poloxamer 188 5.00  
 [C-C-O]  
10% w/w Poloxamer 188 0 7.60 
50% w/w Poloxamer 188 0 38.17 
90% w/w Poloxamer 188 0 68.61 
 [C-C=O] [C-C] 
10% w/w Poloxamer 188 11.25 1.27 
50% w/w Poloxamer 188 6.26 6.36 
90% w/w Poloxamer 188 1.25 11.44 
 [N-C=O]  
10% w/w Poloxamer 188 11.25  
50% w/w Poloxamer 188 6.26  
90% w/w Poloxamer 188 1.25  
Table 7-8 shows the atomic concentrations of each C 1s for blends of paracetamol 
and poloxamer 188 (calculated moles). For instance, in 6.61 x 10-3 mole of 100% w/w of 
paracetamol, the atomic concentration of C-N is 12.50%. Therefore, in 90% w/w of 
paracetamol (10% w/w of poloxamer 188) there is 5.95 x 10-3 mole of paracetamol and 
the atomic concentration of C-N is 11.25%. 
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Table 7-9: Photoemission of C 1s – data for ground and milled mixtures at different 
concentrations of poloxamer 188 
 C-N  C-OH N-C=O C-C=O C-C C=C C-C-O 
(Paracetamol + poloxamer 188) ground 
10% w/w 
Poloxamer 188 6.00 6.00 6.00 6.00 2.97 24.01 48.28 
50% w/w 
Poloxamer 188 2.51 2.51 2.51 2.51 6.35 10.04 73.52 
90% w/w 
Poloxamer 188 1.11 1.11 1.11 1.11 7.29 4.43 83.87 
(Paracetamol + Poloxamer) milled 
10% w/w 
Poloxamer 188 5.16 5.16 5.16 5.16 4.18 20.66 52.78 
50% w/w 
Poloxamer 188 2.29 2.29 2.29 2.29 4.69 9.12 77.00 
90% w/w 
Poloxamer 188 0.46 0.46 0.46 0.46 8.59 1.85 87.71 
Pure powder 
Paracetamol 12.30 12.30 8.00 12.30  49.30  
Poloxamer 188  0.89   10.27  88.84 
Milled 
paracetamol 12.16 12.15 9.37 12.16  48.64  
The C 1s concentrations (Table 7-9) indicate that all milled mixtures had high 
concentrations of C-C-O and C-C from poloxamer 188. As one would expect, the milled 
blend with the highest concentration of C-C-O at the surface was 90 % w/w of poloxamer 
188. C=C aromatic, C-N, C-OH and N-C=O (Table 7-9) were observed to reduce as the 
poloxamer 188 concentration increased. For the ground mixture a higher concentration of 
paracetamol functional groups (C=C, C-C=O, C-N, C-OH and N-C=O) at the mixture 
surface relative to milled mixture was observed at all compositions. The results show that 
grinding the paracetamol/poloxamer 188 mixture was not sufficient to apply a complete 
coat of poloxamer 188 on the paracetamol surface. The highest concentration of 
poloxamer 188 coating was at 10 % and 50 % w/w due to the difference between 
calculated and experimental data. The value difference with regard to C-C-O and C-C of 
milled mixture. The difference value of calculated and experimental atomic concentration  
were 81% for 10 % w/w and of 50 % for 50% w/w mixture.  
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Table 7-10: C 1s binding energy and FWHM of ground and milled mixtures  
Poloxamer 188 
mass percent 
(% w/w) 
C-N  C-OH N-C=O C-C=O C-C C=C C-C-O 
(Paracetamol + poloxamer 188) ground 
10% w/w 
Poloxamer 188 285.9  286.3 287.7 285.4 285.0 284.7 286.5 
50% w/w 
Poloxamer 188 285.4 286.3 287.7 285.1 285.0 284.7 286.5 
90% w/w 
Poloxamer 188 285.9 286.3 287.9 285.3 285.0 284.7 286.5 
(Paracetamol + Poloxamer) milled 
10% w/w 
Poloxamer 188 285.8 286.2 288.0 285.4 285.0 284.7 286.6 
50% w/w 
Poloxamer 188 285.7 286.3 287.9 285.4 285.0 284.7 286.5 
90% w/w 
Poloxamer 188 285.9 286.3 288.2 285.3 285.0 284.7 286.5 
Pure powder 
Paracetamol 285.7 286.2 288.1 285.4  284.7  
Poloxamer 188  286.8   285.0  286.4 
Milled 
paracetamol 285.9 286.2 287.9 285.0  284.7  
O 1s 
Table 7-1l summarises the results of the photoemission analysis of O 1s for all 
the ground and milled samples. Most significant differences between milled and ground 
mixtures were observed at 10 % w/w poloxamer 188, almost certainly as a result of 
poloxamer surface dispersion over the higher concentration of paracetamol after milling; 
in line with this, for the ground mixture the C-OH and N-C=O components were stronger 
and the lower concentration of poloxamer 188 was reflected by a lower C-C-O intensity. 
In the milled mixture the relative concentrations of these two O 1s environments were 
reversed. In contrast, for the mixtures with 50 % w/w and 90 % w/w poloxamer a higher 
concentration of paracetamol was evident in the milled mixture , indicating either that the 
milling process reduces the surface area of paracetamol so much that not all of it can be 
covered by the available poloxamer, or that poloxamer is not mobile enough to coat all 
paracetamol within the time scale of the experimental work. 
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Table 7-11: O 1s atomic concentration of paracetamol and poloxamer 188 blending. 
 
Table 7-12 lists the O 1s EB values for all the samples. Paracetamol exhibits two 
photoemission peaks at 531.4 to 531.9 eV from its N-C=O and its C-OH was between 
533.0 to 533.5 eV. The poloxamer 188 C-C-O was fixed between 532.0 to 532.9 eV. All 
O 1s data were fitted with a FWHM fixed at 0.9 to 1.1 eV. There were no significant 
shifts in EB for the C-OH and C-C-O components. For the N-C=O emission there were 
slight variations as a function of composition by up to about 0.2 eV in the milled 
mixtures.   
 
 
 
 
 
 
Poloxamer 188 mass 
percent 
(% w/w) 
C-OH N-C=O C-C-O 
(Paracetamol + poloxamer 188) ground 
10% w/w Poloxamer 188 15.13 15.13 69.73 
50% w/w Poloxamer 188 3.45 3.45 93.09 
90% w/w Poloxamer 188 1.62 1.62 96.76 
(Paracetamol + poloxamer) milled 
10% w/w Poloxamer 188 11.47 11.47 77.05 
50% w/w Poloxamer 188 4.48 4.48 91.04 
90% w/w Poloxamer 188 1.99 1.99 96.03 
Pure powder 
Paracetamol 59.24 40.76  
Poloxamer 188 0.99  99.01 
Milled paracetamol 54.01 45.99  
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Table 7-12: O 1s binding energy of ground and milled samples 
Poloxamer 188 mass 
percent 
(% w/w) 
C-OH  
[eV] 
N-C=O  
[eV] 
C-C-O  
[eV] 
(Paracetamol + poloxamer 188)ground 
10% w/w Poloxamer 188 533.3 531.4 532.8 
50% w/w Poloxamer 188 533.6 531.2 532.8 
90% w/w Poloxamer 188 533.6 531.2 532.8 
(Paracetamol + poloxamer) milled 
10% w/w Poloxamer 188 533.5 531.1 532.8 
50% w/w Poloxamer 188 533.6 531.2 532.8 
90% w/w Poloxamer 188 533.7 531.4 532.6 
Pure powder 
Paracetamol 533.0 531.5  
Poloxamer 188 533.2  532.5 
Milled paracetamol 532.5 531.1  
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N 1s 
Figure 7-11: N 1s spectra for all the milled paracetaml and poloxamer 188 at 
different mass percent 
 
The region of the N 1s emission is displayed in Figure 7-11. No N 1s feature is 
apparent in the mixture with a high mass percentage of Poloxamer 188 (90% w/w), in 
line with our above conclusion that poloxamer efficiently coats all paracetamol in this 
mixture. The N 1s emission from paracetamol is clearly evident for 10 % w/w Poloxamer 
188 content. At 50% w/w poloxamer a small N 1s peak is visible as well.  
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7.4.7. Radiation Damage 
 
Figure 7-12: C 1s spectra of 90 % w/w of poloxamer 188 for three scans 
Figure 7-12 shows three consecutive C 1s scans of the 90 % w/w poloxamer 188 
mixture with paracetamol. The analysis of spectra composition was presented in barchart 
as in Figure 7-15. It can be seen that the shoulder at lower EB broadens and becomes 
more intense on the second and third scans. The C-C-O peak was less intense on the 
second scan, while the C-N and C-OH peaks were of increased intensity. On the third 
scan the C-C=O and C-C peak broadened and became even less intense, while the 
intensity of the C=C and C-N and C-OH peaks increased.  
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Figure 7-13: C 1s spectra of 50% w/w poloxamer 188 for three scans 
Figure 7-13 shows three consecutively measured C 1s spectra of 50 % w/w poloxamer 
188. The analysis of spectra composition was presented in barchart as in Figure 7-16.It is 
observed that the shoulder at lower EB is increased in the third scan compared with the 
first and second scans. Also, the N-C=O peak was more intense on the third scan, while 
the C=C and C-C=O intensities increased with each successive scan.  
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Figure 7-14: C 1s spectra of 10% w/w poloxamer 188 for three scans 
Figure 7-14 shows three consecutively measured spectra of the 10 % w/w 
poloxamer 188 paracetamol mixture. The analysis of spectra composition was presented 
in barchart as in Figure 7-17. The shoulder peak intensity was reduced in the third scan. 
With each successive scan of the sample surface, there was an increase in C-C-O and C-C 
intensity, but a decrease in C-C=O, N-C=O, C=C, C-N and C-OH intensity. The shake- 
up peak is visible only in the first spectrum. It appears that increasing the X-ray dose 
leads to an increase of the concentration of poloxamer 188 on the surface, burying the 
emission from the paracetamol functional groups.  
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Figure 7-15: Carbon environments of milled (top) and ground (below) mixture of  
90 % w/w poloxamer 188  for three scans. 
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Figure 7-16: Carbon environments of milled (top) and ground (below) mixture of 50 
% w/w poloxamer 188 for three scans 
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Figure 7-17: C 1s of milled (top) and ground (below) mixture of 10 % w/w 
poloxamer 188 for three successive scans 
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The three plots in Figure 7-15 to 7-17 summarise the C 1s results monitoring of radiation 
damage for three scans of milled and ground samples. There was no significant difference 
in N-C=O, C-N, C-C=O, C-C and C-OH of 90 % w/w and 50 % w/w between milled and 
ground mixture, though the plots reveal that the C-C concentration was a little bit higher 
than N-C=O, C-N, C-C=O and C-OH.  At 10 % w/w, C-C slightly decreases for the 
second and third scan. However, there was a sharp decrease in C-C-O, the predominant 
carbon environment of poloxamer 188, at 90 % w/w and 50 % w/w of mixture. The 
pattern of radiation-induced C-C-O formation at each mixture composition was also 
visible through a decrease in the C=C concentration. The same pattern of behaviour is 
evident for the ground mixtures. Interestingly, at 10 % w/w, the C-C concentration was 
significantly increased, while concentrations of other functional groups (N-C=O, C-N, C-
C=O and C-OH) were decreased relative to the first scan. Table 7-13 lists all of the EB 
data. Generally, the C 1s chemical shifts were not significantly different for all milled and 
ground mixture, at any composition. The above observations are again summarised 
through plots shown in Figures 7-18 and 7-20. 
Table 7-13: Induced radiation EB for ground and milled paracetamol / poloxamer 
188 for three scans. 
 C-C-O C=C N-C=O C-C=O C-N C-OH C-C 
90% w/w poloxamer 188 
First Scan (milled) 286.5 284.7 288.2 285.3 285.9 286.3 285.0 
First Scan (ground) 286.5 284.7 287.9 285.3 285.9 286.3 285.0 
Second Scan (milled) 286.4 284.7 287.9 285.1 285.9 286.3 285.0 
Second Scan (ground) 286.5 284.7 287.9 285.3 285.9 286.3 285.0 
Third Scan (milled) 286.5 284.7 288.0 285.3 285.6 286.4 285.0 
Third Scan (ground) 286.5 284.7 287.9 285.3 285.9 286.3 285.0 
50% w/w poloxamer 188 
First Scan (milled) 286.5 284.7 287.9 285.3 285.7 286.3 285.0 
First Scan (ground) 286.5 284.7 287.7 285.1 285.4 286.3 285.0 
Second Scan (milled) 286.4 284.7 287.7 285.3 285.7 286.2 285.0 
Second Scan (ground) 286.4 284.7 287.7 285.1 285.5 286.2 285.0 
Third Scan (milled) 286.4 284.7 287.6 285.2 285.9 286.2 285.0 
Third Scan (ground) 286.4 284.7 287.7 285.4 285.9 286.2 285.0 
10% w/w poloxamer 188 
First Scan (milled) 286.6 284.7 288.0 285.4 285.9 286.3 285.0 
First Scan (ground) 286.5 284.7 287.7 285.4 285.9 286.3 285.0 
Second Scan (milled) 286.6 284.7 287.9 285.3 285.5 286.1 285.0 
Second Scan (ground) 286.5 284.7 287.7 285.3 285.5 286.3 285.0 
Third Scan (milled) 286.5 284.7 287.8 285.4 285.7 286.3 285.0 
Third Scan (ground) 286.5 284.7 287.7 285.3 285.9 286.3 285.0 
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Figure 7-18: O1s of milled (top) and ground (below) mixture of 90 % w/w 
poloxamer 188 for three successive scans 
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Figure 7-19: O1s of milled (top) and ground (below) mixture of 50 % w/w 
poloxamer 188 for three successive scans 
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Figure 7-20: O1s of milled (top) and ground (below) mixture of 90 % w/w 
poloxamer 188 for three successive scans 
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7.5. Discussion 
As stated in Chapter 2 poloxamer 188 is expected to interact strongly with 
paracetamol compared to poloxamer 338 and poloxamer 407. Poloxamer 188 is known to 
contain a high proportion of hydrophilic chains rather than hydrophobic ones. Mechanical 
force applied to the ethyl p-hydroxybenzoate and poloxamer 188 during the 
crystallisation changes the crystalline habit and adsorption of poloxamer 188. The results 
showed that during crystallisation, the hydrophilic part of poloxamer 188 grew, but the 
hydrophobic part exhibited crystallisation10, 11. Ther have been only a few previous 
studies of paracetamol and poloxamer 188 mixture by solid dispersion and melt 
extrusion, due to the gelling effect of poloxamer 188 at low temperature (30 to 37 C)32. 
The evaporation of solvent from the mixture is complicated by this gelling effect: solvent 
is trapped in the mixture, which remains a gel solution. 
The results of the ATR-IR analysis of mixture crystallinity indicate that the 
poloxamer 188 concentration did not affect the bulk properties of paracetamol. 
Furthermore, PXRD results also show that the crystallinity in the mixtures was not 
significantly different. The crystallinity properties of paracetamol and poloxamer 188 
mixtures are in agreement with reports that the composition of ibuprofen and poloxamer 
188 solid dispersion mixtures33 did not affect the crystallinity of the ibuprofen. Recently, 
it has been proposed that the hydrogen bonds of ibuprofen and poloxamer were at the 
head and tail of the poloxamer ends of OH  and H groups34. 
Generally, ground and milled mixture results show that at high poloxamer 188 
stoichiometry, the C 1s of C-C-O, which is characteristic of poloxamer 188, is increased, 
whereas at low poloxamer 188 concentrations, the C-C-O concentration is reduced. 
Conversely, structures characteristic of paracetamol, such as N-C=O, C=C and C-N and 
C-OH, are reduced as paracetamol concentration decreases. However, the  photoemission 
from the characteristic C 1s environment (C=-C, C-C=O, N-C=O) of paracetamol in the 
milled mixture were less relatively intense than in the ground mixture, while poloxamer 
188 characteristic groups (C-C-O and C-C) were more prominently evident on milled 
mixture surfaces. This indicates that the mechanical force associated with milling can be 
put to use for coating paracetamol by poloxamer 188 . Grinding appears to be much less 
efficient in dispersing poloxamer across the paracetamol surfaces. 
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The C 1s high resolution analysis is supported by the results of the O 1s analysis. 
It has been revealed at 10 % w/w milling mixture of poloxamer 188, N-C=O and C-OH; 
both paracetamol characteristic peaks, were lower in intensity in the milled than in the 
ground mixture. In addition, a chemical shift of the N-C=O group is observed for both C 
1s and O 1s results, especially after milling the mixtures. The N-C=O C 1s EB in the 
ground mixture at all compositions was between 287.7 and 287.9 eV. Milling increased it 
to approximately 288.0-288.2 eV. The significance different of 0.3 eV of milling relative 
to ground mixture; indicates a decrease of the N-C=O electron density due to the 
interaction of paracetamol and poloxamer 188. The absence of shake-up peaks and N 1s 
emission from the XPS spectra indicate a loss of aromaticity8. The low intensity of 
elemental N in the scan of 90% w/w poloxamer 188 indicated that the N signal was 
almost absent at the surface of the milled mixture. 
For the 10 % w/w poloxamer 188 mixtures, the lowest concentration of 
poloxamer molecules at the mixture surface was observed (Figure 7-14). The above 
results indicate that the surface of the mixture was rich with poloxamer 188 molecules, 
while the low emission intensity from the paracetamol-specific groups (C=C, N-C=O, C-
N and C-OH) supports the view that adsorption of poloxamer 188 onto the paracetamol 
structure takes place. It appears that only a small amount of poloxamer 188 is sufficient 
to coat the paracetamol molecules. 
High concentrations of excipients in drug formulations will slow down drug 
disintegration, dissolution and/or bioavailability35. XPS has previously been used to study 
polymer conformation31 from valence band data, but no significant valence band changes 
were detectable in the present case. The encapsulation of the drug surface by poloxamer 
is in agreement with previous results reported in the literature35, 36.  
The paracetamol-poloxamer mixtures, milled and ground, were investigated by 
scanning the surface with radiation. The results for the milled mixtures revealed that the 
C-C-O concentration increased with the amount of radiation of the surface. All 
paracetamol / poloxamer 188 compositions showed similar trends. At 50 % w/w and 90 
% w/w of poloxamer 188, the shoulder peak of C=C increase but C-C-O intensity were 
decrease with successive scans, as shown in Figure 7-19 and 7-20. However, at this 
stoichiometry, the C-N, N-C=O and C-OH values showed no significant difference 
among all the scans, indicating that no peroxide was formed by the decomposition of 
ether of Poloxamer 188. The increase of C-C-O over successive XPS scans indicates that 
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the radiation changed the poloxamer 188 chain conformation37, from compressed to loose 
(brush conformation), due to the electrostatic charge created by more C-C-O during the 
radiation process. Part of the polymer is expected to be adsorbed, contributing less to the 
XPS emission signals due to shielding by the free unadsorbed part. Such a morphology 
was apparent form the XPS results of the milled sample. The loose conformation thinned 
the layer of adsorbed poloxamer 188 and made space for exposing paracetamol, as 
suggested in Figure 7.21 . 
    
Figure 7-21: The electrostatic effect of XPS radiation on the C-C-O poloxamer 188 
chain 
A different phenomenon was evident for 10% w/w poloxamer 188. C 1s showed that 
the emission from C-C-O and C-C groups were high, but reduced concentrations of C=C, 
N-C=O, C-OH, C=O and C-N developed from first scan to second scan. The increased 
intensities stemmed from poloxamer 188, while the decreased ones came from 
paracetamol groups. No significant difference in chemical shift was observed for C 1s (C-
C-O). As mentioned earlier, 10% w/w poloxamer perceived the highest coating on the 
mixture surface. It is showed most of the poloxamer 188 on the mixture is on the surface. 
Radiation induced damage increases the poloxamer 188 coverage, probably resulted in 
additional exposure of both PEO and PPO chains at the surface and closer packing of 
surface anchors of the poloxamer molecules on both ground and milled mixture.  
7.6. Conclusion 
XPS supported by ATR-IR, DSC and PXRD indicated that 10 % w/w poloxamer 188 
mixtures in paracetamol, the poloxamer encapsulated paracetamol efficiently. For the 
milled mixture, weak signals were detected in respect of the main carbon environments of 
paracetamol, N-C=O and C-N/C-OH, but there was a high concentration of the main 
carbon environment of poloxamer 188.  
PEO PO
Paracetamol
hν
hν hν
PEO PO
Paracetamol
Chapter 7  Paracetamol and Poloxamer Blends 
223 
 
Radiation-induced degradation of poloxamer 188 resulted in an increase in 
poloxamer 188 concentration, as detected by XPS scanning mainly via the C-C-O carbon 
environment. At higher poloxamer 188 concentration (50% w/w and 90% w/w) during 
XPS radiation, increased electrostatic charge at the surface probably stimulates the 
detachment of poloxamer 188 as well as conformational changes so that emission from 
the underlying paracetamol surface becomes more evident. The exception is the case of 
the lowest poloxamer 188 admixture, where radiation increased the poloxamer coverage 
of the mixture surface. 
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8. CHAPTER 8: CONCLUSION AND FUTURE WORK 
8.1. Conclusions 
The surface sensitive technique XPS complemented by other characterisation techniques 
has been used to investigate a broad range of paracetamol forms, including powders, 
partially amorphous milled powders and a number of single crystal facets obtained from 
different crystallisation media. Because of the high specificity of XPS measurements 
towards the amide group of paracetamol it was possible to distinguish, for the first time, 
the influence of surface contamination and adsorbed species on the paracetamol surface 
from intrinsic contributions from the paracetamol sample itself. While performing these 
analyses it had to be kept in mind that the surface sensitivity of laboratory XPS 
measurements with an Al K source is not sufficient to detect structural or compositional 
changes in the topmost molecular layer of organic materials. Analysis of polycrystalline 
powder samples, including two different polymorphs and various partially amorphous 
forms of paracetamol, indicated that the core-level shifts associated with varying 
intermolecular interactions do not perturb the local electronic structure variations in 
paracetamol enough to become detectable through chemical shifts in the core level 
photoemission spectra. 
 XPS investigations of single crystals indicated that the composition of paracetamol 
single crystal facets prepared from three different solvents was, averaged over the near-
surface volume probed by XPS, identical within the accuracy of the measurements. Any 
variations in the observed spectra were compatible with the presence of adventitious of C 
and O contamination, or adsorbed surface active species that originated in the solvent 
media used for crystal preparations. Especially crystallisation from acetone appeared to 
be associated with the presence of significant contamination layers at the surfaces of the 
single crystal facets. Due to the ultra-high vacuum conditions applied during XPS 
measurements it was not possible to establish whether any co-adsorbed solvent molecules 
would influence the surface composition after preparation. 
 XPS data for three different aged and fresh poloxamer samples revealed that 
quantitative XPS analysis is sensitive to the PO/EO block stoichiometry of different 
poloxamers, through a a combination of survey and high resolution analysis. During 
aging, oxidative degradation leads to the formation of carbonyl functional groups. The 
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PO block only was actively degraded at the early stage of poloxamer degradation, while 
the EO block would later degrade more, especially in a poloxamer with high EO content. 
 Analysis of the milled and physical mixtures of Poloxamer188 and paracetamol 
revealed that poloxamers adsorb on the paracetamol surface, especially at a 10 % w/w 
composition of the poloxamer. Radiation damage during the XPS measurements induced 
significant degradation of Poloxamer188, detectable mainly via the C-C-O C1s 
environment. 
 
8.2. Future Work 
The aim of future work should be to deepen the understanding of surface interactions at 
paracetamol surfaces, to extend the application of core level spectroscopies to other 
molecular organic crystals and to consider other X-ray spectroscopies with sensitivity to 
local structure as techniques for organic solid state surface science. 
 More studies of paracetamol need to address issues whether the surface 
contamination can be reduced, or whether molecularly clean paracetamol surfaces be 
prepared, so that we can realistically hope to start investigating the surface properties 
(reconstructions, terminations) of molecular crystals. Particularly interesting, and a 
logical next step, would be synchrotron XPS studies of these systems to establish whether 
evidence for depth-dependent variations can be obtained by depth profiling with variable 
X-ray energies. 
 Before such work can be undertaken clean surfaces will have to be prepared. Given 
the prohibitive impurity levels in even the purest commercially available solvents and 
chemicals it seems unlikely that crystallisation from solution will ever produce 
sufficiently clean crystal facets to carry out such studies. One strategy could be to find 
techniques that permit cleaning of the facet surfaces in the vacuum chamber. Commonly 
used noble gas ion bombardment (‘sputtering’) techniques will not work for organic 
crystals because they induce too much radiation damage in these materials. Recently 
developed C60 or Au cluster ion sources may permit selective removal of the 
contamination layers observed in the present study, but their application will require 
systematic studies. 
 The alternative to cleaning, preparation of molecularly clean surfaces will require 
setting up a system for the controlled crystal growth under sufficiently clean conditions. 
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As a first step, evaporation under ultra-high vacuum conditions may be considered, but it 
may prove difficult to establish reliably the crystal structures of the evaporated samples. 
Spin coating of films on a suitable substrate may be another possibility. An advantage of 
these approaches would be that additional complications due to solvent inclusions could 
be avoided. 
 Many organic systems have sufficiently high vapour pressures that their 
investigation by XPS is complicated by the need to reduce their vapour pressure through 
constant cooling, which result in additional contamination by adsorption of molecules 
(especially water) from the residual gas in the vacuum chamber. Preparation protocols, 
e.g., cool-heat cycles, need to be established to deal with these adsorbed layers. By using 
high pressure XPS systems one may be able to side-step the vapour pressure issues, but 
high pressure XPS systems are expensive and mostly restricted to use at synchrotron 
radiation sources. 
 In contrast, soft X-ray absorption spectroscopy at high ( = non-UHV) pressures is a 
relatively inexpensive technique that also produces more detailed information about local 
structure and composition than XPS. One drawback is that this technique also requires 
the use of a synchrotron radiation X-ray source. 
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APPENDIX 
Appendix 1 
AceSingle C=C C-C=O C-N C-OH N-C=O Shake-up 
1 0.9 0.9 1.1 1.1 0.8 2.2 
2 0.9 0.9 1.0 1.0 0.9 2.5 
3 1.0 1.1 0.8 1.1 1.1 2.5 
EtSingle C=C C-C=O C-N C-OH N-C=O Shake-up 
1 0.9 0.8 1.0 1.0 0.9 1.8 
2 0.9 0.8 1.0 1.0 1.0 2.5 
3 0.8 0.8 1.0 1.0 0.8 1.8 
4 0.8 0.8 0.9 1.0 0.8 2.0 
5 0.8 0.8 1.0 1.0 0.8 2.0 
6 0.8 0.8 0.9 1.0 0.8 1.8 
7 0.8 0.8 1.1 1.1 0.9 2.0 
8 0.8 0.8 1.1 1.0 0.9 1.8 
9 0.8 0.8 1.0 1.0 0.9 2.1 
10 0.8 0.8 1.0 1.0 0.9 1.8 
11 0.8 0.8 1.0 1.0 0.9 2.1 
12 0.8 0.8 1.0 1.1 1.1 1.9 
13 0.8 0.8 1.1 1.1 0.9 2.0 
14 0.8 0.8 1.0 1.1 0.9 2.0 
15 0.8 0.8 1.0 1.0 0.8 1.8 
16 0.9 0.9 1.1 1.1 1.1 2.0 
17 0.8 0.8 1.0 1.1 1.0 1.9 
18 0.8 0.9 1.1 1.1 0.9 1.8 
19 0.8 0.8 1.1 1.1 0.8 1.8 
20 0.8 0.8 1.1 1.1 0.9 1.7 
21 0.8 0.8 1.0 1.1 0.9 2.0 
22 0.8 0.8 1.1 1.1 0.9 2.0 
23 0.8 0.8 1.0 1.1 0.8 1.9 
MeSingle1 C=C C-C=O C-N C-OH N-C=O Shake-up 
 0.9 0.9 0.9 1.1 0.9 2.1 
 0.9 0.8 0.9 1.0 0.8 1.9 
 0.9 0.8 0.8 0.9 0.8 1.9 
 0.9 0.8 0.8 0.9 0.9 2.3 
 1.1 0.8 0.8 1.1 1.1 2.5 
 0.9 0.8 0.9 0.9 0.9 2.5 
 0.9 0.8 1.0 1.0 0.9 1.9 
MeSingle2 C=C C-C=O C-N C-OH N-C=O Shake-up 
 0.9 0.9 1.1 1.0 0.9 2.0 
 0.9 0.9 1.0 1.0 0.9 2.0 
 0.9 0.9 0.9 1.0 0.9 2.0 
 0.9 0.9 1.1 1.1 0.9 2.1 
 0.9 0.9 1.1 1.1 0.9 2.3 
 0.9 0.9 1.0 0.9 0.9 2.5 
 1.1 1.1 0.8 1.1 1.0 2.3 
 1.0 1.0 0.8 1.0 0.9 2.1 
Powder C=C C-C=O C-N C-OH N-C=O Shake-up 
 0.9 0.9 1.1 0.9 0.8 2.2 
 
 
  Appendix 
231 
 
Appendix 2 
 
AceSingle C=C C-C=O C-N C-OH N-C=O Shake-up 
 284.7 285.3 285.7 286.1 288.1 291.0 
 284.7 285.4 285.7 286.3 288.1 290.9 
 284.7 285.2 285.9 286.3 288.1 291.0 
EtSingle C=C C-C=O C-N C-OH N-C=O Shake-up 
1 284.7 285.3 285.8 286.3 288.1 290.1 
2 284.7 285.1 285.8 286.4 288.1 290.6 
3 284.7 285.3 285.9 286.2 288.1 291.0 
4 284.7 285.3 285.8 286.3 288.1 291.0 
5 284.7 285.2 285.7 286.3 288.1 291.1 
6 284.7 285.3 285.9 286.3 288.1 290.9 
7 284.7 285.1 285.6 286.3 288.2 291.2 
8 284.7 285.2 285.6 286.3 288.2 291.2 
9 284.7 285.1 285.6 286.3 288.2 291.1 
10 284.7 285.1 285.7 286.3 288.2 291.2 
11 284.7 285.1 285.6 286.3 288.2 291.2 
12 284.7 285.2 285.7 286.4 288.3 291.3 
13 284.7 285.2 285.6 286.4 288.3 291.3 
14 284.7 285.0 285.6 286.3 288.3 291.2 
15 284.7 285.0 285.5 286.3 288.2 291.2 
16 284.7 285.1 285.6 286.3 288.3 291.3 
17 284.7 285.1 285.6 286.3 288.3 291.2 
18 284.7 285.0 285.5 286.3 288.2 291.2 
19 284.7 285.0 285.5 286.3 288.2 291.1 
20 284.7 285.1 285.6 286.3 288.3 291.2 
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21 284.7 285.0 285.5 286.3 288.2 291.3 
22 284.7 285.0 285.6 286.3 288.2 291.2 
23 284.7 285.2 285.8 286.3 288.1 291.0 
MeSingle1 C=C C-C=O C-N C-OH N-C=O Shake-up 
 284.7 285.1 285.7 286.3 288.1 291.1 
 284.7 285.3 285.8 286.2 288.1 290.91 
 284.7 285.3 285.8 286.3 288.0 290.91 
 284.7 285.3 285.8 286.3 288.1 291.0 
 284.7 285.3 285.8 286.4 288.1 291.0 
 284.7 285.3 285.9 286.4 288.1 290.9 
 284.7 285.3 285.7 286.2 288.1 291.1 
MeSingle2 C=C C-C=O C-N C-OH N-C=O Shake-up 
 284.7 285.3 285.8 286.2 288.1 291.0 
 284.7 285.3 285.8 286.2 288.1 291.1 
 284.7 285.4 285.8 286.2 288.0 291.0 
 284.7 285.4 285.8 286.3 288.1 291.0 
 284.7 285.4 285.8 286.3 288.1 291.0 
 284.7 285.4 285.8 286.2 288.1 290.8 
 284.7 285.2 285.8 286.3 288.0 291.0 
 284.7 285.0 285.8 286.2 288.0 290.6 
Powder C=C C-C=O C-N C-OH N-C=O Shake-up 
 284.7 285.4 285.7 286.2 288.1 291.1 
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Appendix 3 
 
 
 
MeSingle1 survey analysis at different spots  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Appendix 
234 
Appendix 4 
 
 
 
 
MeSingle1 C1s fitting at different spots analysis 
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Appendix 5
 
MeSingle1 O1s fitting at different spots analysis 
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Appendix 6 
 
MeSingle1 N1s fitting at different spots analysis 
 
  Appendix 
237 
Appendix 7 
 
 
MeSingle2 survey analysis at different spots  
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Appendix 8 
 
 
MeSingle2 C1s fitting at different spots analysis 
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Appendix 9 
 
 
 
MeSingle2 O1s fitting at different spots analysis 
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Appendix 10 
 
 
MeSingle2 N1s fitting at different spots analysis 
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Appendix 11 
 
 
EtSingle C1s fitting at different spots  (1-8) analysis 
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Appendix 12 
 
 
 
EtSingle C1s fitting at different spots  (9-16) analysis 
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Appendix 13 
 
 
 
EtSingle C1s fitting at different spots  (17-23) analysis 
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Appendix 14 
 
EtSingle O1s fitting at different spots  (1-8) analysis 
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Appendix 15 
 
 
 
 
EtSingle O1s fitting at different spots  (9-16) analysis 
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Appendix 16 
 
 
EtSingle O1s fitting at different spots  (17-23) analysis 
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Appendix 17 
 
 
 
EtSingle N1s fitting at different spots  (1-9) analysis 
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Appendix 18 
 
 
 
 
EtSingle N1s fitting at different spots  (9-16) analysis 
 
 
 
  Appendix 
249 
Appendix 19 
 
 
EtSingle N1s fitting at different spots  (17-23) analysis 
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Appendix 20 
 
Vapour diffusion crystallisation of ibuprofen 
 
     
(a)                                                                 (b) 
SEM results of ibuprofen crystallisation. (a) Ibuprofen crystal (b) ‘trapped’ 
impurities 
(No further analysis to Ibuprofen crystal due to the sublimation in XPS chamber and 
broken the XPS pump, major fixing of XPS instrument. No Ibuprofen analysis had been 
allowed by XPS officer.) 
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Appendix 21 
 
 
  
 
 
 
Physical Mixture 
Ibuprofen/PVP  (50% 
PVP w/w)  at 5 months. 
No further analysis can 
be done due to the 
very hard samples 
(sample was like a 
rock). Sample was 
stick at the bootom of 
container. No further 
analysis can be done. 
No Ibuprofen particles 
has been observed at 
this mass percent. 
(refer to Appendix 24 
for ibuprofen 
particles.) 
Physical Mixture 
Ibuprofen/PVP  (50% 
PVP w/w)  12 days. 
Rubbery samples stick 
at the bottom of 
containers. No further 
analysis can be done. 
Ibuprofen and PVP 
particles were 
agglomerate together. 
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Appendix 22 
 
 
 
 
 
 
Physical Mixture 
Ibuprofen/PVP  (25% PVP 
w/w)  at 5 months. Very 
hard samples, no further 
analysis can be done. No 
certain shape of particles 
(neither Ibuprofen nor 
PVP can be observed). 
Physical Mixture 
Ibuprofen/PVP  (25% PVP 
w/w)  at 12 days. Rubbery 
and hard samples, no 
further analysis can be 
done. 
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Appendix 23 
 
 
 
 
 
 
Physical Mixture 
Ibuprofen/PVP  (67.7% 
PVP w/w)  at 5 months. 
Samples was very hard 
like a rock.No further 
analysis can be done. 
Physical Mixture 
Ibuprofen/PVP  (67.7% 
PVP w/w)  at 12 days. 
Rubbery sample, stick 
at the bottom of 
container. No further 
analysis can be done. 
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Appendix 24 
 
 
 
 
 
 
 
Physical Mixture 
Ibuprofen/PVP  (25% PVP 
w/w)  at 12 days. Rubbery 
samples, stick at the 
bottom of the containers. 
No further analysis can 
be done. 
Physical Mixture 
Ibuprofen/PVP  (25% 
PVP w/w)  at 5 months. 
Very hard samples. No 
further analysis can be 
done. 
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Appendix 25 
 
 
 
 
 
 
Physical Mixture 
Ibuprofen/PVP  (75% PVP 
w/w)  at 5 months. 
Sample has been 
changed to very hard 
(like rock)  and no further 
analysis can be done. 
Physical Mixture 
Ibuprofen/PVP  (75% 
PVP w/w)  at 12 days. 
Very rubbery and 
samples cannot take 
out from the container. 
No further analysis can 
be done. 
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Appendix 26 
 
 
 
 
 
 
 
Ibuprofen. Scanning 
Electron Microscope 
micrograph of 
Ibuprofen powder. 
